id	sid	tid	token	lemma	pos
ejop-10097	1	1	a	a	DET
ejop-10097	1	2	network	network	NOUN
ejop-10097	1	3	perspective	perspective	NOUN
ejop-10097	1	4	on	on	ADP
ejop-10097	1	5	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	1	6	and	and	CCONJ
ejop-10097	1	7	cognitive	cognitive	ADJ
ejop-10097	1	8	symptoms	symptom	NOUN
ejop-10097	1	9	of	of	ADP
ejop-10097	1	10	the	the	DET
ejop-10097	1	11	post	post	ADJ
ejop-10097	1	12	-	-	ADJ
ejop-10097	1	13	covid	covid	ADJ
ejop-10097	1	14	syndrome	syndrome	PROPN
ejop-10097	1	15	editorial	editorial	NOUN
ejop-10097	1	16	a	a	DET
ejop-10097	1	17	network	network	NOUN
ejop-10097	1	18	perspective	perspective	NOUN
ejop-10097	1	19	on	on	ADP
ejop-10097	1	20	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	1	21	and	and	CCONJ
ejop-10097	1	22	cognitive	cognitive	ADJ
ejop-10097	1	23	symptoms	symptom	NOUN
ejop-10097	1	24	of	of	ADP
ejop-10097	1	25	the	the	DET
ejop-10097	1	26	post	post	ADJ
ejop-10097	1	27	-	-	ADJ
ejop-10097	1	28	covid	covid	ADJ
ejop-10097	1	29	syndrome	syndrome	PROPN
ejop-10097	1	30	daniel	daniel	PROPN
ejop-10097	1	31	scharfenberg	scharfenberg	PROPN
ejop-10097	1	32	1	1	NUM
ejop-10097	1	33	,	,	PUNCT
ejop-10097	1	34	ann	ann	PROPN
ejop-10097	1	35	-	-	PUNCT
ejop-10097	1	36	katrin	katrin	PROPN
ejop-10097	1	37	schild	schild	PROPN
ejop-10097	1	38	2	2	NUM
ejop-10097	1	39	,	,	PUNCT
ejop-10097	1	40	clemens	clemen	NOUN
ejop-10097	1	41	warnke	warnke	ADJ
ejop-10097	1	42	3	3	NUM
ejop-10097	1	43	,	,	PUNCT
ejop-10097	1	44	franziska	franziska	PROPN
ejop-10097	1	45	maier	maier	X
ejop-10097	1	46	2	2	NUM
ejop-10097	2	1	[	[	X
ejop-10097	2	2	1	1	NUM
ejop-10097	2	3	]	]	PUNCT
ejop-10097	2	4	 	 	SPACE
ejop-10097	2	5	medical	medical	ADJ
ejop-10097	2	6	psychology	psychology	NOUN
ejop-10097	2	7	|	|	ADP
ejop-10097	2	8	neuropsychology	neuropsychology	PROPN
ejop-10097	2	9	&	&	CCONJ
ejop-10097	2	10	gender	gender	PROPN
ejop-10097	2	11	studies	study	NOUN
ejop-10097	2	12	,	,	PUNCT
ejop-10097	2	13	center	center	NOUN
ejop-10097	2	14	for	for	ADP
ejop-10097	2	15	neuropsychological	neuropsychological	ADJ
ejop-10097	2	16	diagnostic	diagnostic	ADJ
ejop-10097	2	17	and	and	CCONJ
ejop-10097	2	18	intervention	intervention	NOUN
ejop-10097	2	19	(	(	PUNCT
ejop-10097	2	20	cendi	cendi	PROPN
ejop-10097	2	21	)	)	PUNCT
ejop-10097	2	22	,	,	PUNCT
ejop-10097	2	23	faculty	faculty	NOUN
ejop-10097	2	24	of	of	ADP
ejop-10097	2	25	medicine	medicine	NOUN
ejop-10097	2	26	and	and	CCONJ
ejop-10097	2	27	university	university	NOUN
ejop-10097	2	28	hospital	hospital	NOUN
ejop-10097	2	29	cologne	cologne	NOUN
ejop-10097	2	30	,	,	PUNCT
ejop-10097	2	31	university	university	NOUN
ejop-10097	2	32	of	of	ADP
ejop-10097	2	33	cologne	cologne	NOUN
ejop-10097	2	34	,	,	PUNCT
ejop-10097	2	35	cologne	cologne	NOUN
ejop-10097	2	36	,	,	PUNCT
ejop-10097	2	37	germany	germany	PROPN
ejop-10097	2	38	.	.	PUNCT
ejop-10097	3	1	[	[	X
ejop-10097	3	2	2	2	NUM
ejop-10097	3	3	]	]	PUNCT
ejop-10097	3	4	 	 	SPACE
ejop-10097	3	5	department	department	NOUN
ejop-10097	3	6	of	of	ADP
ejop-10097	3	7	psychiatry	psychiatry	NOUN
ejop-10097	3	8	,	,	PUNCT
ejop-10097	3	9	faculty	faculty	NOUN
ejop-10097	3	10	of	of	ADP
ejop-10097	3	11	medicine	medicine	NOUN
ejop-10097	3	12	and	and	CCONJ
ejop-10097	3	13	university	university	NOUN
ejop-10097	3	14	hospital	hospital	NOUN
ejop-10097	3	15	cologne	cologne	NOUN
ejop-10097	3	16	,	,	PUNCT
ejop-10097	3	17	university	university	NOUN
ejop-10097	3	18	of	of	ADP
ejop-10097	3	19	cologne	cologne	NOUN
ejop-10097	3	20	,	,	PUNCT
ejop-10097	3	21	cologne	cologne	NOUN
ejop-10097	3	22	,	,	PUNCT
ejop-10097	3	23	germany	germany	PROPN
ejop-10097	3	24	.	.	PUNCT
ejop-10097	4	1	[	[	X
ejop-10097	4	2	3	3	NUM
ejop-10097	4	3	]	]	SYM
ejop-10097	4	4	 	 	SPACE
ejop-10097	4	5	department	department	PROPN
ejop-10097	4	6	of	of	ADP
ejop-10097	4	7	neurology	neurology	NOUN
ejop-10097	4	8	,	,	PUNCT
ejop-10097	4	9	faculty	faculty	NOUN
ejop-10097	4	10	of	of	ADP
ejop-10097	4	11	medicine	medicine	NOUN
ejop-10097	4	12	and	and	CCONJ
ejop-10097	4	13	university	university	NOUN
ejop-10097	4	14	hospital	hospital	NOUN
ejop-10097	4	15	cologne	cologne	NOUN
ejop-10097	4	16	,	,	PUNCT
ejop-10097	4	17	university	university	NOUN
ejop-10097	4	18	of	of	ADP
ejop-10097	4	19	cologne	cologne	NOUN
ejop-10097	4	20	,	,	PUNCT
ejop-10097	4	21	cologne	cologne	NOUN
ejop-10097	4	22	,	,	PUNCT
ejop-10097	4	23	germany	germany	PROPN
ejop-10097	4	24	.	.	PUNCT
ejop-10097	5	1	europe	europe	PROPN
ejop-10097	5	2	's	's	PART
ejop-10097	5	3	journal	journal	PROPN
ejop-10097	5	4	of	of	ADP
ejop-10097	5	5	psychology	psychology	NOUN
ejop-10097	5	6	,	,	PUNCT
ejop-10097	5	7	2022	2022	NUM
ejop-10097	5	8	,	,	PUNCT
ejop-10097	5	9	vol	vol	NOUN
ejop-10097	5	10	.	.	PUNCT
ejop-10097	5	11	18(4	18(4	NUM
ejop-10097	5	12	)	)	PUNCT
ejop-10097	5	13	,	,	PUNCT
ejop-10097	5	14	350–356	350–356	NUM
ejop-10097	5	15	,	,	PUNCT
ejop-10097	5	16	https://doi.org/10.5964/ejop.10097	https://doi.org/10.5964/ejop.10097	NOUN
ejop-10097	5	17	received	receive	VERB
ejop-10097	5	18	:	:	PUNCT
ejop-10097	5	19	2022	2022	NUM
ejop-10097	5	20	-	-	SYM
ejop-10097	5	21	08	08	NUM
ejop-10097	5	22	-	-	SYM
ejop-10097	5	23	19	19	NUM
ejop-10097	5	24	•	•	NUM
ejop-10097	5	25	 	 	SPACE
ejop-10097	5	26	accepted	accept	VERB
ejop-10097	5	27	:	:	PUNCT
ejop-10097	5	28	2022	2022	NUM
ejop-10097	5	29	-	-	SYM
ejop-10097	5	30	09	09	NUM
ejop-10097	5	31	-	-	SYM
ejop-10097	5	32	25	25	NUM
ejop-10097	5	33	•	•	NUM
ejop-10097	5	34	 	 	SPACE
ejop-10097	5	35	published	publish	VERB
ejop-10097	5	36	(	(	PUNCT
ejop-10097	5	37	vor	vor	NOUN
ejop-10097	5	38	):	):	PUNCT
ejop-10097	5	39	2022	2022	NUM
ejop-10097	5	40	-	-	SYM
ejop-10097	5	41	11	11	NUM
ejop-10097	5	42	-	-	SYM
ejop-10097	5	43	30	30	NUM
ejop-10097	5	44	handling	handling	NOUN
ejop-10097	5	45	editor	editor	NOUN
ejop-10097	5	46	:	:	PUNCT
ejop-10097	5	47	vlad	vlad	VERB
ejop-10097	5	48	glăveanu	glăveanu	PROPN
ejop-10097	5	49	,	,	PUNCT
ejop-10097	5	50	dublin	dublin	PROPN
ejop-10097	5	51	city	city	PROPN
ejop-10097	5	52	university	university	PROPN
ejop-10097	5	53	,	,	PUNCT
ejop-10097	5	54	dublin	dublin	PROPN
ejop-10097	5	55	,	,	PUNCT
ejop-10097	5	56	ireland	ireland	PROPN
ejop-10097	5	57	corresponding	corresponding	ADJ
ejop-10097	5	58	author	author	NOUN
ejop-10097	5	59	:	:	PUNCT
ejop-10097	5	60	daniel	daniel	PROPN
ejop-10097	5	61	scharfenberg	scharfenberg	PROPN
ejop-10097	5	62	,	,	PUNCT
ejop-10097	5	63	department	department	PROPN
ejop-10097	5	64	of	of	ADP
ejop-10097	5	65	medical	medical	ADJ
ejop-10097	5	66	psychology	psychology	NOUN
ejop-10097	5	67	|	|	ADP
ejop-10097	5	68	neuropsychology	neuropsychology	PROPN
ejop-10097	5	69	&	&	CCONJ
ejop-10097	5	70	gender	gender	PROPN
ejop-10097	5	71	studies	study	NOUN
ejop-10097	5	72	,	,	PUNCT
ejop-10097	5	73	university	university	NOUN
ejop-10097	5	74	hospital	hospital	NOUN
ejop-10097	5	75	cologne	cologne	NOUN
ejop-10097	5	76	,	,	PUNCT
ejop-10097	5	77	kerpener	kerpener	NOUN
ejop-10097	5	78	str	str	PROPN
ejop-10097	5	79	.	.	PUNCT
ejop-10097	6	1	62	62	NUM
ejop-10097	6	2	,	,	PUNCT
ejop-10097	6	3	50937	50937	NUM
ejop-10097	6	4	cologne	cologne	NOUN
ejop-10097	6	5	,	,	PUNCT
ejop-10097	6	6	germany	germany	PROPN
ejop-10097	6	7	.	.	PUNCT
ejop-10097	7	1	e	e	X
ejop-10097	7	2	-	-	NOUN
ejop-10097	7	3	mail	mail	NOUN
ejop-10097	7	4	:	:	PUNCT
ejop-10097	7	5	daniel.scharfenberg@uk-koeln.de	daniel.scharfenberg@uk-koeln.de	PUNCT
ejop-10097	7	6	abstract	abstract	ADJ
ejop-10097	7	7	many	many	ADJ
ejop-10097	7	8	patients	patient	NOUN
ejop-10097	7	9	that	that	PRON
ejop-10097	7	10	were	be	AUX
ejop-10097	7	11	infected	infect	VERB
ejop-10097	7	12	with	with	ADP
ejop-10097	7	13	sars	sar	NOUN
ejop-10097	7	14	-	-	PUNCT
ejop-10097	7	15	cov-2	cov-2	PART
ejop-10097	7	16	experience	experience	NOUN
ejop-10097	7	17	cognitive	cognitive	ADJ
ejop-10097	7	18	and	and	CCONJ
ejop-10097	7	19	affective	affective	ADJ
ejop-10097	7	20	symptoms	symptom	NOUN
ejop-10097	7	21	weeks	week	NOUN
ejop-10097	7	22	and	and	CCONJ
ejop-10097	7	23	months	month	NOUN
ejop-10097	7	24	after	after	ADP
ejop-10097	7	25	their	their	PRON
ejop-10097	7	26	acute	acute	ADJ
ejop-10097	7	27	covid-19	covid-19	PROPN
ejop-10097	7	28	disease	disease	NOUN
ejop-10097	7	29	,	,	PUNCT
ejop-10097	7	30	even	even	ADV
ejop-10097	7	31	when	when	SCONJ
ejop-10097	7	32	acute	acute	ADJ
ejop-10097	7	33	symptoms	symptom	NOUN
ejop-10097	7	34	were	be	AUX
ejop-10097	7	35	mild	mild	ADJ
ejop-10097	7	36	to	to	PART
ejop-10097	7	37	moderate	moderate	VERB
ejop-10097	7	38	.	.	PUNCT
ejop-10097	8	1	for	for	ADP
ejop-10097	8	2	these	these	DET
ejop-10097	8	3	patients	patient	NOUN
ejop-10097	8	4	,	,	PUNCT
ejop-10097	8	5	purely	purely	ADV
ejop-10097	8	6	neurological	neurological	ADJ
ejop-10097	8	7	explanations	explanation	NOUN
ejop-10097	8	8	are	be	AUX
ejop-10097	8	9	struggling	struggle	VERB
ejop-10097	8	10	to	to	PART
ejop-10097	8	11	explain	explain	VERB
ejop-10097	8	12	the	the	DET
ejop-10097	8	13	development	development	NOUN
ejop-10097	8	14	and	and	CCONJ
ejop-10097	8	15	maintenance	maintenance	NOUN
ejop-10097	8	16	of	of	ADP
ejop-10097	8	17	the	the	DET
ejop-10097	8	18	great	great	ADJ
ejop-10097	8	19	variety	variety	NOUN
ejop-10097	8	20	of	of	ADP
ejop-10097	8	21	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	8	22	and	and	CCONJ
ejop-10097	8	23	cognitive	cognitive	ADJ
ejop-10097	8	24	symptoms	symptom	NOUN
ejop-10097	8	25	occurring	occur	VERB
ejop-10097	8	26	after	after	ADP
ejop-10097	8	27	covid-19	covid-19	PROPN
ejop-10097	8	28	.	.	PUNCT
ejop-10097	9	1	we	we	PRON
ejop-10097	9	2	provide	provide	VERB
ejop-10097	9	3	a	a	DET
ejop-10097	9	4	psychological	psychological	ADJ
ejop-10097	9	5	perspective	perspective	NOUN
ejop-10097	9	6	based	base	VERB
ejop-10097	9	7	on	on	ADP
ejop-10097	9	8	the	the	DET
ejop-10097	9	9	network	network	NOUN
ejop-10097	9	10	theory	theory	NOUN
ejop-10097	9	11	of	of	ADP
ejop-10097	9	12	mental	mental	ADJ
ejop-10097	9	13	disorders	disorder	NOUN
ejop-10097	9	14	as	as	ADP
ejop-10097	9	15	an	an	DET
ejop-10097	9	16	added	add	VERB
ejop-10097	9	17	explanation	explanation	NOUN
ejop-10097	9	18	that	that	PRON
ejop-10097	9	19	does	do	AUX
ejop-10097	9	20	not	not	PART
ejop-10097	9	21	displace	displace	VERB
ejop-10097	9	22	neurological	neurological	ADJ
ejop-10097	9	23	mechanism	mechanism	NOUN
ejop-10097	9	24	but	but	CCONJ
ejop-10097	9	25	rather	rather	ADV
ejop-10097	9	26	complements	complement	VERB
ejop-10097	9	27	them	they	PRON
ejop-10097	9	28	.	.	PUNCT
ejop-10097	10	1	we	we	PRON
ejop-10097	10	2	suggest	suggest	AUX
ejop-10097	10	3	viewing	view	VERB
ejop-10097	10	4	the	the	DET
ejop-10097	10	5	sars	sar	NOUN
ejop-10097	10	6	-	-	PUNCT
ejop-10097	10	7	cov-2	cov-2	NOUN
ejop-10097	10	8	infection	infection	NOUN
ejop-10097	10	9	as	as	ADP
ejop-10097	10	10	a	a	DET
ejop-10097	10	11	trigger	trigger	NOUN
ejop-10097	10	12	that	that	PRON
ejop-10097	10	13	first	first	ADV
ejop-10097	10	14	activates	activate	VERB
ejop-10097	10	15	nodes	node	NOUN
ejop-10097	10	16	in	in	ADP
ejop-10097	10	17	a	a	DET
ejop-10097	10	18	causally	causally	ADV
ejop-10097	10	19	connected	connected	ADJ
ejop-10097	10	20	network	network	NOUN
ejop-10097	10	21	of	of	ADP
ejop-10097	10	22	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	10	23	and	and	CCONJ
ejop-10097	10	24	cognitive	cognitive	ADJ
ejop-10097	10	25	symptoms	symptom	NOUN
ejop-10097	10	26	.	.	PUNCT
ejop-10097	11	1	in	in	ADP
ejop-10097	11	2	the	the	DET
ejop-10097	11	3	following	following	NOUN
ejop-10097	11	4	,	,	PUNCT
ejop-10097	11	5	activation	activation	NOUN
ejop-10097	11	6	will	will	AUX
ejop-10097	11	7	spread	spread	VERB
ejop-10097	11	8	throughout	throughout	ADP
ejop-10097	11	9	the	the	DET
ejop-10097	11	10	network	network	NOUN
ejop-10097	11	11	that	that	PRON
ejop-10097	11	12	will	will	AUX
ejop-10097	11	13	get	get	VERB
ejop-10097	11	14	in	in	ADP
ejop-10097	11	15	a	a	DET
ejop-10097	11	16	self	self	NOUN
ejop-10097	11	17	-	-	PUNCT
ejop-10097	11	18	sustaining	sustain	VERB
ejop-10097	11	19	stable	stable	ADJ
ejop-10097	11	20	and	and	CCONJ
ejop-10097	11	21	dysfunctional	dysfunctional	ADJ
ejop-10097	11	22	state	state	NOUN
ejop-10097	11	23	manifesting	manifest	VERB
ejop-10097	11	24	in	in	ADP
ejop-10097	11	25	ongoing	ongoing	ADJ
ejop-10097	11	26	symptoms	symptom	NOUN
ejop-10097	11	27	known	know	VERB
ejop-10097	11	28	as	as	ADP
ejop-10097	11	29	post	post	ADJ
ejop-10097	11	30	-	-	ADJ
ejop-10097	11	31	covid-19	covid-19	ADJ
ejop-10097	11	32	syndrome	syndrome	NOUN
ejop-10097	11	33	.	.	PUNCT
ejop-10097	12	1	the	the	DET
ejop-10097	12	2	network	network	NOUN
ejop-10097	12	3	perspective	perspective	NOUN
ejop-10097	12	4	allows	allow	VERB
ejop-10097	12	5	to	to	PART
ejop-10097	12	6	generalize	generalize	VERB
ejop-10097	12	7	explanations	explanation	NOUN
ejop-10097	12	8	for	for	ADP
ejop-10097	12	9	persistent	persistent	ADJ
ejop-10097	12	10	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	12	11	and	and	CCONJ
ejop-10097	12	12	cognitive	cognitive	ADJ
ejop-10097	12	13	symptoms	symptom	NOUN
ejop-10097	12	14	to	to	ADP
ejop-10097	12	15	patients	patient	NOUN
ejop-10097	12	16	that	that	PRON
ejop-10097	12	17	experienced	experience	VERB
ejop-10097	12	18	mild	mild	ADJ
ejop-10097	12	19	or	or	CCONJ
ejop-10097	12	20	moderate	moderate	ADJ
ejop-10097	12	21	acute	acute	ADJ
ejop-10097	12	22	courses	course	NOUN
ejop-10097	12	23	of	of	ADP
ejop-10097	12	24	covid-19	covid-19	PROPN
ejop-10097	12	25	,	,	PUNCT
ejop-10097	12	26	but	but	CCONJ
ejop-10097	12	27	also	also	ADV
ejop-10097	12	28	to	to	ADP
ejop-10097	12	29	similar	similar	ADJ
ejop-10097	12	30	phenomena	phenomenon	NOUN
ejop-10097	12	31	following	follow	VERB
ejop-10097	12	32	other	other	ADJ
ejop-10097	12	33	viral	viral	ADJ
ejop-10097	12	34	infections	infection	NOUN
ejop-10097	12	35	.	.	PUNCT
ejop-10097	13	1	in	in	ADP
ejop-10097	13	2	addition	addition	NOUN
ejop-10097	13	3	,	,	PUNCT
ejop-10097	13	4	it	it	PRON
ejop-10097	13	5	could	could	AUX
ejop-10097	13	6	explain	explain	VERB
ejop-10097	13	7	why	why	SCONJ
ejop-10097	13	8	some	some	DET
ejop-10097	13	9	symptoms	symptom	NOUN
ejop-10097	13	10	did	do	AUX
ejop-10097	13	11	not	not	PART
ejop-10097	13	12	occur	occur	VERB
ejop-10097	13	13	during	during	ADP
ejop-10097	13	14	acute	acute	NOUN
ejop-10097	13	15	covid-19	covid-19	PROPN
ejop-10097	13	16	,	,	PUNCT
ejop-10097	13	17	but	but	CCONJ
ejop-10097	13	18	develop	develop	VERB
ejop-10097	13	19	weeks	week	NOUN
ejop-10097	13	20	or	or	CCONJ
ejop-10097	13	21	months	month	NOUN
ejop-10097	13	22	after	after	ADP
ejop-10097	13	23	it	it	PRON
ejop-10097	13	24	.	.	PUNCT
ejop-10097	14	1	this	this	DET
ejop-10097	14	2	network	network	NOUN
ejop-10097	14	3	perspective	perspective	NOUN
ejop-10097	14	4	shifts	shift	NOUN
ejop-10097	14	5	the	the	DET
ejop-10097	14	6	focus	focus	NOUN
ejop-10097	14	7	from	from	ADP
ejop-10097	14	8	viewing	view	VERB
ejop-10097	14	9	persistent	persistent	ADJ
ejop-10097	14	10	symptoms	symptom	NOUN
ejop-10097	14	11	as	as	ADP
ejop-10097	14	12	a	a	DET
ejop-10097	14	13	continuation	continuation	NOUN
ejop-10097	14	14	of	of	ADP
ejop-10097	14	15	covid-19	covid-19	PROPN
ejop-10097	14	16	to	to	ADP
ejop-10097	14	17	acknowledging	acknowledge	VERB
ejop-10097	14	18	it	it	PRON
ejop-10097	14	19	as	as	ADP
ejop-10097	14	20	a	a	DET
ejop-10097	14	21	complex	complex	ADJ
ejop-10097	14	22	syndrome	syndrome	NOUN
ejop-10097	14	23	that	that	PRON
ejop-10097	14	24	indeed	indeed	ADV
ejop-10097	14	25	originates	originate	VERB
ejop-10097	14	26	from	from	ADP
ejop-10097	14	27	the	the	DET
ejop-10097	14	28	disease	disease	NOUN
ejop-10097	14	29	but	but	CCONJ
ejop-10097	14	30	fully	fully	ADV
ejop-10097	14	31	unfolds	unfold	VERB
ejop-10097	14	32	after	after	ADP
ejop-10097	14	33	it	it	PRON
ejop-10097	14	34	(	(	PUNCT
ejop-10097	14	35	post	post	NOUN
ejop-10097	14	36	-	-	NOUN
ejop-10097	14	37	covid	covid	ADJ
ejop-10097	14	38	)	)	PUNCT
ejop-10097	14	39	.	.	PUNCT
ejop-10097	15	1	to	to	PART
ejop-10097	15	2	test	test	VERB
ejop-10097	15	3	the	the	DET
ejop-10097	15	4	presented	present	VERB
ejop-10097	15	5	network	network	NOUN
ejop-10097	15	6	perspective	perspective	NOUN
ejop-10097	15	7	,	,	PUNCT
ejop-10097	15	8	we	we	PRON
ejop-10097	15	9	will	will	AUX
ejop-10097	15	10	need	need	VERB
ejop-10097	15	11	extensive	extensive	ADJ
ejop-10097	15	12	cross	cross	ADJ
ejop-10097	15	13	-	-	ADJ
ejop-10097	15	14	sectional	sectional	ADJ
ejop-10097	15	15	as	as	ADV
ejop-10097	15	16	well	well	ADV
ejop-10097	15	17	as	as	ADP
ejop-10097	15	18	longitudinal	longitudinal	ADJ
ejop-10097	15	19	data	datum	NOUN
ejop-10097	15	20	on	on	ADP
ejop-10097	15	21	cognitive	cognitive	ADJ
ejop-10097	15	22	and	and	CCONJ
ejop-10097	15	23	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	15	24	symptoms	symptom	NOUN
ejop-10097	15	25	in	in	ADP
ejop-10097	15	26	post	post	ADJ
ejop-10097	15	27	-	-	ADJ
ejop-10097	15	28	covid	covid	ADJ
ejop-10097	15	29	patients	patient	NOUN
ejop-10097	15	30	.	.	PUNCT
ejop-10097	16	1	keywords	keyword	NOUN
ejop-10097	16	2	long	long	ADJ
ejop-10097	16	3	covid	covid	PROPN
ejop-10097	16	4	,	,	PUNCT
ejop-10097	16	5	network	network	NOUN
ejop-10097	16	6	model	model	NOUN
ejop-10097	16	7	,	,	PUNCT
ejop-10097	16	8	brain	brain	NOUN
ejop-10097	16	9	fog	fog	PROPN
ejop-10097	16	10	,	,	PUNCT
ejop-10097	16	11	cognitive	cognitive	ADJ
ejop-10097	16	12	deficits	deficit	NOUN
ejop-10097	16	13	,	,	PUNCT
ejop-10097	16	14	sars	sar	NOUN
ejop-10097	16	15	-	-	PUNCT
ejop-10097	16	16	cov-2	cov-2	NOUN
ejop-10097	16	17	,	,	PUNCT
ejop-10097	16	18	fatigue	fatigue	NOUN
ejop-10097	16	19	,	,	PUNCT
ejop-10097	16	20	post	post	ADJ
ejop-10097	16	21	-	-	ADJ
ejop-10097	16	22	vac	vac	ADJ
ejop-10097	16	23	syndrome	syndrome	NOUN
ejop-10097	16	24	many	many	ADJ
ejop-10097	16	25	individuals	individual	NOUN
ejop-10097	16	26	who	who	PRON
ejop-10097	16	27	were	be	AUX
ejop-10097	16	28	infected	infect	VERB
ejop-10097	16	29	with	with	ADP
ejop-10097	16	30	sars	sar	NOUN
ejop-10097	16	31	-	-	PUNCT
ejop-10097	16	32	cov-2	cov-2	NOUN
ejop-10097	16	33	experience	experience	NOUN
ejop-10097	16	34	symptoms	symptom	NOUN
ejop-10097	16	35	of	of	ADP
ejop-10097	16	36	illness	illness	NOUN
ejop-10097	16	37	even	even	ADV
ejop-10097	16	38	weeks	week	NOUN
ejop-10097	16	39	and	and	CCONJ
ejop-10097	16	40	months	month	NOUN
ejop-10097	16	41	after	after	ADP
ejop-10097	16	42	their	their	PRON
ejop-10097	16	43	acute	acute	ADJ
ejop-10097	16	44	covid-19	covid-19	PROPN
ejop-10097	16	45	disease	disease	NOUN
ejop-10097	16	46	.	.	PUNCT
ejop-10097	17	1	this	this	DET
ejop-10097	17	2	phenomenon	phenomenon	NOUN
ejop-10097	17	3	has	have	AUX
ejop-10097	17	4	been	be	AUX
ejop-10097	17	5	referred	refer	VERB
ejop-10097	17	6	to	to	ADP
ejop-10097	17	7	as	as	ADP
ejop-10097	17	8	ongoing	ongoing	ADJ
ejop-10097	17	9	symptomatic	symptomatic	ADJ
ejop-10097	17	10	covid-19	covid-19	PROPN
ejop-10097	17	11	,	,	PUNCT
ejop-10097	17	12	post	post	ADJ
ejop-10097	17	13	-	-	ADJ
ejop-10097	17	14	acute	acute	ADJ
ejop-10097	17	15	covid-19	covid-19	PROPN
ejop-10097	17	16	,	,	PUNCT
ejop-10097	17	17	long	long	ADJ
ejop-10097	17	18	-	-	PUNCT
ejop-10097	17	19	covid	covid	NOUN
ejop-10097	17	20	syndrome	syndrome	NOUN
ejop-10097	17	21	or	or	CCONJ
ejop-10097	17	22	post	post	ADJ
ejop-10097	17	23	-	-	ADJ
ejop-10097	17	24	covid	covid	ADJ
ejop-10097	17	25	syndrome	syndrome	NOUN
ejop-10097	17	26	,	,	PUNCT
ejop-10097	17	27	with	with	ADP
ejop-10097	17	28	varying	vary	VERB
ejop-10097	17	29	definitions	definition	NOUN
ejop-10097	17	30	of	of	ADP
ejop-10097	17	31	the	the	DET
ejop-10097	17	32	latter	latter	ADJ
ejop-10097	17	33	terms	term	NOUN
ejop-10097	17	34	in	in	ADP
ejop-10097	17	35	the	the	DET
ejop-10097	17	36	current	current	ADJ
ejop-10097	17	37	literature	literature	NOUN
ejop-10097	17	38	.	.	PUNCT
ejop-10097	18	1	the	the	DET
ejop-10097	18	2	nice	nice	ADJ
ejop-10097	18	3	guideline	guideline	NOUN
ejop-10097	18	4	suggests	suggest	VERB
ejop-10097	18	5	using	use	VERB
ejop-10097	18	6	the	the	DET
ejop-10097	18	7	term	term	NOUN
ejop-10097	18	8	“	"	PUNCT
ejop-10097	18	9	post	post	ADJ
ejop-10097	18	10	-	-	ADJ
ejop-10097	18	11	covid-19	covid-19	ADJ
ejop-10097	18	12	syndrome	syndrome	NOUN
ejop-10097	18	13	”	"	PUNCT
ejop-10097	18	14	for	for	ADP
ejop-10097	18	15	“	"	PUNCT
ejop-10097	18	16	signs	sign	NOUN
ejop-10097	18	17	and	and	CCONJ
ejop-10097	18	18	symptoms	symptom	NOUN
ejop-10097	18	19	that	that	PRON
ejop-10097	18	20	develop	develop	VERB
ejop-10097	18	21	during	during	ADP
ejop-10097	18	22	or	or	CCONJ
ejop-10097	18	23	after	after	ADP
ejop-10097	18	24	an	an	DET
ejop-10097	18	25	infection	infection	NOUN
ejop-10097	18	26	consistent	consistent	ADJ
ejop-10097	18	27	with	with	ADP
ejop-10097	18	28	covid-19	covid-19	PROPN
ejop-10097	18	29	”	"	PUNCT
ejop-10097	18	30	and	and	CCONJ
ejop-10097	18	31	are	be	AUX
ejop-10097	18	32	“	"	PUNCT
ejop-10097	18	33	present	present	ADJ
ejop-10097	18	34	for	for	ADP
ejop-10097	18	35	more	more	ADJ
ejop-10097	18	36	than	than	ADP
ejop-10097	18	37	12	12	NUM
ejop-10097	18	38	weeks	week	NOUN
ejop-10097	18	39	and	and	CCONJ
ejop-10097	18	40	are	be	AUX
ejop-10097	18	41	not	not	PART
ejop-10097	18	42	attributable	attributable	ADJ
ejop-10097	18	43	to	to	ADP
ejop-10097	18	44	alternative	alternative	ADJ
ejop-10097	18	45	diagnoses	diagnosis	NOUN
ejop-10097	18	46	”	"	PUNCT
ejop-10097	18	47	(	(	PUNCT
ejop-10097	18	48	national	national	PROPN
ejop-10097	18	49	institute	institute	NOUN
ejop-10097	18	50	for	for	ADP
ejop-10097	18	51	health	health	NOUN
ejop-10097	18	52	and	and	CCONJ
ejop-10097	18	53	care	care	PROPN
ejop-10097	18	54	excellence	excellence	PROPN
ejop-10097	18	55	,	,	PUNCT
ejop-10097	18	56	2020	2020	NUM
ejop-10097	18	57	)	)	PUNCT
ejop-10097	18	58	.	.	PUNCT
ejop-10097	19	1	the	the	DET
ejop-10097	19	2	post	post	ADJ
ejop-10097	19	3	-	-	ADJ
ejop-10097	19	4	covid	covid	ADJ
ejop-10097	19	5	syndrome	syndrome	NOUN
ejop-10097	19	6	does	do	AUX
ejop-10097	19	7	not	not	PART
ejop-10097	19	8	only	only	ADV
ejop-10097	19	9	affect	affect	VERB
ejop-10097	19	10	patients	patient	NOUN
ejop-10097	19	11	with	with	ADP
ejop-10097	19	12	severe	severe	ADJ
ejop-10097	19	13	course	course	NOUN
ejop-10097	19	14	of	of	ADP
ejop-10097	19	15	the	the	DET
ejop-10097	19	16	disease	disease	NOUN
ejop-10097	19	17	,	,	PUNCT
ejop-10097	19	18	namely	namely	ADV
ejop-10097	19	19	those	those	PRON
ejop-10097	19	20	who	who	PRON
ejop-10097	19	21	were	be	AUX
ejop-10097	19	22	hospitalized	hospitalize	VERB
ejop-10097	19	23	or	or	CCONJ
ejop-10097	19	24	ventilated	ventilate	VERB
ejop-10097	19	25	(	(	PUNCT
ejop-10097	19	26	bellan	bellan	NOUN
ejop-10097	19	27	et	et	PROPN
ejop-10097	19	28	al	al	PROPN
ejop-10097	19	29	.	.	PROPN
ejop-10097	19	30	,	,	PUNCT
ejop-10097	19	31	2021	2021	NUM
ejop-10097	19	32	)	)	PUNCT
ejop-10097	19	33	,	,	PUNCT
ejop-10097	19	34	but	but	CCONJ
ejop-10097	19	35	also	also	ADV
ejop-10097	19	36	patients	patient	NOUN
ejop-10097	19	37	who	who	PRON
ejop-10097	19	38	had	have	VERB
ejop-10097	19	39	mild	mild	ADJ
ejop-10097	19	40	to	to	ADP
ejop-10097	19	41	moderate	moderate	ADJ
ejop-10097	19	42	symptoms	symptom	NOUN
ejop-10097	19	43	and	and	CCONJ
ejop-10097	19	44	stayed	stay	VERB
ejop-10097	19	45	at	at	ADP
ejop-10097	19	46	home	home	NOUN
ejop-10097	19	47	or	or	CCONJ
ejop-10097	19	48	even	even	ADV
ejop-10097	19	49	this	this	PRON
ejop-10097	19	50	is	be	AUX
ejop-10097	19	51	an	an	DET
ejop-10097	19	52	open	open	ADJ
ejop-10097	19	53	access	access	NOUN
ejop-10097	19	54	article	article	NOUN
ejop-10097	19	55	distributed	distribute	VERB
ejop-10097	19	56	under	under	ADP
ejop-10097	19	57	the	the	DET
ejop-10097	19	58	terms	term	NOUN
ejop-10097	19	59	of	of	ADP
ejop-10097	19	60	the	the	DET
ejop-10097	19	61	creative	creative	ADJ
ejop-10097	19	62	commons	common	NOUN
ejop-10097	19	63	attribution	attribution	NOUN
ejop-10097	19	64	4.0	4.0	NUM
ejop-10097	19	65	international	international	ADJ
ejop-10097	19	66	license	license	NOUN
ejop-10097	19	67	,	,	PUNCT
ejop-10097	19	68	cc	cc	VERB
ejop-10097	19	69	by	by	ADP
ejop-10097	19	70	4.0	4.0	NUM
ejop-10097	19	71	,	,	PUNCT
ejop-10097	19	72	which	which	PRON
ejop-10097	19	73	permits	permit	VERB
ejop-10097	19	74	unrestricted	unrestricted	ADJ
ejop-10097	19	75	use	use	NOUN
ejop-10097	19	76	,	,	PUNCT
ejop-10097	19	77	distribution	distribution	NOUN
ejop-10097	19	78	,	,	PUNCT
ejop-10097	19	79	and	and	CCONJ
ejop-10097	19	80	reproduction	reproduction	NOUN
ejop-10097	19	81	,	,	PUNCT
ejop-10097	19	82	provided	provide	VERB
ejop-10097	19	83	the	the	DET
ejop-10097	19	84	original	original	ADJ
ejop-10097	19	85	work	work	NOUN
ejop-10097	19	86	is	be	AUX
ejop-10097	19	87	properly	properly	ADV
ejop-10097	19	88	cited	cite	VERB
ejop-10097	19	89	.	.	PUNCT
ejop-10097	20	1	https://crossmark.crossref.org/dialog/?doi=10.5964/ejop.10097&domain=pdf&date_stamp=2022-11-30	https://crossmark.crossref.org/dialog/?doi=10.5964/ejop.10097&domain=pdf&date_stamp=2022-11-30	NOUN
ejop-10097	20	2	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
ejop-10097	20	3	https://ejop.psychopen.eu/	https://ejop.psychopen.eu/	NOUN
ejop-10097	20	4	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
ejop-10097	20	5	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
ejop-10097	20	6	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
ejop-10097	20	7	experienced	experience	VERB
ejop-10097	20	8	asymptomatic	asymptomatic	ADJ
ejop-10097	20	9	infections	infection	NOUN
ejop-10097	20	10	(	(	PUNCT
ejop-10097	20	11	augustin	augustin	PROPN
ejop-10097	20	12	et	et	PROPN
ejop-10097	20	13	al	al	PROPN
ejop-10097	20	14	.	.	PROPN
ejop-10097	20	15	,	,	PUNCT
ejop-10097	20	16	2021	2021	NUM
ejop-10097	20	17	)	)	PUNCT
ejop-10097	20	18	.	.	PUNCT
ejop-10097	21	1	a	a	DET
ejop-10097	21	2	recent	recent	ADJ
ejop-10097	21	3	meta	meta	ADJ
ejop-10097	21	4	-	-	PUNCT
ejop-10097	21	5	analysis	analysis	NOUN
ejop-10097	21	6	estimated	estimate	VERB
ejop-10097	21	7	that	that	SCONJ
ejop-10097	21	8	up	up	ADP
ejop-10097	21	9	to	to	PART
ejop-10097	21	10	43	43	NUM
ejop-10097	21	11	%	%	NOUN
ejop-10097	21	12	of	of	ADP
ejop-10097	21	13	people	people	NOUN
ejop-10097	21	14	experience	experience	VERB
ejop-10097	21	15	persistent	persistent	ADJ
ejop-10097	21	16	symptoms	symptom	NOUN
ejop-10097	21	17	after	after	ADP
ejop-10097	21	18	covid-19	covid-19	PROPN
ejop-10097	21	19	(	(	PUNCT
ejop-10097	21	20	chen	chen	PROPN
ejop-10097	21	21	et	et	PROPN
ejop-10097	21	22	al	al	PROPN
ejop-10097	21	23	.	.	PROPN
ejop-10097	21	24	,	,	PUNCT
ejop-10097	21	25	2022	2022	NUM
ejop-10097	21	26	)	)	PUNCT
ejop-10097	21	27	.	.	PUNCT
ejop-10097	22	1	patients	patient	NOUN
ejop-10097	22	2	with	with	ADP
ejop-10097	22	3	post	post	ADJ
ejop-10097	22	4	-	-	ADJ
ejop-10097	22	5	covid	covid	ADJ
ejop-10097	22	6	syndrome	syndrome	PROPN
ejop-10097	22	7	report	report	NOUN
ejop-10097	22	8	varying	vary	VERB
ejop-10097	22	9	symptoms	symptom	NOUN
ejop-10097	22	10	including	include	VERB
ejop-10097	22	11	pulmonary	pulmonary	ADJ
ejop-10097	22	12	,	,	PUNCT
ejop-10097	22	13	hematologic	hematologic	NOUN
ejop-10097	22	14	,	,	PUNCT
ejop-10097	22	15	renal	renal	ADJ
ejop-10097	22	16	,	,	PUNCT
ejop-10097	22	17	endocrine	endocrine	NOUN
ejop-10097	22	18	,	,	PUNCT
ejop-10097	22	19	gastrointestinal	gastrointestinal	ADJ
ejop-10097	22	20	or	or	CCONJ
ejop-10097	22	21	dermatologic	dermatologic	ADJ
ejop-10097	22	22	manifestations	manifestation	NOUN
ejop-10097	22	23	(	(	PUNCT
ejop-10097	22	24	nalbandian	nalbandian	PROPN
ejop-10097	22	25	et	et	PROPN
ejop-10097	22	26	al	al	PROPN
ejop-10097	22	27	.	.	PROPN
ejop-10097	22	28	,	,	PUNCT
ejop-10097	22	29	2021	2021	NUM
ejop-10097	22	30	)	)	PUNCT
ejop-10097	22	31	.	.	PUNCT
ejop-10097	23	1	in	in	ADP
ejop-10097	23	2	addition	addition	NOUN
ejop-10097	23	3	,	,	PUNCT
ejop-10097	23	4	patients	patient	NOUN
ejop-10097	23	5	often	often	ADV
ejop-10097	23	6	report	report	VERB
ejop-10097	23	7	neuropsychi­	neuropsychi­	ADV
ejop-10097	23	8	atric	atric	ADJ
ejop-10097	23	9	and	and	CCONJ
ejop-10097	23	10	cognitive	cognitive	ADJ
ejop-10097	23	11	symptoms	symptom	NOUN
ejop-10097	23	12	.	.	PUNCT
ejop-10097	24	1	a	a	DET
ejop-10097	24	2	recent	recent	ADJ
ejop-10097	24	3	meta	meta	ADJ
ejop-10097	24	4	-	-	PUNCT
ejop-10097	24	5	analysis	analysis	NOUN
ejop-10097	24	6	and	and	CCONJ
ejop-10097	24	7	systematic	systematic	ADJ
ejop-10097	24	8	review	review	NOUN
ejop-10097	24	9	estimated	estimate	VERB
ejop-10097	24	10	that	that	SCONJ
ejop-10097	24	11	a	a	DET
ejop-10097	24	12	substantial	substantial	ADJ
ejop-10097	24	13	proportion	proportion	NOUN
ejop-10097	24	14	of	of	ADP
ejop-10097	24	15	persons	person	NOUN
ejop-10097	24	16	experience	experience	NOUN
ejop-10097	24	17	symptoms	symptom	NOUN
ejop-10097	24	18	like	like	ADP
ejop-10097	24	19	sleep	sleep	NOUN
ejop-10097	24	20	disorders	disorder	NOUN
ejop-10097	24	21	(	(	PUNCT
ejop-10097	24	22	24	24	NUM
ejop-10097	24	23	%	%	NOUN
ejop-10097	24	24	)	)	PUNCT
ejop-10097	24	25	,	,	PUNCT
ejop-10097	24	26	depression	depression	NOUN
ejop-10097	24	27	(	(	PUNCT
ejop-10097	24	28	14	14	NUM
ejop-10097	24	29	%	%	NOUN
ejop-10097	24	30	)	)	PUNCT
ejop-10097	24	31	,	,	PUNCT
ejop-10097	24	32	anxiety	anxiety	NOUN
ejop-10097	24	33	(	(	PUNCT
ejop-10097	24	34	21	21	NUM
ejop-10097	24	35	%	%	NOUN
ejop-10097	24	36	)	)	PUNCT
ejop-10097	24	37	and	and	CCONJ
ejop-10097	24	38	fatigue	fatigue	NOUN
ejop-10097	24	39	(	(	PUNCT
ejop-10097	24	40	32	32	NUM
ejop-10097	24	41	%	%	NOUN
ejop-10097	24	42	)	)	PUNCT
ejop-10097	24	43	3	3	NUM
ejop-10097	24	44	to	to	PART
ejop-10097	24	45	6	6	NUM
ejop-10097	24	46	months	month	NOUN
ejop-10097	24	47	after	after	ADP
ejop-10097	24	48	having	having	AUX
ejop-10097	24	49	been	be	AUX
ejop-10097	24	50	infected	infect	VERB
ejop-10097	24	51	with	with	ADP
ejop-10097	24	52	sars	sar	NOUN
ejop-10097	24	53	-	-	PUNCT
ejop-10097	24	54	cov-2	cov-2	NOUN
ejop-10097	24	55	.	.	PUNCT
ejop-10097	24	56	cognitive	cognitive	ADJ
ejop-10097	24	57	symptoms	symptom	NOUN
ejop-10097	24	58	(	(	PUNCT
ejop-10097	24	59	36	36	NUM
ejop-10097	24	60	%	%	NOUN
ejop-10097	24	61	)	)	PUNCT
ejop-10097	24	62	include	include	VERB
ejop-10097	24	63	difficulties	difficulty	NOUN
ejop-10097	24	64	to	to	PART
ejop-10097	24	65	concentrate	concentrate	VERB
ejop-10097	24	66	,	,	PUNCT
ejop-10097	24	67	brain	brain	NOUN
ejop-10097	24	68	fog	fog	NOUN
ejop-10097	24	69	or	or	CCONJ
ejop-10097	24	70	confusion	confusion	NOUN
ejop-10097	24	71	(	(	PUNCT
ejop-10097	24	72	alkodaymi	alkodaymi	VERB
ejop-10097	24	73	et	et	PROPN
ejop-10097	24	74	al	al	PROPN
ejop-10097	24	75	.	.	PROPN
ejop-10097	24	76	,	,	PUNCT
ejop-10097	24	77	2022	2022	NUM
ejop-10097	24	78	)	)	PUNCT
ejop-10097	24	79	.	.	PUNCT
ejop-10097	25	1	two	two	NUM
ejop-10097	25	2	recent	recent	ADJ
ejop-10097	25	3	reviews	review	NOUN
ejop-10097	25	4	found	find	VERB
ejop-10097	25	5	cognitive	cognitive	ADJ
ejop-10097	25	6	impairments	impairment	NOUN
ejop-10097	25	7	in	in	ADP
ejop-10097	25	8	patients	patient	NOUN
ejop-10097	25	9	with	with	ADP
ejop-10097	25	10	the	the	DET
ejop-10097	25	11	post	post	ADJ
ejop-10097	25	12	-	-	ADJ
ejop-10097	25	13	covid	covid	ADJ
ejop-10097	25	14	syndrome	syndrome	NOUN
ejop-10097	25	15	in	in	ADP
ejop-10097	25	16	all	all	DET
ejop-10097	25	17	neurocognitive	neurocognitive	ADJ
ejop-10097	25	18	domains	domain	NOUN
ejop-10097	25	19	,	,	PUNCT
ejop-10097	25	20	namely	namely	ADV
ejop-10097	25	21	memory	memory	NOUN
ejop-10097	25	22	and	and	CCONJ
ejop-10097	25	23	learning	learning	NOUN
ejop-10097	25	24	,	,	PUNCT
ejop-10097	25	25	attention	attention	NOUN
ejop-10097	25	26	,	,	PUNCT
ejop-10097	25	27	executive	executive	ADJ
ejop-10097	25	28	functioning	functioning	NOUN
ejop-10097	25	29	,	,	PUNCT
ejop-10097	25	30	language	language	NOUN
ejop-10097	25	31	,	,	PUNCT
ejop-10097	25	32	and	and	CCONJ
ejop-10097	25	33	visual	visual	ADJ
ejop-10097	25	34	perceptive	perceptive	ADJ
ejop-10097	25	35	functions	function	NOUN
ejop-10097	25	36	,	,	PUNCT
ejop-10097	25	37	with	with	ADP
ejop-10097	25	38	a	a	DET
ejop-10097	25	39	focus	focus	NOUN
ejop-10097	25	40	on	on	ADP
ejop-10097	25	41	deficits	deficit	NOUN
ejop-10097	25	42	in	in	ADP
ejop-10097	25	43	memory	memory	NOUN
ejop-10097	25	44	and	and	CCONJ
ejop-10097	25	45	learning	learning	NOUN
ejop-10097	25	46	,	,	PUNCT
ejop-10097	25	47	attention	attention	NOUN
ejop-10097	25	48	and	and	CCONJ
ejop-10097	25	49	executive	executive	ADJ
ejop-10097	25	50	functioning	functioning	NOUN
ejop-10097	25	51	(	(	PUNCT
ejop-10097	25	52	bertuccelli	bertuccelli	PROPN
ejop-10097	25	53	et	et	PROPN
ejop-10097	25	54	al	al	PROPN
ejop-10097	25	55	.	.	PROPN
ejop-10097	25	56	,	,	PUNCT
ejop-10097	25	57	2022	2022	NUM
ejop-10097	25	58	;	;	PUNCT
ejop-10097	25	59	daroische	daroische	NOUN
ejop-10097	25	60	et	et	PROPN
ejop-10097	25	61	al	al	PROPN
ejop-10097	25	62	.	.	PROPN
ejop-10097	25	63	,	,	PUNCT
ejop-10097	25	64	2021	2021	NUM
ejop-10097	25	65	)	)	PUNCT
ejop-10097	25	66	.	.	PUNCT
ejop-10097	26	1	a	a	DET
ejop-10097	26	2	study	study	NOUN
ejop-10097	26	3	that	that	PRON
ejop-10097	26	4	extensively	extensively	ADV
ejop-10097	26	5	assessed	assess	VERB
ejop-10097	26	6	cognitive	cognitive	ADJ
ejop-10097	26	7	function	function	NOUN
ejop-10097	26	8	solely	solely	ADV
ejop-10097	26	9	in	in	ADP
ejop-10097	26	10	patients	patient	NOUN
ejop-10097	26	11	that	that	PRON
ejop-10097	26	12	experienced	experience	VERB
ejop-10097	26	13	asymptomatic	asymptomatic	ADJ
ejop-10097	26	14	or	or	CCONJ
ejop-10097	26	15	mild	mild	ADJ
ejop-10097	26	16	to	to	ADP
ejop-10097	26	17	moderate	moderate	ADJ
ejop-10097	26	18	acute	acute	PROPN
ejop-10097	26	19	covid-19	covid-19	PROPN
ejop-10097	26	20	symptoms	symptom	NOUN
ejop-10097	26	21	obtained	obtain	VERB
ejop-10097	26	22	similar	similar	ADJ
ejop-10097	26	23	results	result	NOUN
ejop-10097	26	24	,	,	PUNCT
ejop-10097	26	25	finding	find	VERB
ejop-10097	26	26	impairments	impairment	NOUN
ejop-10097	26	27	in	in	ADP
ejop-10097	26	28	all	all	DET
ejop-10097	26	29	assessed	assessed	ADJ
ejop-10097	26	30	cognitive	cognitive	ADJ
ejop-10097	26	31	domains	domain	NOUN
ejop-10097	26	32	that	that	PRON
ejop-10097	26	33	are	be	AUX
ejop-10097	26	34	learning	learn	VERB
ejop-10097	26	35	and	and	CCONJ
ejop-10097	26	36	memory	memory	NOUN
ejop-10097	26	37	,	,	PUNCT
ejop-10097	26	38	complex	complex	ADJ
ejop-10097	26	39	attention	attention	NOUN
ejop-10097	26	40	,	,	PUNCT
ejop-10097	26	41	executive	executive	ADJ
ejop-10097	26	42	function	function	NOUN
ejop-10097	26	43	,	,	PUNCT
ejop-10097	26	44	language	language	NOUN
ejop-10097	26	45	and	and	CCONJ
ejop-10097	26	46	perceptual	perceptual	ADJ
ejop-10097	26	47	-	-	PUNCT
ejop-10097	26	48	motor	motor	NOUN
ejop-10097	26	49	function	function	NOUN
ejop-10097	26	50	(	(	PUNCT
ejop-10097	26	51	schild	schild	PROPN
ejop-10097	26	52	et	et	PROPN
ejop-10097	26	53	al	al	PROPN
ejop-10097	26	54	.	.	PROPN
ejop-10097	26	55	,	,	PUNCT
ejop-10097	26	56	2022	2022	NUM
ejop-10097	26	57	)	)	PUNCT
ejop-10097	26	58	.	.	PUNCT
ejop-10097	27	1	similar	similar	ADJ
ejop-10097	27	2	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	27	3	symptoms	symptom	NOUN
ejop-10097	27	4	were	be	AUX
ejop-10097	27	5	also	also	ADV
ejop-10097	27	6	reported	report	VERB
ejop-10097	27	7	in	in	ADP
ejop-10097	27	8	sars	sar	NOUN
ejop-10097	27	9	-	-	PUNCT
ejop-10097	27	10	cov-1	cov-1	PRON
ejop-10097	27	11	and	and	CCONJ
ejop-10097	27	12	mers	mer	NOUN
ejop-10097	27	13	-	-	PUNCT
ejop-10097	27	14	cov	cov	NOUN
ejop-10097	27	15	,	,	PUNCT
ejop-10097	27	16	two	two	NUM
ejop-10097	27	17	other	other	ADJ
ejop-10097	27	18	viruses	virus	NOUN
ejop-10097	27	19	from	from	ADP
ejop-10097	27	20	the	the	DET
ejop-10097	27	21	corona	corona	PROPN
ejop-10097	27	22	virus	virus	NOUN
ejop-10097	27	23	family	family	PROPN
ejop-10097	27	24	(	(	PUNCT
ejop-10097	27	25	rogers	rogers	PROPN
ejop-10097	27	26	et	et	PROPN
ejop-10097	27	27	al	al	PROPN
ejop-10097	27	28	.	.	PROPN
ejop-10097	27	29	,	,	PUNCT
ejop-10097	27	30	2020	2020	NUM
ejop-10097	27	31	)	)	PUNCT
ejop-10097	27	32	.	.	PUNCT
ejop-10097	28	1	however	however	ADV
ejop-10097	28	2	,	,	PUNCT
ejop-10097	28	3	it	it	PRON
ejop-10097	28	4	is	be	AUX
ejop-10097	28	5	still	still	ADV
ejop-10097	28	6	unclear	unclear	ADJ
ejop-10097	28	7	how	how	SCONJ
ejop-10097	28	8	these	these	DET
ejop-10097	28	9	symptoms	symptom	NOUN
ejop-10097	28	10	develop	develop	VERB
ejop-10097	28	11	and	and	CCONJ
ejop-10097	28	12	persist	persist	VERB
ejop-10097	28	13	over	over	ADP
ejop-10097	28	14	time	time	NOUN
ejop-10097	28	15	.	.	PUNCT
ejop-10097	29	1	so	so	ADV
ejop-10097	29	2	far	far	ADV
ejop-10097	29	3	,	,	PUNCT
ejop-10097	29	4	explanations	explanation	NOUN
ejop-10097	29	5	for	for	ADP
ejop-10097	29	6	these	these	DET
ejop-10097	29	7	symptoms	symptom	NOUN
ejop-10097	29	8	as	as	ADP
ejop-10097	29	9	part	part	NOUN
ejop-10097	29	10	of	of	ADP
ejop-10097	29	11	the	the	DET
ejop-10097	29	12	post	post	ADJ
ejop-10097	29	13	-	-	ADJ
ejop-10097	29	14	covid	covid	ADJ
ejop-10097	29	15	syndrome	syndrome	NOUN
ejop-10097	29	16	focused	focus	VERB
ejop-10097	29	17	on	on	ADP
ejop-10097	29	18	neurological	neurological	ADJ
ejop-10097	29	19	or	or	CCONJ
ejop-10097	29	20	neu­	neu­	NOUN
ejop-10097	29	21	roimmunological	roimmunological	ADJ
ejop-10097	29	22	causes	cause	NOUN
ejop-10097	29	23	.	.	PUNCT
ejop-10097	30	1	potential	potential	ADJ
ejop-10097	30	2	neurological	neurological	ADJ
ejop-10097	30	3	mechanisms	mechanism	NOUN
ejop-10097	30	4	that	that	PRON
ejop-10097	30	5	lead	lead	VERB
ejop-10097	30	6	to	to	ADP
ejop-10097	30	7	cognitive	cognitive	ADJ
ejop-10097	30	8	and	and	CCONJ
ejop-10097	30	9	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	30	10	symptoms	symptom	NOUN
ejop-10097	30	11	include	include	VERB
ejop-10097	30	12	viral	viral	ADJ
ejop-10097	30	13	persistence	persistence	NOUN
ejop-10097	30	14	and	and	CCONJ
ejop-10097	30	15	infiltration	infiltration	NOUN
ejop-10097	30	16	of	of	ADP
ejop-10097	30	17	the	the	DET
ejop-10097	30	18	central	central	ADJ
ejop-10097	30	19	nervous	nervous	ADJ
ejop-10097	30	20	system	system	NOUN
ejop-10097	30	21	(	(	PUNCT
ejop-10097	30	22	mehandru	mehandru	NOUN
ejop-10097	30	23	&	&	CCONJ
ejop-10097	30	24	merad	merad	PROPN
ejop-10097	30	25	,	,	PUNCT
ejop-10097	30	26	2022	2022	NUM
ejop-10097	30	27	;	;	PUNCT
ejop-10097	30	28	troyer	troyer	PROPN
ejop-10097	30	29	et	et	PROPN
ejop-10097	30	30	al	al	PROPN
ejop-10097	30	31	.	.	PROPN
ejop-10097	30	32	,	,	PUNCT
ejop-10097	30	33	2020	2020	NUM
ejop-10097	30	34	)	)	PUNCT
ejop-10097	30	35	.	.	PUNCT
ejop-10097	31	1	however	however	ADV
ejop-10097	31	2	,	,	PUNCT
ejop-10097	31	3	analyses	analysis	NOUN
ejop-10097	31	4	of	of	ADP
ejop-10097	31	5	the	the	DET
ejop-10097	31	6	cerebrospinal	cerebrospinal	ADJ
ejop-10097	31	7	fluid	fluid	NOUN
ejop-10097	31	8	that	that	PRON
ejop-10097	31	9	show	show	VERB
ejop-10097	31	10	no	no	DET
ejop-10097	31	11	viral	viral	ADJ
ejop-10097	31	12	rna	rna	NOUN
ejop-10097	31	13	in	in	ADP
ejop-10097	31	14	post	post	ADJ
ejop-10097	31	15	-	-	ADJ
ejop-10097	31	16	covid	covid	ADJ
ejop-10097	31	17	patients	patient	NOUN
ejop-10097	31	18	and	and	CCONJ
ejop-10097	31	19	no	no	DET
ejop-10097	31	20	hint	hint	NOUN
ejop-10097	31	21	for	for	ADP
ejop-10097	31	22	chronic	chronic	ADJ
ejop-10097	31	23	sars	sar	NOUN
ejop-10097	31	24	-	-	PUNCT
ejop-10097	31	25	cov2	cov2	PROPN
ejop-10097	31	26	-	-	PUNCT
ejop-10097	31	27	directed	direct	VERB
ejop-10097	31	28	intrathecal	intrathecal	ADJ
ejop-10097	31	29	igg	igg	NOUN
ejop-10097	31	30	response	response	NOUN
ejop-10097	31	31	with	with	ADP
ejop-10097	31	32	neurological	neurological	ADJ
ejop-10097	31	33	symptoms	symptom	NOUN
ejop-10097	31	34	do	do	AUX
ejop-10097	31	35	not	not	PART
ejop-10097	31	36	support	support	VERB
ejop-10097	31	37	the	the	DET
ejop-10097	31	38	hypothesis	hypothesis	NOUN
ejop-10097	31	39	of	of	ADP
ejop-10097	31	40	persistent	persistent	ADJ
ejop-10097	31	41	infection	infection	NOUN
ejop-10097	31	42	of	of	ADP
ejop-10097	31	43	the	the	DET
ejop-10097	31	44	central	central	ADJ
ejop-10097	31	45	nervous	nervous	ADJ
ejop-10097	31	46	system	system	NOUN
ejop-10097	31	47	as	as	ADP
ejop-10097	31	48	a	a	DET
ejop-10097	31	49	cause	cause	NOUN
ejop-10097	31	50	of	of	ADP
ejop-10097	31	51	neurological	neurological	ADJ
ejop-10097	31	52	and	and	CCONJ
ejop-10097	31	53	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	31	54	symptoms	symptom	NOUN
ejop-10097	31	55	(	(	PUNCT
ejop-10097	31	56	schweitzer	schweitzer	PROPN
ejop-10097	31	57	et	et	PROPN
ejop-10097	31	58	al	al	PROPN
ejop-10097	31	59	.	.	PROPN
ejop-10097	31	60	,	,	PUNCT
ejop-10097	31	61	2022	2022	NUM
ejop-10097	31	62	)	)	PUNCT
ejop-10097	31	63	.	.	PUNCT
ejop-10097	32	1	other	other	ADJ
ejop-10097	32	2	potential	potential	ADJ
ejop-10097	32	3	neurological	neurological	ADJ
ejop-10097	32	4	mechanisms	mechanism	NOUN
ejop-10097	32	5	include	include	VERB
ejop-10097	32	6	cytokine	cytokine	NOUN
ejop-10097	32	7	network	network	NOUN
ejop-10097	32	8	dysregulation	dysregulation	NOUN
ejop-10097	32	9	,	,	PUNCT
ejop-10097	32	10	peripheral	peripheral	ADJ
ejop-10097	32	11	immune	immune	ADJ
ejop-10097	32	12	cell	cell	NOUN
ejop-10097	32	13	transmigration	transmigration	NOUN
ejop-10097	32	14	,	,	PUNCT
ejop-10097	32	15	post	post	ADJ
ejop-10097	32	16	-	-	ADJ
ejop-10097	32	17	infectious	infectious	ADJ
ejop-10097	32	18	autoimmunity	autoimmunity	NOUN
ejop-10097	32	19	or	or	CCONJ
ejop-10097	32	20	immunomodulatory	immunomodulatory	ADJ
ejop-10097	32	21	treatments	treatment	NOUN
ejop-10097	32	22	(	(	PUNCT
ejop-10097	32	23	troyer	troyer	NOUN
ejop-10097	32	24	et	et	PROPN
ejop-10097	32	25	al	al	PROPN
ejop-10097	32	26	.	.	PROPN
ejop-10097	32	27	,	,	PUNCT
ejop-10097	32	28	2020	2020	NUM
ejop-10097	32	29	)	)	PUNCT
ejop-10097	32	30	.	.	PUNCT
ejop-10097	33	1	to	to	ADP
ejop-10097	33	2	date	date	NOUN
ejop-10097	33	3	,	,	PUNCT
ejop-10097	33	4	these	these	DET
ejop-10097	33	5	neurological	neurological	ADJ
ejop-10097	33	6	hypotheses	hypothesis	NOUN
ejop-10097	33	7	could	could	AUX
ejop-10097	33	8	not	not	PART
ejop-10097	33	9	provide	provide	VERB
ejop-10097	33	10	direct	direct	ADJ
ejop-10097	33	11	evidence	evidence	NOUN
ejop-10097	33	12	to	to	PART
ejop-10097	33	13	fully	fully	ADV
ejop-10097	33	14	explain	explain	VERB
ejop-10097	33	15	the	the	DET
ejop-10097	33	16	development	development	NOUN
ejop-10097	33	17	,	,	PUNCT
ejop-10097	33	18	maintenance	maintenance	NOUN
ejop-10097	33	19	and	and	CCONJ
ejop-10097	33	20	diversity	diversity	NOUN
ejop-10097	33	21	of	of	ADP
ejop-10097	33	22	observed	observe	VERB
ejop-10097	33	23	cognitive	cognitive	ADJ
ejop-10097	33	24	and	and	CCONJ
ejop-10097	33	25	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	33	26	symptoms	symptom	NOUN
ejop-10097	33	27	in	in	ADP
ejop-10097	33	28	post	post	ADJ
ejop-10097	33	29	-	-	ADJ
ejop-10097	33	30	covid	covid	ADJ
ejop-10097	33	31	syndrome	syndrome	NOUN
ejop-10097	33	32	.	.	PUNCT
ejop-10097	34	1	hypothesis	hypothesis	NOUN
ejop-10097	34	2	we	we	PRON
ejop-10097	34	3	will	will	AUX
ejop-10097	34	4	provide	provide	VERB
ejop-10097	34	5	an	an	DET
ejop-10097	34	6	interdisciplinary	interdisciplinary	ADJ
ejop-10097	34	7	network	network	NOUN
ejop-10097	34	8	perspective	perspective	NOUN
ejop-10097	34	9	based	base	VERB
ejop-10097	34	10	on	on	ADP
ejop-10097	34	11	the	the	DET
ejop-10097	34	12	network	network	NOUN
ejop-10097	34	13	theory	theory	NOUN
ejop-10097	34	14	of	of	ADP
ejop-10097	34	15	mental	mental	ADJ
ejop-10097	34	16	disorders	disorder	NOUN
ejop-10097	34	17	(	(	PUNCT
ejop-10097	34	18	borsboom	borsboom	NOUN
ejop-10097	34	19	,	,	PUNCT
ejop-10097	34	20	2017	2017	NUM
ejop-10097	34	21	)	)	PUNCT
ejop-10097	34	22	that	that	PRON
ejop-10097	34	23	could	could	AUX
ejop-10097	34	24	possibly	possibly	ADV
ejop-10097	34	25	explain	explain	VERB
ejop-10097	34	26	persistent	persistent	ADJ
ejop-10097	34	27	psychiatric	psychiatric	ADJ
ejop-10097	34	28	and	and	CCONJ
ejop-10097	34	29	cognitive	cognitive	ADJ
ejop-10097	34	30	symptoms	symptom	NOUN
ejop-10097	34	31	in	in	ADP
ejop-10097	34	32	patients	patient	NOUN
ejop-10097	34	33	after	after	ADP
ejop-10097	34	34	mild	mild	ADJ
ejop-10097	34	35	to	to	ADP
ejop-10097	34	36	moderate	moderate	ADJ
ejop-10097	34	37	course	course	NOUN
ejop-10097	34	38	of	of	ADP
ejop-10097	34	39	covid-19	covid-19	PROPN
ejop-10097	34	40	.	.	PUNCT
ejop-10097	35	1	intriguingly	intriguingly	ADV
ejop-10097	35	2	,	,	PUNCT
ejop-10097	35	3	such	such	ADJ
ejop-10097	35	4	hypothesis	hypothesis	NOUN
ejop-10097	35	5	would	would	AUX
ejop-10097	35	6	not	not	PART
ejop-10097	35	7	be	be	AUX
ejop-10097	35	8	exclusive	exclusive	ADJ
ejop-10097	35	9	,	,	PUNCT
ejop-10097	35	10	and	and	CCONJ
ejop-10097	35	11	may	may	AUX
ejop-10097	35	12	add	add	VERB
ejop-10097	35	13	to	to	ADP
ejop-10097	35	14	other	other	ADJ
ejop-10097	35	15	possible	possible	ADJ
ejop-10097	35	16	elements	element	NOUN
ejop-10097	35	17	that	that	PRON
ejop-10097	35	18	contribute	contribute	VERB
ejop-10097	35	19	to	to	ADP
ejop-10097	35	20	pathogenesis	pathogenesis	NOUN
ejop-10097	35	21	,	,	PUNCT
ejop-10097	35	22	such	such	ADJ
ejop-10097	35	23	as	as	ADP
ejop-10097	35	24	viral	viral	ADJ
ejop-10097	35	25	persistency	persistency	NOUN
ejop-10097	35	26	or	or	CCONJ
ejop-10097	35	27	secondary	secondary	ADJ
ejop-10097	35	28	autoimmunity	autoimmunity	NOUN
ejop-10097	35	29	discussed	discuss	VERB
ejop-10097	35	30	above	above	ADV
ejop-10097	35	31	.	.	PUNCT
ejop-10097	36	1	the	the	DET
ejop-10097	36	2	network	network	NOUN
ejop-10097	36	3	theory	theory	NOUN
ejop-10097	36	4	of	of	ADP
ejop-10097	36	5	mental	mental	ADJ
ejop-10097	36	6	disorders	disorder	NOUN
ejop-10097	36	7	would	would	AUX
ejop-10097	36	8	provide	provide	VERB
ejop-10097	36	9	an	an	DET
ejop-10097	36	10	(	(	PUNCT
ejop-10097	36	11	added	add	VERB
ejop-10097	36	12	)	)	PUNCT
ejop-10097	36	13	explanation	explanation	NOUN
ejop-10097	36	14	for	for	ADP
ejop-10097	36	15	post	post	NOUN
ejop-10097	36	16	covid-19	covid-19	PROPN
ejop-10097	36	17	,	,	PUNCT
ejop-10097	36	18	but	but	CCONJ
ejop-10097	36	19	also	also	ADV
ejop-10097	36	20	for	for	ADP
ejop-10097	36	21	similar	similar	ADJ
ejop-10097	36	22	observations	observation	NOUN
ejop-10097	36	23	after	after	ADP
ejop-10097	36	24	other	other	ADJ
ejop-10097	36	25	viral	viral	ADJ
ejop-10097	36	26	infections	infection	NOUN
ejop-10097	36	27	of	of	ADP
ejop-10097	36	28	the	the	DET
ejop-10097	36	29	past	past	NOUN
ejop-10097	36	30	,	,	PUNCT
ejop-10097	36	31	such	such	ADJ
ejop-10097	36	32	as	as	ADP
ejop-10097	36	33	following	follow	VERB
ejop-10097	36	34	the	the	DET
ejop-10097	36	35	mers	mer	NOUN
ejop-10097	36	36	-	-	PUNCT
ejop-10097	36	37	cov	cov	NOUN
ejop-10097	36	38	and	and	CCONJ
ejop-10097	36	39	sars	sars	PROPN
ejop-10097	36	40	-	-	PUNCT
ejop-10097	36	41	cov	cov	NOUN
ejop-10097	36	42	pandemics	pandemic	NOUN
ejop-10097	36	43	(	(	PUNCT
ejop-10097	36	44	rogers	roger	NOUN
ejop-10097	36	45	et	et	PROPN
ejop-10097	36	46	al	al	PROPN
ejop-10097	36	47	.	.	PROPN
ejop-10097	36	48	,	,	PUNCT
ejop-10097	36	49	2020	2020	NUM
ejop-10097	36	50	)	)	PUNCT
ejop-10097	36	51	.	.	PUNCT
ejop-10097	37	1	during	during	ADP
ejop-10097	37	2	the	the	DET
ejop-10097	37	3	last	last	ADJ
ejop-10097	37	4	years	year	NOUN
ejop-10097	37	5	,	,	PUNCT
ejop-10097	37	6	the	the	DET
ejop-10097	37	7	network	network	NOUN
ejop-10097	37	8	theory	theory	NOUN
ejop-10097	37	9	of	of	ADP
ejop-10097	37	10	mental	mental	ADJ
ejop-10097	37	11	disorders	disorder	NOUN
ejop-10097	37	12	gained	gain	VERB
ejop-10097	37	13	increasing	increase	VERB
ejop-10097	37	14	reputation	reputation	NOUN
ejop-10097	37	15	as	as	ADP
ejop-10097	37	16	an	an	DET
ejop-10097	37	17	alternative	alternative	ADJ
ejop-10097	37	18	conceptualization	conceptualization	NOUN
ejop-10097	37	19	of	of	ADP
ejop-10097	37	20	mental	mental	ADJ
ejop-10097	37	21	disorders	disorder	NOUN
ejop-10097	37	22	opposed	oppose	VERB
ejop-10097	37	23	to	to	ADP
ejop-10097	37	24	categorical	categorical	ADJ
ejop-10097	37	25	classification	classification	NOUN
ejop-10097	37	26	systems	system	NOUN
ejop-10097	37	27	.	.	PUNCT
ejop-10097	38	1	it	it	PRON
ejop-10097	38	2	considers	consider	VERB
ejop-10097	38	3	mental	mental	ADJ
ejop-10097	38	4	disorders	disorder	NOUN
ejop-10097	38	5	as	as	ADP
ejop-10097	38	6	syndromes	syndrome	NOUN
ejop-10097	38	7	,	,	PUNCT
ejop-10097	38	8	i.e.	i.e.	X
ejop-10097	38	9	constellations	constellation	NOUN
ejop-10097	38	10	of	of	ADP
ejop-10097	38	11	symptoms	symptom	NOUN
ejop-10097	38	12	that	that	PRON
ejop-10097	38	13	occur	occur	VERB
ejop-10097	38	14	together	together	ADV
ejop-10097	38	15	.	.	PUNCT
ejop-10097	39	1	in	in	ADP
ejop-10097	39	2	its	its	PRON
ejop-10097	39	3	core	core	NOUN
ejop-10097	39	4	,	,	PUNCT
ejop-10097	39	5	the	the	DET
ejop-10097	39	6	theory	theory	NOUN
ejop-10097	39	7	does	do	AUX
ejop-10097	39	8	not	not	PART
ejop-10097	39	9	rely	rely	VERB
ejop-10097	39	10	on	on	ADP
ejop-10097	39	11	aetiologies	aetiology	NOUN
ejop-10097	39	12	but	but	CCONJ
ejop-10097	39	13	rather	rather	ADV
ejop-10097	39	14	states	state	VERB
ejop-10097	39	15	that	that	SCONJ
ejop-10097	39	16	symptoms	symptom	NOUN
ejop-10097	39	17	are	be	AUX
ejop-10097	39	18	causally	causally	ADV
ejop-10097	39	19	connected	connect	VERB
ejop-10097	39	20	to	to	ADP
ejop-10097	39	21	other	other	ADJ
ejop-10097	39	22	symptoms	symptom	NOUN
ejop-10097	39	23	.	.	PUNCT
ejop-10097	40	1	these	these	DET
ejop-10097	40	2	interactions	interaction	NOUN
ejop-10097	40	3	between	between	ADP
ejop-10097	40	4	symptoms	symptom	NOUN
ejop-10097	40	5	can	can	AUX
ejop-10097	40	6	be	be	AUX
ejop-10097	40	7	portrayed	portray	VERB
ejop-10097	40	8	in	in	ADP
ejop-10097	40	9	a	a	DET
ejop-10097	40	10	network	network	NOUN
ejop-10097	40	11	,	,	PUNCT
ejop-10097	40	12	in	in	ADP
ejop-10097	40	13	which	which	PRON
ejop-10097	40	14	nodes	node	NOUN
ejop-10097	40	15	depict	depict	VERB
ejop-10097	40	16	symptoms	symptom	NOUN
ejop-10097	40	17	while	while	SCONJ
ejop-10097	40	18	the	the	DET
ejop-10097	40	19	edges	edge	NOUN
ejop-10097	40	20	between	between	ADP
ejop-10097	40	21	nodes	node	NOUN
ejop-10097	40	22	depict	depict	VERB
ejop-10097	40	23	causal	causal	ADJ
ejop-10097	40	24	relationships	relationship	NOUN
ejop-10097	40	25	.	.	PUNCT
ejop-10097	41	1	an	an	DET
ejop-10097	41	2	edge	edge	NOUN
ejop-10097	41	3	between	between	ADP
ejop-10097	41	4	two	two	NUM
ejop-10097	41	5	symptoms	symptom	NOUN
ejop-10097	41	6	means	mean	VERB
ejop-10097	41	7	that	that	SCONJ
ejop-10097	41	8	a	a	DET
ejop-10097	41	9	change	change	NOUN
ejop-10097	41	10	in	in	ADP
ejop-10097	41	11	the	the	DET
ejop-10097	41	12	activation	activation	NOUN
ejop-10097	41	13	of	of	ADP
ejop-10097	41	14	one	one	NUM
ejop-10097	41	15	node	node	NOUN
ejop-10097	41	16	leads	lead	VERB
ejop-10097	41	17	to	to	ADP
ejop-10097	41	18	a	a	DET
ejop-10097	41	19	change	change	NOUN
ejop-10097	41	20	in	in	ADP
ejop-10097	41	21	the	the	DET
ejop-10097	41	22	activation	activation	NOUN
ejop-10097	41	23	of	of	ADP
ejop-10097	41	24	another	another	DET
ejop-10097	41	25	node	node	NOUN
ejop-10097	41	26	.	.	PUNCT
ejop-10097	42	1	these	these	DET
ejop-10097	42	2	connections	connection	NOUN
ejop-10097	42	3	could	could	AUX
ejop-10097	42	4	arise	arise	VERB
ejop-10097	42	5	inter	inter	ADJ
ejop-10097	42	6	alia	alia	NOUN
ejop-10097	42	7	due	due	ADP
ejop-10097	42	8	to	to	ADP
ejop-10097	42	9	biological	biological	ADJ
ejop-10097	42	10	or	or	CCONJ
ejop-10097	42	11	psychological	psychological	ADJ
ejop-10097	42	12	mechanisms	mechanism	NOUN
ejop-10097	42	13	.	.	PUNCT
ejop-10097	43	1	additionally	additionally	ADV
ejop-10097	43	2	,	,	PUNCT
ejop-10097	43	3	nodes	node	NOUN
ejop-10097	43	4	,	,	PUNCT
ejop-10097	43	5	or	or	CCONJ
ejop-10097	43	6	symptoms	symptom	NOUN
ejop-10097	43	7	,	,	PUNCT
ejop-10097	43	8	can	can	AUX
ejop-10097	43	9	be	be	AUX
ejop-10097	43	10	influenced	influence	VERB
ejop-10097	43	11	by	by	ADP
ejop-10097	43	12	factors	factor	NOUN
ejop-10097	43	13	that	that	PRON
ejop-10097	43	14	stand	stand	VERB
ejop-10097	43	15	outside	outside	ADP
ejop-10097	43	16	the	the	DET
ejop-10097	43	17	network	network	NOUN
ejop-10097	43	18	system	system	NOUN
ejop-10097	43	19	in	in	ADP
ejop-10097	43	20	the	the	DET
ejop-10097	43	21	so	so	ADV
ejop-10097	43	22	-	-	PUNCT
ejop-10097	43	23	called	call	VERB
ejop-10097	43	24	“	"	PUNCT
ejop-10097	43	25	external	external	ADJ
ejop-10097	43	26	field	field	NOUN
ejop-10097	43	27	”	"	PUNCT
ejop-10097	43	28	.	.	PUNCT
ejop-10097	44	1	examples	example	NOUN
ejop-10097	44	2	for	for	ADP
ejop-10097	44	3	this	this	DET
ejop-10097	44	4	kind	kind	NOUN
ejop-10097	44	5	of	of	ADP
ejop-10097	44	6	network	network	NOUN
ejop-10097	44	7	could	could	AUX
ejop-10097	44	8	be	be	AUX
ejop-10097	44	9	critical	critical	ADJ
ejop-10097	44	10	life	life	NOUN
ejop-10097	44	11	events	event	NOUN
ejop-10097	44	12	or	or	CCONJ
ejop-10097	44	13	somatic	somatic	ADJ
ejop-10097	44	14	conditions	condition	NOUN
ejop-10097	44	15	like	like	ADP
ejop-10097	44	16	inflammation	inflammation	NOUN
ejop-10097	44	17	processes	process	NOUN
ejop-10097	44	18	or	or	CCONJ
ejop-10097	44	19	viral	viral	ADJ
ejop-10097	44	20	infections	infection	NOUN
ejop-10097	44	21	(	(	PUNCT
ejop-10097	44	22	borsboom	borsboom	NOUN
ejop-10097	44	23	,	,	PUNCT
ejop-10097	44	24	2017	2017	NUM
ejop-10097	44	25	)	)	PUNCT
ejop-10097	44	26	.	.	PUNCT
ejop-10097	45	1	although	although	SCONJ
ejop-10097	45	2	covid-19	covid-19	PROPN
ejop-10097	45	3	has	have	VERB
ejop-10097	45	4	a	a	DET
ejop-10097	45	5	clear	clear	ADJ
ejop-10097	45	6	medical	medical	ADJ
ejop-10097	45	7	aetiology	aetiology	NOUN
ejop-10097	45	8	,	,	PUNCT
ejop-10097	45	9	the	the	DET
ejop-10097	45	10	sars	sar	NOUN
ejop-10097	45	11	-	-	PUNCT
ejop-10097	45	12	cov-2	cov-2	PART
ejop-10097	45	13	virus	virus	NOUN
ejop-10097	45	14	,	,	PUNCT
ejop-10097	45	15	it	it	PRON
ejop-10097	45	16	is	be	AUX
ejop-10097	45	17	still	still	ADV
ejop-10097	45	18	possible	possible	ADJ
ejop-10097	45	19	to	to	PART
ejop-10097	45	20	apply	apply	VERB
ejop-10097	45	21	the	the	DET
ejop-10097	45	22	network	network	NOUN
ejop-10097	45	23	theory	theory	NOUN
ejop-10097	45	24	of	of	ADP
ejop-10097	45	25	mental	mental	ADJ
ejop-10097	45	26	disorders	disorder	NOUN
ejop-10097	45	27	to	to	ADP
ejop-10097	45	28	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	45	29	and	and	CCONJ
ejop-10097	45	30	cognitive	cognitive	ADJ
ejop-10097	45	31	symptoms	symptom	NOUN
ejop-10097	45	32	of	of	ADP
ejop-10097	45	33	the	the	DET
ejop-10097	45	34	post	post	ADJ
ejop-10097	45	35	-	-	ADJ
ejop-10097	45	36	covid	covid	ADJ
ejop-10097	45	37	syndrome	syndrome	NOUN
ejop-10097	45	38	.	.	PUNCT
ejop-10097	46	1	that	that	PRON
ejop-10097	46	2	is	be	AUX
ejop-10097	46	3	,	,	PUNCT
ejop-10097	46	4	if	if	SCONJ
ejop-10097	46	5	we	we	PRON
ejop-10097	46	6	view	view	VERB
ejop-10097	46	7	the	the	DET
ejop-10097	46	8	viral	viral	ADJ
ejop-10097	46	9	infection	infection	NOUN
ejop-10097	46	10	as	as	ADP
ejop-10097	46	11	a	a	DET
ejop-10097	46	12	factor	factor	NOUN
ejop-10097	46	13	in	in	ADP
ejop-10097	46	14	the	the	DET
ejop-10097	46	15	external	external	ADJ
ejop-10097	46	16	field	field	NOUN
ejop-10097	46	17	that	that	PRON
ejop-10097	46	18	causes	cause	VERB
ejop-10097	46	19	initial	initial	ADJ
ejop-10097	46	20	activation	activation	NOUN
ejop-10097	46	21	of	of	ADP
ejop-10097	46	22	nodes	node	NOUN
ejop-10097	46	23	in	in	ADP
ejop-10097	46	24	the	the	DET
ejop-10097	46	25	symptom	symptom	NOUN
ejop-10097	46	26	network	network	NOUN
ejop-10097	46	27	.	.	PUNCT
ejop-10097	47	1	scharfenberg	scharfenberg	PROPN
ejop-10097	47	2	,	,	PUNCT
ejop-10097	47	3	schild	schild	PROPN
ejop-10097	47	4	,	,	PUNCT
ejop-10097	47	5	warnke	warnke	NOUN
ejop-10097	47	6	,	,	PUNCT
ejop-10097	47	7	&	&	CCONJ
ejop-10097	47	8	maier	maier	PROPN
ejop-10097	47	9	351	351	NUM
ejop-10097	47	10	europe	europe	PROPN
ejop-10097	47	11	's	's	PART
ejop-10097	47	12	journal	journal	NOUN
ejop-10097	47	13	of	of	ADP
ejop-10097	47	14	psychology	psychology	NOUN
ejop-10097	47	15	2022	2022	NUM
ejop-10097	47	16	,	,	PUNCT
ejop-10097	47	17	vol	vol	NOUN
ejop-10097	47	18	.	.	PUNCT
ejop-10097	47	19	18(4	18(4	NUM
ejop-10097	47	20	)	)	PUNCT
ejop-10097	47	21	,	,	PUNCT
ejop-10097	47	22	350–356	350–356	NUM
ejop-10097	47	23	https://doi.org/10.5964/ejop.10097	https://doi.org/10.5964/ejop.10097	NUM
ejop-10097	47	24	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
ejop-10097	47	25	for	for	ADP
ejop-10097	47	26	example	example	NOUN
ejop-10097	47	27	,	,	PUNCT
ejop-10097	47	28	it	it	PRON
ejop-10097	47	29	is	be	AUX
ejop-10097	47	30	possible	possible	ADJ
ejop-10097	47	31	that	that	SCONJ
ejop-10097	47	32	the	the	DET
ejop-10097	47	33	infection	infection	NOUN
ejop-10097	47	34	could	could	AUX
ejop-10097	47	35	cause	cause	VERB
ejop-10097	47	36	initial	initial	ADJ
ejop-10097	47	37	symptoms	symptom	NOUN
ejop-10097	47	38	like	like	ADP
ejop-10097	47	39	fatigue	fatigue	NOUN
ejop-10097	47	40	and	and	CCONJ
ejop-10097	47	41	tiredness	tiredness	NOUN
ejop-10097	47	42	.	.	PUNCT
ejop-10097	48	1	from	from	ADP
ejop-10097	48	2	these	these	DET
ejop-10097	48	3	initial	initial	ADJ
ejop-10097	48	4	symptoms	symptom	NOUN
ejop-10097	48	5	,	,	PUNCT
ejop-10097	48	6	activation	activation	NOUN
ejop-10097	48	7	will	will	AUX
ejop-10097	48	8	spread	spread	VERB
ejop-10097	48	9	throughout	throughout	ADP
ejop-10097	48	10	the	the	DET
ejop-10097	48	11	network	network	NOUN
ejop-10097	48	12	.	.	PUNCT
ejop-10097	49	1	figure	figure	NOUN
ejop-10097	49	2	1	1	NUM
ejop-10097	49	3	displays	display	VERB
ejop-10097	49	4	a	a	DET
ejop-10097	49	5	possible	possible	ADJ
ejop-10097	49	6	pathway	pathway	NOUN
ejop-10097	49	7	of	of	ADP
ejop-10097	49	8	activation	activation	NOUN
ejop-10097	49	9	.	.	PUNCT
ejop-10097	50	1	in	in	ADP
ejop-10097	50	2	this	this	DET
ejop-10097	50	3	example	example	NOUN
ejop-10097	50	4	,	,	PUNCT
ejop-10097	50	5	fatigue	fatigue	NOUN
ejop-10097	50	6	may	may	AUX
ejop-10097	50	7	lead	lead	VERB
ejop-10097	50	8	to	to	ADP
ejop-10097	50	9	disrupted	disrupt	VERB
ejop-10097	50	10	sleep	sleep	NOUN
ejop-10097	50	11	,	,	PUNCT
ejop-10097	50	12	which	which	PRON
ejop-10097	50	13	in	in	ADP
ejop-10097	50	14	turn	turn	NOUN
ejop-10097	50	15	could	could	AUX
ejop-10097	50	16	lead	lead	VERB
ejop-10097	50	17	to	to	ADP
ejop-10097	50	18	tiredness	tiredness	NOUN
ejop-10097	50	19	and	and	CCONJ
ejop-10097	50	20	finally	finally	ADV
ejop-10097	50	21	induces	induce	VERB
ejop-10097	50	22	impaired	impaired	ADJ
ejop-10097	50	23	cognitive	cognitive	ADJ
ejop-10097	50	24	performance	performance	NOUN
ejop-10097	50	25	or	or	CCONJ
ejop-10097	50	26	depressive	depressive	ADJ
ejop-10097	50	27	symptoms	symptom	NOUN
ejop-10097	50	28	that	that	PRON
ejop-10097	50	29	are	be	AUX
ejop-10097	50	30	connected	connect	VERB
ejop-10097	50	31	with	with	ADP
ejop-10097	50	32	the	the	DET
ejop-10097	50	33	anxiety	anxiety	NOUN
ejop-10097	50	34	symptom	symptom	NOUN
ejop-10097	50	35	cluster	cluster	NOUN
ejop-10097	50	36	.	.	PUNCT
ejop-10097	51	1	note	note	VERB
ejop-10097	51	2	that	that	SCONJ
ejop-10097	51	3	this	this	PRON
ejop-10097	51	4	is	be	AUX
ejop-10097	51	5	one	one	NUM
ejop-10097	51	6	of	of	ADP
ejop-10097	51	7	many	many	ADJ
ejop-10097	51	8	possible	possible	ADJ
ejop-10097	51	9	causal	causal	ADJ
ejop-10097	51	10	pathways	pathway	NOUN
ejop-10097	51	11	in	in	ADP
ejop-10097	51	12	the	the	DET
ejop-10097	51	13	network	network	NOUN
ejop-10097	51	14	and	and	CCONJ
ejop-10097	51	15	edges	edge	NOUN
ejop-10097	51	16	in	in	ADP
ejop-10097	51	17	individual	individual	ADJ
ejop-10097	51	18	symptom	symptom	NOUN
ejop-10097	51	19	networks	network	NOUN
ejop-10097	51	20	may	may	AUX
ejop-10097	51	21	even	even	ADV
ejop-10097	51	22	differ	differ	VERB
ejop-10097	51	23	between	between	ADP
ejop-10097	51	24	persons	person	NOUN
ejop-10097	51	25	.	.	PUNCT
ejop-10097	52	1	figure	figure	VERB
ejop-10097	52	2	1	1	NUM
ejop-10097	52	3	possible	possible	ADJ
ejop-10097	52	4	pathway	pathway	NOUN
ejop-10097	52	5	of	of	ADP
ejop-10097	52	6	activation	activation	NOUN
ejop-10097	52	7	in	in	ADP
ejop-10097	52	8	the	the	DET
ejop-10097	52	9	post	post	ADJ
ejop-10097	52	10	-	-	ADJ
ejop-10097	52	11	covid	covid	ADJ
ejop-10097	52	12	network	network	NOUN
ejop-10097	52	13	of	of	ADP
ejop-10097	52	14	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	52	15	and	and	CCONJ
ejop-10097	52	16	cognitive	cognitive	ADJ
ejop-10097	52	17	symptoms	symptom	NOUN
ejop-10097	52	18	note	note	VERB
ejop-10097	52	19	.	.	PUNCT
ejop-10097	53	1	acute	acute	PROPN
ejop-10097	53	2	covid-19	covid-19	PROPN
ejop-10097	53	3	infection	infection	NOUN
ejop-10097	53	4	in	in	ADP
ejop-10097	53	5	the	the	DET
ejop-10097	53	6	external	external	ADJ
ejop-10097	53	7	field	field	NOUN
ejop-10097	53	8	(	(	PUNCT
ejop-10097	53	9	black	black	ADJ
ejop-10097	53	10	node	node	NOUN
ejop-10097	53	11	)	)	PUNCT
ejop-10097	53	12	initially	initially	ADV
ejop-10097	53	13	activates	activate	VERB
ejop-10097	53	14	symptoms	symptom	NOUN
ejop-10097	53	15	,	,	PUNCT
ejop-10097	53	16	e.g.	e.g.	ADV
ejop-10097	53	17	,	,	PUNCT
ejop-10097	53	18	fatigue	fatigue	NOUN
ejop-10097	53	19	,	,	PUNCT
ejop-10097	53	20	that	that	PRON
ejop-10097	53	21	spread	spread	VERB
ejop-10097	53	22	the	the	DET
ejop-10097	53	23	activation	activation	NOUN
ejop-10097	53	24	to	to	ADP
ejop-10097	53	25	other	other	ADJ
ejop-10097	53	26	symptoms	symptom	NOUN
ejop-10097	53	27	in	in	ADP
ejop-10097	53	28	the	the	DET
ejop-10097	53	29	network	network	NOUN
ejop-10097	53	30	(	(	PUNCT
ejop-10097	53	31	grey	grey	PROPN
ejop-10097	53	32	nodes	node	NOUN
ejop-10097	53	33	)	)	PUNCT
ejop-10097	53	34	.	.	PUNCT
ejop-10097	54	1	however	however	ADV
ejop-10097	54	2	,	,	PUNCT
ejop-10097	54	3	the	the	DET
ejop-10097	54	4	question	question	NOUN
ejop-10097	54	5	remains	remain	VERB
ejop-10097	54	6	as	as	ADP
ejop-10097	54	7	to	to	ADP
ejop-10097	54	8	why	why	SCONJ
ejop-10097	54	9	symptoms	symptom	NOUN
ejop-10097	54	10	persist	persist	VERB
ejop-10097	54	11	even	even	ADV
ejop-10097	54	12	after	after	SCONJ
ejop-10097	54	13	the	the	DET
ejop-10097	54	14	source	source	NOUN
ejop-10097	54	15	of	of	ADP
ejop-10097	54	16	initial	initial	ADJ
ejop-10097	54	17	activation	activation	NOUN
ejop-10097	54	18	is	be	AUX
ejop-10097	54	19	already	already	ADV
ejop-10097	54	20	gone	go	VERB
ejop-10097	54	21	.	.	PUNCT
ejop-10097	55	1	to	to	PART
ejop-10097	55	2	explain	explain	VERB
ejop-10097	55	3	this	this	DET
ejop-10097	55	4	phenomenon	phenomenon	NOUN
ejop-10097	55	5	,	,	PUNCT
ejop-10097	55	6	we	we	PRON
ejop-10097	55	7	need	need	VERB
ejop-10097	55	8	to	to	PART
ejop-10097	55	9	apply	apply	VERB
ejop-10097	55	10	the	the	DET
ejop-10097	55	11	principle	principle	NOUN
ejop-10097	55	12	of	of	ADP
ejop-10097	55	13	hysteresis	hysteresis	NOUN
ejop-10097	55	14	that	that	PRON
ejop-10097	55	15	is	be	AUX
ejop-10097	55	16	described	describe	VERB
ejop-10097	55	17	in	in	ADP
ejop-10097	55	18	the	the	DET
ejop-10097	55	19	network	network	NOUN
ejop-10097	55	20	theory	theory	NOUN
ejop-10097	55	21	of	of	ADP
ejop-10097	55	22	mental	mental	ADJ
ejop-10097	55	23	disorders	disorder	NOUN
ejop-10097	55	24	.	.	PUNCT
ejop-10097	56	1	it	it	PRON
ejop-10097	56	2	“	"	PUNCT
ejop-10097	56	3	implies	imply	VERB
ejop-10097	56	4	that	that	SCONJ
ejop-10097	56	5	symptoms	symptom	NOUN
ejop-10097	56	6	continue	continue	VERB
ejop-10097	56	7	to	to	PART
ejop-10097	56	8	activate	activate	VERB
ejop-10097	56	9	each	each	DET
ejop-10097	56	10	other	other	ADJ
ejop-10097	56	11	,	,	PUNCT
ejop-10097	56	12	even	even	ADV
ejop-10097	56	13	after	after	SCONJ
ejop-10097	56	14	the	the	DET
ejop-10097	56	15	triggering	triggering	NOUN
ejop-10097	56	16	cause	cause	NOUN
ejop-10097	56	17	of	of	ADP
ejop-10097	56	18	the	the	DET
ejop-10097	56	19	disorder	disorder	NOUN
ejop-10097	56	20	has	have	AUX
ejop-10097	56	21	disappeared	disappear	VERB
ejop-10097	56	22	”	"	PUNCT
ejop-10097	56	23	(	(	PUNCT
ejop-10097	56	24	borsboom	borsboom	NOUN
ejop-10097	56	25	,	,	PUNCT
ejop-10097	56	26	2017	2017	NUM
ejop-10097	56	27	,	,	PUNCT
ejop-10097	56	28	p.	p.	NOUN
ejop-10097	56	29	9	9	NUM
ejop-10097	56	30	)	)	PUNCT
ejop-10097	56	31	.	.	PUNCT
ejop-10097	57	1	to	to	PART
ejop-10097	57	2	apply	apply	VERB
ejop-10097	57	3	this	this	DET
ejop-10097	57	4	principle	principle	NOUN
ejop-10097	57	5	,	,	PUNCT
ejop-10097	57	6	the	the	DET
ejop-10097	57	7	network	network	NOUN
ejop-10097	57	8	needs	need	VERB
ejop-10097	57	9	to	to	PART
ejop-10097	57	10	be	be	AUX
ejop-10097	57	11	strongly	strongly	ADV
ejop-10097	57	12	interconnected	interconnect	VERB
ejop-10097	57	13	.	.	PUNCT
ejop-10097	58	1	then	then	ADV
ejop-10097	58	2	,	,	PUNCT
ejop-10097	58	3	it	it	PRON
ejop-10097	58	4	results	result	VERB
ejop-10097	58	5	in	in	ADP
ejop-10097	58	6	a	a	DET
ejop-10097	58	7	self	self	NOUN
ejop-10097	58	8	-	-	PUNCT
ejop-10097	58	9	sustaining	sustain	VERB
ejop-10097	58	10	network	network	NOUN
ejop-10097	58	11	,	,	PUNCT
ejop-10097	58	12	as	as	SCONJ
ejop-10097	58	13	feedback	feedback	NOUN
ejop-10097	58	14	interactions	interaction	NOUN
ejop-10097	58	15	between	between	ADP
ejop-10097	58	16	nodes	node	NOUN
ejop-10097	58	17	do	do	AUX
ejop-10097	58	18	not	not	PART
ejop-10097	58	19	lead	lead	VERB
ejop-10097	58	20	to	to	ADP
ejop-10097	58	21	a	a	DET
ejop-10097	58	22	loss	loss	NOUN
ejop-10097	58	23	in	in	ADP
ejop-10097	58	24	activation	activation	NOUN
ejop-10097	58	25	.	.	PUNCT
ejop-10097	59	1	by	by	ADP
ejop-10097	59	2	this	this	PRON
ejop-10097	59	3	,	,	PUNCT
ejop-10097	59	4	the	the	DET
ejop-10097	59	5	network	network	NOUN
ejop-10097	59	6	remains	remain	VERB
ejop-10097	59	7	in	in	ADP
ejop-10097	59	8	a	a	DET
ejop-10097	59	9	stable	stable	ADJ
ejop-10097	59	10	but	but	CCONJ
ejop-10097	59	11	dysfunctional	dysfunctional	ADJ
ejop-10097	59	12	state	state	NOUN
ejop-10097	59	13	with	with	ADP
ejop-10097	59	14	activated	activate	VERB
ejop-10097	59	15	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	59	16	and	and	CCONJ
ejop-10097	59	17	cognitive	cognitive	ADJ
ejop-10097	59	18	symptoms	symptom	NOUN
ejop-10097	59	19	.	.	PUNCT
ejop-10097	60	1	relevant	relevant	ADJ
ejop-10097	60	2	nodes	node	NOUN
ejop-10097	60	3	of	of	ADP
ejop-10097	60	4	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	60	5	symptoms	symptom	NOUN
ejop-10097	60	6	in	in	ADP
ejop-10097	60	7	this	this	DET
ejop-10097	60	8	network	network	NOUN
ejop-10097	60	9	could	could	AUX
ejop-10097	60	10	be	be	AUX
ejop-10097	60	11	fatigue	fatigue	NOUN
ejop-10097	60	12	,	,	PUNCT
ejop-10097	60	13	anxiety	anxiety	NOUN
ejop-10097	60	14	and	and	CCONJ
ejop-10097	60	15	depressive	depressive	ADJ
ejop-10097	60	16	symptoms	symptom	NOUN
ejop-10097	60	17	,	,	PUNCT
ejop-10097	60	18	disturbed	disturbed	ADJ
ejop-10097	60	19	sleep	sleep	NOUN
ejop-10097	60	20	,	,	PUNCT
ejop-10097	60	21	distress	distress	NOUN
ejop-10097	60	22	and	and	CCONJ
ejop-10097	60	23	cognitive	cognitive	ADJ
ejop-10097	60	24	impairment	impairment	NOUN
ejop-10097	60	25	but	but	CCONJ
ejop-10097	60	26	may	may	AUX
ejop-10097	60	27	also	also	ADV
ejop-10097	60	28	be	be	AUX
ejop-10097	60	29	connected	connect	VERB
ejop-10097	60	30	to	to	ADP
ejop-10097	60	31	neurological	neurological	ADJ
ejop-10097	60	32	symptoms	symptom	NOUN
ejop-10097	60	33	in	in	ADP
ejop-10097	60	34	the	the	DET
ejop-10097	60	35	external	external	ADJ
ejop-10097	60	36	field	field	NOUN
ejop-10097	60	37	,	,	PUNCT
ejop-10097	60	38	e.g.	e.g.	ADV
ejop-10097	60	39	myalgia	myalgia	NOUN
ejop-10097	60	40	or	or	CCONJ
ejop-10097	60	41	neuroinflammatory	neuroinflammatory	NOUN
ejop-10097	60	42	processes	process	NOUN
ejop-10097	60	43	.	.	PUNCT
ejop-10097	61	1	discussion	discussion	NOUN
ejop-10097	61	2	the	the	DET
ejop-10097	61	3	network	network	NOUN
ejop-10097	61	4	theory	theory	NOUN
ejop-10097	61	5	of	of	ADP
ejop-10097	61	6	mental	mental	ADJ
ejop-10097	61	7	disorders	disorder	NOUN
ejop-10097	61	8	can	can	AUX
ejop-10097	61	9	be	be	AUX
ejop-10097	61	10	a	a	DET
ejop-10097	61	11	useful	useful	ADJ
ejop-10097	61	12	approach	approach	NOUN
ejop-10097	61	13	to	to	PART
ejop-10097	61	14	explain	explain	VERB
ejop-10097	61	15	psychiatric	psychiatric	ADJ
ejop-10097	61	16	and	and	CCONJ
ejop-10097	61	17	cognitive	cognitive	ADJ
ejop-10097	61	18	symptoms	symptom	NOUN
ejop-10097	61	19	in	in	ADP
ejop-10097	61	20	post	post	ADJ
ejop-10097	61	21	-	-	ADJ
ejop-10097	61	22	covid	covid	ADJ
ejop-10097	61	23	syndrome	syndrome	NOUN
ejop-10097	61	24	.	.	PUNCT
ejop-10097	62	1	it	it	PRON
ejop-10097	62	2	has	have	VERB
ejop-10097	62	3	some	some	DET
ejop-10097	62	4	advantages	advantage	NOUN
ejop-10097	62	5	over	over	ADP
ejop-10097	62	6	other	other	ADJ
ejop-10097	62	7	offered	offer	VERB
ejop-10097	62	8	explanations	explanation	NOUN
ejop-10097	62	9	.	.	PUNCT
ejop-10097	63	1	as	as	SCONJ
ejop-10097	63	2	already	already	ADV
ejop-10097	63	3	mentioned	mention	VERB
ejop-10097	63	4	,	,	PUNCT
ejop-10097	63	5	the	the	DET
ejop-10097	63	6	principle	principle	NOUN
ejop-10097	63	7	of	of	ADP
ejop-10097	63	8	hysteresis	hysteresis	NOUN
ejop-10097	63	9	can	can	AUX
ejop-10097	63	10	explain	explain	VERB
ejop-10097	63	11	why	why	SCONJ
ejop-10097	63	12	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	63	13	post	post	ADJ
ejop-10097	63	14	-	-	ADJ
ejop-10097	63	15	covid	covid	ADJ
ejop-10097	63	16	symptoms	symptom	NOUN
ejop-10097	63	17	are	be	AUX
ejop-10097	63	18	so	so	ADV
ejop-10097	63	19	stable	stable	ADJ
ejop-10097	63	20	over	over	ADP
ejop-10097	63	21	the	the	DET
ejop-10097	63	22	time	time	NOUN
ejop-10097	63	23	,	,	PUNCT
ejop-10097	63	24	even	even	ADV
ejop-10097	63	25	when	when	SCONJ
ejop-10097	63	26	the	the	DET
ejop-10097	63	27	virus	virus	NOUN
ejop-10097	63	28	is	be	AUX
ejop-10097	63	29	no	no	ADV
ejop-10097	63	30	longer	long	ADV
ejop-10097	63	31	apparent	apparent	ADJ
ejop-10097	63	32	in	in	ADP
ejop-10097	63	33	the	the	DET
ejop-10097	63	34	body	body	NOUN
ejop-10097	63	35	(	(	PUNCT
ejop-10097	63	36	schweitzer	schweitzer	PROPN
ejop-10097	63	37	et	et	PROPN
ejop-10097	63	38	al	al	PROPN
ejop-10097	63	39	.	.	PROPN
ejop-10097	63	40	,	,	PUNCT
ejop-10097	63	41	2022	2022	NUM
ejop-10097	63	42	)	)	PUNCT
ejop-10097	63	43	.	.	PUNCT
ejop-10097	64	1	additionally	additionally	ADV
ejop-10097	64	2	,	,	PUNCT
ejop-10097	64	3	the	the	DET
ejop-10097	64	4	network	network	NOUN
ejop-10097	64	5	perspective	perspective	NOUN
ejop-10097	64	6	can	can	AUX
ejop-10097	64	7	explain	explain	VERB
ejop-10097	64	8	the	the	DET
ejop-10097	64	9	phenomenon	phenomenon	NOUN
ejop-10097	64	10	that	that	SCONJ
ejop-10097	64	11	some	some	DET
ejop-10097	64	12	post	post	ADJ
ejop-10097	64	13	-	-	ADJ
ejop-10097	64	14	covid	covid	ADJ
ejop-10097	64	15	symptoms	symptom	NOUN
ejop-10097	64	16	do	do	AUX
ejop-10097	64	17	not	not	PART
ejop-10097	64	18	persist	persist	VERB
ejop-10097	64	19	following	follow	VERB
ejop-10097	64	20	the	the	DET
ejop-10097	64	21	a	a	DET
ejop-10097	64	22	network	network	NOUN
ejop-10097	64	23	perspective	perspective	NOUN
ejop-10097	64	24	on	on	ADP
ejop-10097	64	25	the	the	DET
ejop-10097	64	26	post	post	ADJ
ejop-10097	64	27	-	-	ADJ
ejop-10097	64	28	covid	covid	ADJ
ejop-10097	64	29	syndrome	syndrome	PROPN
ejop-10097	64	30	352	352	NUM
ejop-10097	64	31	europe	europe	PROPN
ejop-10097	64	32	's	's	PART
ejop-10097	64	33	journal	journal	NOUN
ejop-10097	64	34	of	of	ADP
ejop-10097	64	35	psychology	psychology	NOUN
ejop-10097	64	36	2022	2022	NUM
ejop-10097	64	37	,	,	PUNCT
ejop-10097	64	38	vol	vol	NOUN
ejop-10097	64	39	.	.	PUNCT
ejop-10097	64	40	18(4	18(4	NUM
ejop-10097	64	41	)	)	PUNCT
ejop-10097	64	42	,	,	PUNCT
ejop-10097	64	43	350–356	350–356	NUM
ejop-10097	64	44	https://doi.org/10.5964/ejop.10097	https://doi.org/10.5964/ejop.10097	NOUN
ejop-10097	64	45	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
ejop-10097	64	46	acute	acute	ADJ
ejop-10097	64	47	infection	infection	NOUN
ejop-10097	64	48	but	but	CCONJ
ejop-10097	64	49	rather	rather	ADV
ejop-10097	64	50	newly	newly	ADV
ejop-10097	64	51	develop	develop	VERB
ejop-10097	64	52	afterwards	afterwards	ADV
ejop-10097	64	53	(	(	PUNCT
ejop-10097	64	54	national	national	PROPN
ejop-10097	64	55	institute	institute	NOUN
ejop-10097	64	56	for	for	ADP
ejop-10097	64	57	health	health	NOUN
ejop-10097	64	58	and	and	CCONJ
ejop-10097	64	59	care	care	PROPN
ejop-10097	64	60	excellence	excellence	PROPN
ejop-10097	64	61	,	,	PUNCT
ejop-10097	64	62	2020	2020	NUM
ejop-10097	64	63	)	)	PUNCT
ejop-10097	64	64	.	.	PUNCT
ejop-10097	65	1	this	this	DET
ejop-10097	65	2	explanation	explanation	NOUN
ejop-10097	65	3	could	could	AUX
ejop-10097	65	4	change	change	VERB
ejop-10097	65	5	our	our	PRON
ejop-10097	65	6	view	view	NOUN
ejop-10097	65	7	(	(	PUNCT
ejop-10097	65	8	at	at	ADP
ejop-10097	65	9	least	least	ADJ
ejop-10097	65	10	for	for	ADP
ejop-10097	65	11	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	65	12	and	and	CCONJ
ejop-10097	65	13	cognitive	cognitive	ADJ
ejop-10097	65	14	symptoms	symptom	NOUN
ejop-10097	65	15	)	)	PUNCT
ejop-10097	65	16	on	on	ADP
ejop-10097	65	17	the	the	DET
ejop-10097	65	18	syndrome	syndrome	NOUN
ejop-10097	65	19	not	not	PART
ejop-10097	65	20	to	to	PART
ejop-10097	65	21	be	be	AUX
ejop-10097	65	22	the	the	DET
ejop-10097	65	23	prolongation	prolongation	NOUN
ejop-10097	65	24	of	of	ADP
ejop-10097	65	25	the	the	DET
ejop-10097	65	26	viral	viral	ADJ
ejop-10097	65	27	disease	disease	NOUN
ejop-10097	65	28	,	,	PUNCT
ejop-10097	65	29	as	as	SCONJ
ejop-10097	65	30	it	it	PRON
ejop-10097	65	31	is	be	AUX
ejop-10097	65	32	reflected	reflect	VERB
ejop-10097	65	33	by	by	ADP
ejop-10097	65	34	the	the	DET
ejop-10097	65	35	term	term	NOUN
ejop-10097	65	36	“	"	PUNCT
ejop-10097	65	37	long	long	ADJ
ejop-10097	65	38	-	-	PUNCT
ejop-10097	65	39	covid	covid	NOUN
ejop-10097	65	40	”	"	PUNCT
ejop-10097	65	41	which	which	PRON
ejop-10097	65	42	is	be	AUX
ejop-10097	65	43	often	often	ADV
ejop-10097	65	44	used	use	VERB
ejop-10097	65	45	in	in	ADP
ejop-10097	65	46	ongoing	ongoing	ADJ
ejop-10097	65	47	science	science	NOUN
ejop-10097	65	48	communication	communication	NOUN
ejop-10097	65	49	,	,	PUNCT
ejop-10097	65	50	but	but	CCONJ
ejop-10097	65	51	rather	rather	ADV
ejop-10097	65	52	a	a	DET
ejop-10097	65	53	separate	separate	ADJ
ejop-10097	65	54	condition	condition	NOUN
ejop-10097	65	55	that	that	SCONJ
ejop-10097	65	56	only	only	ADV
ejop-10097	65	57	originates	originate	NOUN
ejop-10097	65	58	in	in	ADP
ejop-10097	65	59	the	the	DET
ejop-10097	65	60	acute	acute	ADJ
ejop-10097	65	61	infection	infection	NOUN
ejop-10097	65	62	with	with	ADP
ejop-10097	65	63	sars	sar	NOUN
ejop-10097	65	64	-	-	PUNCT
ejop-10097	65	65	cov-2	cov-2	NOUN
ejop-10097	65	66	,	,	PUNCT
ejop-10097	65	67	as	as	SCONJ
ejop-10097	65	68	it	it	PRON
ejop-10097	65	69	is	be	AUX
ejop-10097	65	70	reflected	reflect	VERB
ejop-10097	65	71	in	in	ADP
ejop-10097	65	72	the	the	DET
ejop-10097	65	73	term	term	NOUN
ejop-10097	65	74	“	"	PUNCT
ejop-10097	65	75	post	post	ADJ
ejop-10097	65	76	-	-	NOUN
ejop-10097	65	77	covid	covid	NOUN
ejop-10097	65	78	”	"	PUNCT
ejop-10097	65	79	.	.	PUNCT
ejop-10097	66	1	this	this	PRON
ejop-10097	66	2	especially	especially	ADV
ejop-10097	66	3	applies	apply	VERB
ejop-10097	66	4	to	to	ADP
ejop-10097	66	5	patients	patient	NOUN
ejop-10097	66	6	who	who	PRON
ejop-10097	66	7	experienced	experience	VERB
ejop-10097	66	8	a	a	DET
ejop-10097	66	9	mild	mild	ADJ
ejop-10097	66	10	course	course	NOUN
ejop-10097	66	11	of	of	ADP
ejop-10097	66	12	acute	acute	NOUN
ejop-10097	66	13	covid-19	covid-19	PROPN
ejop-10097	66	14	but	but	CCONJ
ejop-10097	66	15	developed	develop	VERB
ejop-10097	66	16	post	post	ADJ
ejop-10097	66	17	-	-	ADJ
ejop-10097	66	18	covid	covid	ADJ
ejop-10097	66	19	symptoms	symptom	NOUN
ejop-10097	66	20	nonetheless	nonetheless	ADV
ejop-10097	66	21	.	.	PUNCT
ejop-10097	67	1	the	the	DET
ejop-10097	67	2	network	network	NOUN
ejop-10097	67	3	perspective	perspective	NOUN
ejop-10097	67	4	is	be	AUX
ejop-10097	67	5	able	able	ADJ
ejop-10097	67	6	to	to	PART
ejop-10097	67	7	explain	explain	VERB
ejop-10097	67	8	this	this	DET
ejop-10097	67	9	phenomenon	phenomenon	NOUN
ejop-10097	67	10	by	by	ADP
ejop-10097	67	11	arguing	argue	VERB
ejop-10097	67	12	that	that	DET
ejop-10097	67	13	strength	strength	NOUN
ejop-10097	67	14	and	and	CCONJ
ejop-10097	67	15	stability	stability	NOUN
ejop-10097	67	16	of	of	ADP
ejop-10097	67	17	causal	causal	ADJ
ejop-10097	67	18	relationships	relationship	NOUN
ejop-10097	67	19	between	between	ADP
ejop-10097	67	20	symptoms	symptom	NOUN
ejop-10097	67	21	(	(	PUNCT
ejop-10097	67	22	i.e.	i.e.	X
ejop-10097	67	23	,	,	PUNCT
ejop-10097	67	24	edges	edge	NOUN
ejop-10097	67	25	)	)	PUNCT
ejop-10097	67	26	are	be	AUX
ejop-10097	67	27	more	more	ADV
ejop-10097	67	28	important	important	ADJ
ejop-10097	67	29	for	for	ADP
ejop-10097	67	30	spreading	spread	VERB
ejop-10097	67	31	activation	activation	NOUN
ejop-10097	67	32	in	in	ADP
ejop-10097	67	33	a	a	DET
ejop-10097	67	34	network	network	NOUN
ejop-10097	67	35	than	than	ADP
ejop-10097	67	36	the	the	DET
ejop-10097	67	37	severity	severity	NOUN
ejop-10097	67	38	of	of	ADP
ejop-10097	67	39	the	the	DET
ejop-10097	67	40	initial	initial	ADJ
ejop-10097	67	41	symptom	symptom	NOUN
ejop-10097	67	42	(	(	PUNCT
ejop-10097	67	43	i.e.	i.e.	X
ejop-10097	67	44	,	,	PUNCT
ejop-10097	67	45	activation	activation	NOUN
ejop-10097	67	46	of	of	ADP
ejop-10097	67	47	the	the	DET
ejop-10097	67	48	node	node	NOUN
ejop-10097	67	49	)	)	PUNCT
ejop-10097	67	50	,	,	PUNCT
ejop-10097	67	51	e.g.	e.g.	ADV
ejop-10097	67	52	,	,	PUNCT
ejop-10097	67	53	the	the	DET
ejop-10097	67	54	feeling	feeling	NOUN
ejop-10097	67	55	of	of	ADP
ejop-10097	67	56	fatigue	fatigue	NOUN
ejop-10097	67	57	and	and	CCONJ
ejop-10097	67	58	illness	illness	NOUN
ejop-10097	67	59	experienced	experience	VERB
ejop-10097	67	60	during	during	ADP
ejop-10097	67	61	the	the	DET
ejop-10097	67	62	acute	acute	ADJ
ejop-10097	67	63	phase	phase	NOUN
ejop-10097	67	64	of	of	ADP
ejop-10097	67	65	covid-19	covid-19	PROPN
ejop-10097	67	66	.	.	PUNCT
ejop-10097	68	1	another	another	DET
ejop-10097	68	2	advantage	advantage	NOUN
ejop-10097	68	3	is	be	AUX
ejop-10097	68	4	the	the	DET
ejop-10097	68	5	generalizability	generalizability	NOUN
ejop-10097	68	6	of	of	ADP
ejop-10097	68	7	this	this	DET
ejop-10097	68	8	approach	approach	NOUN
ejop-10097	68	9	.	.	PUNCT
ejop-10097	69	1	this	this	DET
ejop-10097	69	2	network	network	NOUN
ejop-10097	69	3	perspective	perspective	NOUN
ejop-10097	69	4	can	can	AUX
ejop-10097	69	5	not	not	PART
ejop-10097	69	6	only	only	ADV
ejop-10097	69	7	explain	explain	VERB
ejop-10097	69	8	symptoms	symptom	NOUN
ejop-10097	69	9	of	of	ADP
ejop-10097	69	10	the	the	DET
ejop-10097	69	11	post	post	ADJ
ejop-10097	69	12	-	-	ADJ
ejop-10097	69	13	covid	covid	ADJ
ejop-10097	69	14	syndrome	syndrome	NOUN
ejop-10097	69	15	,	,	PUNCT
ejop-10097	69	16	but	but	CCONJ
ejop-10097	69	17	also	also	ADV
ejop-10097	69	18	similar	similar	ADJ
ejop-10097	69	19	phenomena	phenomenon	NOUN
ejop-10097	69	20	occurring	occur	VERB
ejop-10097	69	21	after	after	ADP
ejop-10097	69	22	different	different	ADJ
ejop-10097	69	23	viral	viral	ADJ
ejop-10097	69	24	infections	infection	NOUN
ejop-10097	69	25	as	as	SCONJ
ejop-10097	69	26	observed	observe	VERB
ejop-10097	69	27	in	in	ADP
ejop-10097	69	28	infections	infection	NOUN
ejop-10097	69	29	with	with	ADP
ejop-10097	69	30	other	other	ADJ
ejop-10097	69	31	corona	corona	NOUN
ejop-10097	69	32	viruses	virus	NOUN
ejop-10097	69	33	like	like	ADP
ejop-10097	69	34	mers	mer	NOUN
ejop-10097	69	35	-	-	PUNCT
ejop-10097	69	36	cov	cov	NOUN
ejop-10097	69	37	and	and	CCONJ
ejop-10097	69	38	sars	sars	PROPN
ejop-10097	69	39	-	-	PUNCT
ejop-10097	69	40	cov	cov	PROPN
ejop-10097	69	41	(	(	PUNCT
ejop-10097	69	42	rogers	rogers	PROPN
ejop-10097	69	43	et	et	PROPN
ejop-10097	69	44	al	al	PROPN
ejop-10097	69	45	.	.	PROPN
ejop-10097	69	46	,	,	PUNCT
ejop-10097	69	47	2020	2020	NUM
ejop-10097	69	48	)	)	PUNCT
ejop-10097	69	49	.	.	PUNCT
ejop-10097	70	1	it	it	PRON
ejop-10097	70	2	could	could	AUX
ejop-10097	70	3	possibly	possibly	ADV
ejop-10097	70	4	even	even	ADV
ejop-10097	70	5	explain	explain	VERB
ejop-10097	70	6	cognitive	cognitive	ADJ
ejop-10097	70	7	and	and	CCONJ
ejop-10097	70	8	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	70	9	symptoms	symptom	NOUN
ejop-10097	70	10	similar	similar	ADJ
ejop-10097	70	11	to	to	ADP
ejop-10097	70	12	those	those	PRON
ejop-10097	70	13	observed	observe	VERB
ejop-10097	70	14	in	in	ADP
ejop-10097	70	15	the	the	DET
ejop-10097	70	16	post	post	ADJ
ejop-10097	70	17	-	-	ADJ
ejop-10097	70	18	covid	covid	ADJ
ejop-10097	70	19	syndrome	syndrome	NOUN
ejop-10097	70	20	following	follow	VERB
ejop-10097	70	21	other	other	ADJ
ejop-10097	70	22	viral	viral	ADJ
ejop-10097	70	23	or	or	CCONJ
ejop-10097	70	24	bacterial	bacterial	ADJ
ejop-10097	70	25	infections	infection	NOUN
ejop-10097	70	26	,	,	PUNCT
ejop-10097	70	27	e.g.	e.g.	ADV
ejop-10097	70	28	in	in	ADP
ejop-10097	70	29	infections	infection	NOUN
ejop-10097	70	30	with	with	ADP
ejop-10097	70	31	influenza	influenza	NOUN
ejop-10097	70	32	,	,	PUNCT
ejop-10097	70	33	the	the	DET
ejop-10097	70	34	west	west	PROPN
ejop-10097	70	35	-	-	PUNCT
ejop-10097	70	36	nile	nile	PROPN
ejop-10097	70	37	virus	virus	PROPN
ejop-10097	70	38	(	(	PUNCT
ejop-10097	70	39	damiano	damiano	PROPN
ejop-10097	70	40	et	et	PROPN
ejop-10097	70	41	al	al	PROPN
ejop-10097	70	42	.	.	PROPN
ejop-10097	70	43	,	,	PUNCT
ejop-10097	70	44	2022	2022	NUM
ejop-10097	70	45	)	)	PUNCT
ejop-10097	70	46	,	,	PUNCT
ejop-10097	70	47	the	the	DET
ejop-10097	70	48	hepatitis	hepatitis	NOUN
ejop-10097	70	49	-	-	PUNCT
ejop-10097	70	50	c	c	PROPN
ejop-10097	70	51	virus	virus	NOUN
ejop-10097	70	52	(	(	PUNCT
ejop-10097	70	53	monaco	monaco	PROPN
ejop-10097	70	54	et	et	PROPN
ejop-10097	70	55	al	al	PROPN
ejop-10097	70	56	.	.	PROPN
ejop-10097	70	57	,	,	PUNCT
ejop-10097	70	58	2015	2015	NUM
ejop-10097	70	59	)	)	PUNCT
ejop-10097	70	60	or	or	CCONJ
ejop-10097	70	61	multi	multi	ADJ
ejop-10097	70	62	-	-	ADJ
ejop-10097	70	63	bacterial	bacterial	ADJ
ejop-10097	70	64	infections	infection	NOUN
ejop-10097	70	65	that	that	PRON
ejop-10097	70	66	cause	cause	VERB
ejop-10097	70	67	periodontitis	periodontitis	NOUN
ejop-10097	70	68	(	(	PUNCT
ejop-10097	70	69	hashioka	hashioka	PROPN
ejop-10097	70	70	et	et	PROPN
ejop-10097	70	71	al	al	PROPN
ejop-10097	70	72	.	.	PROPN
ejop-10097	70	73	,	,	PUNCT
ejop-10097	70	74	2019	2019	NUM
ejop-10097	70	75	)	)	PUNCT
ejop-10097	70	76	.	.	PUNCT
ejop-10097	71	1	to	to	PART
ejop-10097	71	2	test	test	VERB
ejop-10097	71	3	applications	application	NOUN
ejop-10097	71	4	of	of	ADP
ejop-10097	71	5	the	the	DET
ejop-10097	71	6	network	network	NOUN
ejop-10097	71	7	theory	theory	NOUN
ejop-10097	71	8	on	on	ADP
ejop-10097	71	9	the	the	DET
ejop-10097	71	10	post	post	ADJ
ejop-10097	71	11	-	-	ADJ
ejop-10097	71	12	covid	covid	ADJ
ejop-10097	71	13	syndrome	syndrome	NOUN
ejop-10097	71	14	,	,	PUNCT
ejop-10097	71	15	future	future	ADJ
ejop-10097	71	16	research	research	NOUN
ejop-10097	71	17	should	should	AUX
ejop-10097	71	18	collect	collect	VERB
ejop-10097	71	19	not	not	PART
ejop-10097	71	20	only	only	ADV
ejop-10097	71	21	cross	cross	ADJ
ejop-10097	71	22	-	-	ADJ
ejop-10097	71	23	sectional	sectional	ADJ
ejop-10097	71	24	but	but	CCONJ
ejop-10097	71	25	also	also	ADV
ejop-10097	71	26	longitudinal	longitudinal	ADJ
ejop-10097	71	27	data	datum	NOUN
ejop-10097	71	28	on	on	ADP
ejop-10097	71	29	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	71	30	and	and	CCONJ
ejop-10097	71	31	cognitive	cognitive	ADJ
ejop-10097	71	32	symptoms	symptom	NOUN
ejop-10097	71	33	in	in	ADP
ejop-10097	71	34	patients	patient	NOUN
ejop-10097	71	35	that	that	PRON
ejop-10097	71	36	were	be	AUX
ejop-10097	71	37	infected	infect	VERB
ejop-10097	71	38	with	with	ADP
ejop-10097	71	39	sars	sar	NOUN
ejop-10097	71	40	-	-	PUNCT
ejop-10097	71	41	cov-2	cov-2	NOUN
ejop-10097	71	42	.	.	PUNCT
ejop-10097	72	1	the	the	DET
ejop-10097	72	2	method	method	NOUN
ejop-10097	72	3	of	of	ADP
ejop-10097	72	4	network	network	NOUN
ejop-10097	72	5	analysis	analysis	NOUN
ejop-10097	72	6	will	will	AUX
ejop-10097	72	7	help	help	VERB
ejop-10097	72	8	to	to	PART
ejop-10097	72	9	identify	identify	VERB
ejop-10097	72	10	potential	potential	ADJ
ejop-10097	72	11	causal	causal	ADJ
ejop-10097	72	12	associations	association	NOUN
ejop-10097	72	13	between	between	ADP
ejop-10097	72	14	symptoms	symptom	NOUN
ejop-10097	72	15	that	that	PRON
ejop-10097	72	16	could	could	AUX
ejop-10097	72	17	contribute	contribute	VERB
ejop-10097	72	18	to	to	PART
ejop-10097	72	19	explain	explain	VERB
ejop-10097	72	20	persistent	persistent	ADJ
ejop-10097	72	21	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	72	22	symptoms	symptom	NOUN
ejop-10097	72	23	of	of	ADP
ejop-10097	72	24	covid-19	covid-19	PROPN
ejop-10097	72	25	and	and	CCONJ
ejop-10097	72	26	show	show	VERB
ejop-10097	72	27	how	how	SCONJ
ejop-10097	72	28	post	post	ADJ
ejop-10097	72	29	-	-	ADJ
ejop-10097	72	30	covid	covid	ADJ
ejop-10097	72	31	networks	network	NOUN
ejop-10097	72	32	evolve	evolve	VERB
ejop-10097	72	33	and	and	CCONJ
ejop-10097	72	34	maintain	maintain	VERB
ejop-10097	72	35	over	over	ADP
ejop-10097	72	36	the	the	DET
ejop-10097	72	37	course	course	NOUN
ejop-10097	72	38	of	of	ADP
ejop-10097	72	39	time	time	NOUN
ejop-10097	72	40	(	(	PUNCT
ejop-10097	72	41	borsboom	borsboom	NOUN
ejop-10097	72	42	et	et	PROPN
ejop-10097	72	43	al	al	PROPN
ejop-10097	72	44	.	.	PROPN
ejop-10097	72	45	,	,	PUNCT
ejop-10097	72	46	2021	2021	NUM
ejop-10097	72	47	;	;	PUNCT
ejop-10097	72	48	borsboom	borsboom	NOUN
ejop-10097	72	49	&	&	CCONJ
ejop-10097	72	50	cramer	cramer	PROPN
ejop-10097	72	51	,	,	PUNCT
ejop-10097	72	52	2013	2013	NUM
ejop-10097	72	53	)	)	PUNCT
ejop-10097	72	54	.	.	PUNCT
ejop-10097	73	1	there	there	PRON
ejop-10097	73	2	already	already	ADV
ejop-10097	73	3	are	be	AUX
ejop-10097	73	4	some	some	DET
ejop-10097	73	5	studies	study	NOUN
ejop-10097	73	6	that	that	PRON
ejop-10097	73	7	applied	apply	VERB
ejop-10097	73	8	network	network	NOUN
ejop-10097	73	9	analyses	analysis	NOUN
ejop-10097	73	10	to	to	ADP
ejop-10097	73	11	covid-19	covid-19	PROPN
ejop-10097	73	12	symptom	symptom	NOUN
ejop-10097	73	13	networks	network	NOUN
ejop-10097	73	14	(	(	PUNCT
ejop-10097	73	15	liu	liu	PROPN
ejop-10097	73	16	et	et	PROPN
ejop-10097	73	17	al	al	PROPN
ejop-10097	73	18	.	.	PROPN
ejop-10097	73	19	,	,	PUNCT
ejop-10097	73	20	2021	2021	NUM
ejop-10097	73	21	;	;	PUNCT
ejop-10097	73	22	taquet	taquet	NOUN
ejop-10097	73	23	et	et	PROPN
ejop-10097	73	24	al	al	PROPN
ejop-10097	73	25	.	.	PROPN
ejop-10097	73	26	,	,	PUNCT
ejop-10097	73	27	2021	2021	NUM
ejop-10097	73	28	)	)	PUNCT
ejop-10097	73	29	.	.	PUNCT
ejop-10097	74	1	therefore	therefore	ADV
ejop-10097	74	2	,	,	PUNCT
ejop-10097	74	3	future	future	ADJ
ejop-10097	74	4	studies	study	NOUN
ejop-10097	74	5	should	should	AUX
ejop-10097	74	6	apply	apply	VERB
ejop-10097	74	7	network	network	NOUN
ejop-10097	74	8	analysis	analysis	NOUN
ejop-10097	74	9	based	base	VERB
ejop-10097	74	10	on	on	ADP
ejop-10097	74	11	the	the	DET
ejop-10097	74	12	perspective	perspective	NOUN
ejop-10097	74	13	provided	provide	VERB
ejop-10097	74	14	in	in	ADP
ejop-10097	74	15	this	this	DET
ejop-10097	74	16	article	article	NOUN
ejop-10097	74	17	to	to	PART
ejop-10097	74	18	test	test	VERB
ejop-10097	74	19	the	the	DET
ejop-10097	74	20	hypothesis	hypothesis	NOUN
ejop-10097	74	21	that	that	PRON
ejop-10097	74	22	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	74	23	and	and	CCONJ
ejop-10097	74	24	cognitive	cognitive	ADJ
ejop-10097	74	25	symptoms	symptom	NOUN
ejop-10097	74	26	of	of	ADP
ejop-10097	74	27	the	the	DET
ejop-10097	74	28	post	post	ADJ
ejop-10097	74	29	-	-	ADJ
ejop-10097	74	30	covid	covid	ADJ
ejop-10097	74	31	syndrome	syndrome	NOUN
ejop-10097	74	32	can	can	AUX
ejop-10097	74	33	be	be	AUX
ejop-10097	74	34	conceptualized	conceptualize	VERB
ejop-10097	74	35	within	within	ADP
ejop-10097	74	36	the	the	DET
ejop-10097	74	37	network	network	NOUN
ejop-10097	74	38	theory	theory	NOUN
ejop-10097	74	39	of	of	ADP
ejop-10097	74	40	mental	mental	ADJ
ejop-10097	74	41	disorders	disorder	NOUN
ejop-10097	74	42	.	.	PUNCT
ejop-10097	75	1	confirmatory	confirmatory	NOUN
ejop-10097	75	2	analyses	analysis	NOUN
ejop-10097	75	3	could	could	AUX
ejop-10097	75	4	build	build	VERB
ejop-10097	75	5	on	on	ADP
ejop-10097	75	6	the	the	DET
ejop-10097	75	7	extensive	extensive	ADJ
ejop-10097	75	8	body	body	NOUN
ejop-10097	75	9	of	of	ADP
ejop-10097	75	10	literature	literature	NOUN
ejop-10097	75	11	that	that	PRON
ejop-10097	75	12	provides	provide	VERB
ejop-10097	75	13	evidence	evidence	NOUN
ejop-10097	75	14	of	of	ADP
ejop-10097	75	15	at	at	ADP
ejop-10097	75	16	least	least	ADJ
ejop-10097	75	17	correlational	correlational	ADJ
ejop-10097	75	18	relationships	relationship	NOUN
ejop-10097	75	19	between	between	ADP
ejop-10097	75	20	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	75	21	and	and	CCONJ
ejop-10097	75	22	cognitive	cognitive	ADJ
ejop-10097	75	23	symptoms	symptom	NOUN
ejop-10097	75	24	.	.	PUNCT
ejop-10097	76	1	it	it	PRON
ejop-10097	76	2	is	be	AUX
ejop-10097	76	3	well	well	ADV
ejop-10097	76	4	known	know	VERB
ejop-10097	76	5	that	that	SCONJ
ejop-10097	76	6	several	several	ADJ
ejop-10097	76	7	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	76	8	symptoms	symptom	NOUN
ejop-10097	76	9	are	be	AUX
ejop-10097	76	10	not	not	PART
ejop-10097	76	11	independent	independent	ADJ
ejop-10097	76	12	,	,	PUNCT
ejop-10097	76	13	e.g.	e.g.	ADV
ejop-10097	76	14	that	that	DET
ejop-10097	76	15	depressive	depressive	ADJ
ejop-10097	76	16	and	and	CCONJ
ejop-10097	76	17	anxiety	anxiety	NOUN
ejop-10097	76	18	disorders	disorder	NOUN
ejop-10097	76	19	have	have	VERB
ejop-10097	76	20	common	common	ADJ
ejop-10097	76	21	symptoms	symptom	NOUN
ejop-10097	76	22	connecting	connect	VERB
ejop-10097	76	23	their	their	PRON
ejop-10097	76	24	network	network	NOUN
ejop-10097	76	25	symptom	symptom	NOUN
ejop-10097	76	26	clusters	cluster	NOUN
ejop-10097	76	27	(	(	PUNCT
ejop-10097	76	28	beard	beard	NOUN
ejop-10097	76	29	et	et	PROPN
ejop-10097	76	30	al	al	PROPN
ejop-10097	76	31	.	.	PROPN
ejop-10097	76	32	,	,	PUNCT
ejop-10097	76	33	2016	2016	NUM
ejop-10097	76	34	;	;	PUNCT
ejop-10097	77	1	kaiser	kaiser	PROPN
ejop-10097	77	2	et	et	PROPN
ejop-10097	77	3	al	al	PROPN
ejop-10097	77	4	.	.	PROPN
ejop-10097	77	5	,	,	PUNCT
ejop-10097	77	6	2021	2021	NUM
ejop-10097	77	7	)	)	PUNCT
ejop-10097	77	8	or	or	CCONJ
ejop-10097	77	9	that	that	SCONJ
ejop-10097	77	10	both	both	PRON
ejop-10097	77	11	of	of	ADP
ejop-10097	77	12	them	they	PRON
ejop-10097	77	13	are	be	AUX
ejop-10097	77	14	associated	associate	VERB
ejop-10097	77	15	with	with	ADP
ejop-10097	77	16	sleeping	sleep	VERB
ejop-10097	77	17	disorders	disorder	NOUN
ejop-10097	77	18	(	(	PUNCT
ejop-10097	77	19	becker	becker	PROPN
ejop-10097	77	20	et	et	PROPN
ejop-10097	77	21	al	al	PROPN
ejop-10097	77	22	.	.	PROPN
ejop-10097	77	23	,	,	PUNCT
ejop-10097	77	24	2017	2017	NUM
ejop-10097	77	25	;	;	PUNCT
ejop-10097	77	26	cox	cox	PROPN
ejop-10097	77	27	&	&	CCONJ
ejop-10097	77	28	olatunji	olatunji	PROPN
ejop-10097	77	29	,	,	PUNCT
ejop-10097	77	30	2020	2020	NUM
ejop-10097	77	31	)	)	PUNCT
ejop-10097	77	32	.	.	PUNCT
ejop-10097	78	1	furthermore	furthermore	ADV
ejop-10097	78	2	,	,	PUNCT
ejop-10097	78	3	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	78	4	symptoms	symptom	NOUN
ejop-10097	78	5	often	often	ADV
ejop-10097	78	6	occur	occur	VERB
ejop-10097	78	7	together	together	ADV
ejop-10097	78	8	with	with	ADP
ejop-10097	78	9	cognitive	cognitive	ADJ
ejop-10097	78	10	disorders	disorder	NOUN
ejop-10097	78	11	(	(	PUNCT
ejop-10097	78	12	martin	martin	PROPN
ejop-10097	78	13	&	&	CCONJ
ejop-10097	78	14	velayudhan	velayudhan	PROPN
ejop-10097	78	15	,	,	PUNCT
ejop-10097	78	16	2020	2020	NUM
ejop-10097	78	17	)	)	PUNCT
ejop-10097	78	18	.	.	PUNCT
ejop-10097	79	1	specifically	specifically	ADV
ejop-10097	79	2	,	,	PUNCT
ejop-10097	79	3	there	there	PRON
ejop-10097	79	4	is	be	VERB
ejop-10097	79	5	evidence	evidence	NOUN
ejop-10097	79	6	for	for	ADP
ejop-10097	79	7	associations	association	NOUN
ejop-10097	79	8	between	between	ADP
ejop-10097	79	9	cognition	cognition	NOUN
ejop-10097	79	10	and	and	CCONJ
ejop-10097	79	11	depression	depression	NOUN
ejop-10097	79	12	(	(	PUNCT
ejop-10097	79	13	anapa	anapa	VERB
ejop-10097	79	14	et	et	PROPN
ejop-10097	79	15	al	al	PROPN
ejop-10097	79	16	.	.	PROPN
ejop-10097	79	17	,	,	PUNCT
ejop-10097	79	18	2021	2021	NUM
ejop-10097	79	19	;	;	PUNCT
ejop-10097	79	20	rock	rock	NOUN
ejop-10097	79	21	et	et	PROPN
ejop-10097	79	22	al	al	PROPN
ejop-10097	79	23	.	.	PROPN
ejop-10097	79	24	,	,	PUNCT
ejop-10097	79	25	2014	2014	NUM
ejop-10097	79	26	)	)	PUNCT
ejop-10097	79	27	,	,	PUNCT
ejop-10097	79	28	anxiety	anxiety	NOUN
ejop-10097	79	29	(	(	PUNCT
ejop-10097	79	30	gulpers	gulper	NOUN
ejop-10097	79	31	et	et	NOUN
ejop-10097	79	32	al	al	PROPN
ejop-10097	79	33	.	.	PROPN
ejop-10097	79	34	,	,	PUNCT
ejop-10097	79	35	2016	2016	NUM
ejop-10097	79	36	)	)	PUNCT
ejop-10097	79	37	or	or	CCONJ
ejop-10097	79	38	sleeping	sleep	VERB
ejop-10097	79	39	disorders	disorder	NOUN
ejop-10097	79	40	(	(	PUNCT
ejop-10097	79	41	fortier	fortier	NOUN
ejop-10097	79	42	-	-	PUNCT
ejop-10097	79	43	brochu	brochu	PROPN
ejop-10097	79	44	et	et	PROPN
ejop-10097	79	45	al	al	PROPN
ejop-10097	79	46	.	.	PROPN
ejop-10097	79	47	,	,	PUNCT
ejop-10097	79	48	2012	2012	NUM
ejop-10097	79	49	;	;	PUNCT
ejop-10097	79	50	miyata	miyata	PROPN
ejop-10097	79	51	et	et	PROPN
ejop-10097	79	52	al	al	PROPN
ejop-10097	79	53	.	.	PROPN
ejop-10097	79	54	,	,	PUNCT
ejop-10097	79	55	2013	2013	NUM
ejop-10097	79	56	)	)	PUNCT
ejop-10097	79	57	.	.	PUNCT
ejop-10097	80	1	to	to	PART
ejop-10097	80	2	overcome	overcome	VERB
ejop-10097	80	3	the	the	DET
ejop-10097	80	4	challenge	challenge	NOUN
ejop-10097	80	5	of	of	ADP
ejop-10097	80	6	only	only	ADV
ejop-10097	80	7	describing	describe	VERB
ejop-10097	80	8	bivariate	bivariate	ADJ
ejop-10097	80	9	correlations	correlation	NOUN
ejop-10097	80	10	among	among	ADP
ejop-10097	80	11	possibly	possibly	ADV
ejop-10097	80	12	relevant	relevant	ADJ
ejop-10097	80	13	symptoms	symptom	NOUN
ejop-10097	80	14	in	in	ADP
ejop-10097	80	15	post	post	ADJ
ejop-10097	80	16	-	-	ADJ
ejop-10097	80	17	covid	covid	ADJ
ejop-10097	80	18	syndrome	syndrome	NOUN
ejop-10097	80	19	,	,	PUNCT
ejop-10097	80	20	causal	causal	ADJ
ejop-10097	80	21	relationships	relationship	NOUN
ejop-10097	80	22	from	from	ADP
ejop-10097	80	23	symptom	symptom	NOUN
ejop-10097	80	24	networks	network	NOUN
ejop-10097	80	25	have	have	VERB
ejop-10097	80	26	to	to	PART
ejop-10097	80	27	be	be	AUX
ejop-10097	80	28	identified	identify	VERB
ejop-10097	80	29	by	by	ADP
ejop-10097	80	30	collecting	collect	VERB
ejop-10097	80	31	longitudinal	longitudinal	ADJ
ejop-10097	80	32	data	datum	NOUN
ejop-10097	80	33	on	on	ADP
ejop-10097	80	34	various	various	ADJ
ejop-10097	80	35	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	80	36	and	and	CCONJ
ejop-10097	80	37	cognitive	cognitive	ADJ
ejop-10097	80	38	symptoms	symptom	NOUN
ejop-10097	80	39	in	in	ADP
ejop-10097	80	40	post	post	ADJ
ejop-10097	80	41	-	-	ADJ
ejop-10097	80	42	covid	covid	ADJ
ejop-10097	80	43	patients	patient	NOUN
ejop-10097	80	44	.	.	PUNCT
ejop-10097	81	1	conclusion	conclusion	NOUN
ejop-10097	81	2	the	the	DET
ejop-10097	81	3	provided	provide	VERB
ejop-10097	81	4	network	network	NOUN
ejop-10097	81	5	perspective	perspective	NOUN
ejop-10097	81	6	on	on	ADP
ejop-10097	81	7	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	81	8	and	and	CCONJ
ejop-10097	81	9	cognitive	cognitive	ADJ
ejop-10097	81	10	symptoms	symptom	NOUN
ejop-10097	81	11	could	could	AUX
ejop-10097	81	12	help	help	VERB
ejop-10097	81	13	to	to	PART
ejop-10097	81	14	better	well	ADV
ejop-10097	81	15	understand	understand	VERB
ejop-10097	81	16	de­	de­	ADJ
ejop-10097	81	17	velopment	velopment	NOUN
ejop-10097	81	18	,	,	PUNCT
ejop-10097	81	19	maintenance	maintenance	NOUN
ejop-10097	81	20	and	and	CCONJ
ejop-10097	81	21	diversity	diversity	NOUN
ejop-10097	81	22	of	of	ADP
ejop-10097	81	23	persistent	persistent	ADJ
ejop-10097	81	24	symptoms	symptom	NOUN
ejop-10097	81	25	observed	observe	VERB
ejop-10097	81	26	in	in	ADP
ejop-10097	81	27	patients	patient	NOUN
ejop-10097	81	28	with	with	ADP
ejop-10097	81	29	the	the	DET
ejop-10097	81	30	post	post	ADJ
ejop-10097	81	31	-	-	ADJ
ejop-10097	81	32	covid	covid	ADJ
ejop-10097	81	33	syndrome	syndrome	NOUN
ejop-10097	81	34	.	.	PUNCT
ejop-10097	82	1	this	this	DET
ejop-10097	82	2	approach	approach	NOUN
ejop-10097	82	3	explains	explain	VERB
ejop-10097	82	4	the	the	DET
ejop-10097	82	5	post	post	ADJ
ejop-10097	82	6	-	-	ADJ
ejop-10097	82	7	covid	covid	ADJ
ejop-10097	82	8	syndrome	syndrome	NOUN
ejop-10097	82	9	equally	equally	ADV
ejop-10097	82	10	well	well	ADV
ejop-10097	82	11	for	for	ADP
ejop-10097	82	12	patients	patient	NOUN
ejop-10097	82	13	who	who	PRON
ejop-10097	82	14	experienced	experience	VERB
ejop-10097	82	15	severe	severe	ADJ
ejop-10097	82	16	courses	course	NOUN
ejop-10097	82	17	of	of	ADP
ejop-10097	82	18	acute	acute	NOUN
ejop-10097	82	19	covid-19	covid-19	PROPN
ejop-10097	82	20	as	as	ADV
ejop-10097	82	21	well	well	ADV
ejop-10097	82	22	as	as	ADP
ejop-10097	82	23	for	for	ADP
ejop-10097	82	24	patients	patient	NOUN
ejop-10097	82	25	with	with	ADP
ejop-10097	82	26	mild	mild	ADJ
ejop-10097	82	27	to	to	ADP
ejop-10097	82	28	moderate	moderate	ADJ
ejop-10097	82	29	acute	acute	ADJ
ejop-10097	82	30	covid-19	covid-19	PROPN
ejop-10097	82	31	symptoms	symptom	NOUN
ejop-10097	82	32	.	.	PUNCT
ejop-10097	83	1	additionally	additionally	ADV
ejop-10097	83	2	,	,	PUNCT
ejop-10097	83	3	it	it	PRON
ejop-10097	83	4	offers	offer	VERB
ejop-10097	83	5	the	the	DET
ejop-10097	83	6	possibility	possibility	NOUN
ejop-10097	83	7	to	to	PART
ejop-10097	83	8	explain	explain	VERB
ejop-10097	83	9	similar	similar	ADJ
ejop-10097	83	10	symptoms	symptom	NOUN
ejop-10097	83	11	occurring	occur	VERB
ejop-10097	83	12	after	after	ADP
ejop-10097	83	13	other	other	ADJ
ejop-10097	83	14	types	type	NOUN
ejop-10097	83	15	of	of	ADP
ejop-10097	83	16	viral	viral	ADJ
ejop-10097	83	17	infections	infection	NOUN
ejop-10097	83	18	,	,	PUNCT
ejop-10097	83	19	or	or	CCONJ
ejop-10097	83	20	even	even	ADV
ejop-10097	83	21	reports	report	NOUN
ejop-10097	83	22	of	of	ADP
ejop-10097	83	23	post	post	ADJ
ejop-10097	83	24	-	-	ADJ
ejop-10097	83	25	covid	covid	ADJ
ejop-10097	83	26	-	-	PUNCT
ejop-10097	83	27	like	like	ADJ
ejop-10097	83	28	symp­	symp­	PROPN
ejop-10097	83	29	toms	tom	NOUN
ejop-10097	83	30	following	follow	VERB
ejop-10097	83	31	vaccination	vaccination	NOUN
ejop-10097	83	32	(	(	PUNCT
ejop-10097	83	33	post	post	ADJ
ejop-10097	83	34	-	-	ADJ
ejop-10097	83	35	vac	vac	ADJ
ejop-10097	83	36	syndrome	syndrome	NOUN
ejop-10097	83	37	)	)	PUNCT
ejop-10097	83	38	that	that	PRON
ejop-10097	83	39	recently	recently	ADV
ejop-10097	83	40	arose	arise	VERB
ejop-10097	83	41	in	in	ADP
ejop-10097	83	42	present	present	ADJ
ejop-10097	83	43	science	science	NOUN
ejop-10097	83	44	communication	communication	NOUN
ejop-10097	83	45	(	(	PUNCT
ejop-10097	83	46	couzin	couzin	PROPN
ejop-10097	83	47	-	-	PUNCT
ejop-10097	83	48	frankel	frankel	PROPN
ejop-10097	83	49	&	&	CCONJ
ejop-10097	83	50	vogel	vogel	NOUN
ejop-10097	83	51	,	,	PUNCT
ejop-10097	83	52	2022	2022	NUM
ejop-10097	83	53	)	)	PUNCT
ejop-10097	83	54	.	.	PUNCT
ejop-10097	84	1	being	be	AUX
ejop-10097	84	2	a	a	DET
ejop-10097	84	3	psychological	psychological	ADJ
ejop-10097	84	4	approach	approach	NOUN
ejop-10097	84	5	to	to	PART
ejop-10097	84	6	explain	explain	VERB
ejop-10097	84	7	post	post	ADJ
ejop-10097	84	8	-	-	ADJ
ejop-10097	84	9	covid	covid	ADJ
ejop-10097	84	10	symptoms	symptom	NOUN
ejop-10097	84	11	,	,	PUNCT
ejop-10097	84	12	it	it	PRON
ejop-10097	84	13	provides	provide	VERB
ejop-10097	84	14	an	an	DET
ejop-10097	84	15	added	add	VERB
ejop-10097	84	16	interdisciplinary	interdisciplinary	ADJ
ejop-10097	84	17	understanding	understanding	NOUN
ejop-10097	84	18	of	of	ADP
ejop-10097	84	19	post	post	ADJ
ejop-10097	84	20	-	-	ADJ
ejop-10097	84	21	covid	covid	ADJ
ejop-10097	84	22	syndrome	syndrome	NOUN
ejop-10097	84	23	.	.	PUNCT
ejop-10097	85	1	it	it	PRON
ejop-10097	85	2	complements	complement	VERB
ejop-10097	85	3	prevailing	prevail	VERB
ejop-10097	85	4	neurological	neurological	ADJ
ejop-10097	85	5	theories	theory	NOUN
ejop-10097	85	6	that	that	PRON
ejop-10097	85	7	were	be	AUX
ejop-10097	85	8	not	not	PART
ejop-10097	85	9	able	able	ADJ
ejop-10097	85	10	to	to	PART
ejop-10097	85	11	fully	fully	ADV
ejop-10097	85	12	ex­	ex­	VERB
ejop-10097	85	13	plain	plain	VERB
ejop-10097	86	1	the	the	DET
ejop-10097	86	2	syndrome	syndrome	NOUN
ejop-10097	86	3	yet	yet	ADV
ejop-10097	86	4	,	,	PUNCT
ejop-10097	86	5	because	because	SCONJ
ejop-10097	86	6	the	the	DET
ejop-10097	86	7	causal	causal	ADJ
ejop-10097	86	8	relationships	relationship	NOUN
ejop-10097	86	9	between	between	ADP
ejop-10097	86	10	symptoms	symptom	NOUN
ejop-10097	86	11	or	or	CCONJ
ejop-10097	86	12	the	the	DET
ejop-10097	86	13	initial	initial	ADJ
ejop-10097	86	14	activation	activation	NOUN
ejop-10097	86	15	of	of	ADP
ejop-10097	86	16	symptoms	symptom	NOUN
ejop-10097	86	17	in	in	ADP
ejop-10097	86	18	the	the	DET
ejop-10097	86	19	network	network	NOUN
ejop-10097	86	20	may	may	AUX
ejop-10097	86	21	be	be	AUX
ejop-10097	86	22	best	well	ADV
ejop-10097	86	23	explained	explain	VERB
ejop-10097	86	24	by	by	ADP
ejop-10097	86	25	neurological	neurological	ADJ
ejop-10097	86	26	mechanisms	mechanism	NOUN
ejop-10097	86	27	,	,	PUNCT
ejop-10097	86	28	e.g.	e.g.	ADV
ejop-10097	86	29	inflammation	inflammation	NOUN
ejop-10097	86	30	processes	process	NOUN
ejop-10097	86	31	in	in	ADP
ejop-10097	86	32	the	the	DET
ejop-10097	86	33	central	central	ADJ
ejop-10097	86	34	nervous	nervous	ADJ
ejop-10097	86	35	system	system	PROPN
ejop-10097	86	36	scharfenberg	scharfenberg	PROPN
ejop-10097	86	37	,	,	PUNCT
ejop-10097	86	38	schild	schild	PROPN
ejop-10097	86	39	,	,	PUNCT
ejop-10097	86	40	warnke	warnke	NOUN
ejop-10097	86	41	,	,	PUNCT
ejop-10097	86	42	&	&	CCONJ
ejop-10097	86	43	maier	maier	PROPN
ejop-10097	86	44	353	353	NUM
ejop-10097	86	45	europe	europe	PROPN
ejop-10097	86	46	's	's	PART
ejop-10097	86	47	journal	journal	NOUN
ejop-10097	86	48	of	of	ADP
ejop-10097	86	49	psychology	psychology	NOUN
ejop-10097	86	50	2022	2022	NUM
ejop-10097	86	51	,	,	PUNCT
ejop-10097	86	52	vol	vol	NOUN
ejop-10097	86	53	.	.	PUNCT
ejop-10097	86	54	18(4	18(4	NUM
ejop-10097	86	55	)	)	PUNCT
ejop-10097	86	56	,	,	PUNCT
ejop-10097	86	57	350–356	350–356	NUM
ejop-10097	86	58	https://doi.org/10.5964/ejop.10097	https://doi.org/10.5964/ejop.10097	NUM
ejop-10097	86	59	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
ejop-10097	86	60	during	during	ADP
ejop-10097	86	61	acute	acute	ADJ
ejop-10097	86	62	infection	infection	NOUN
ejop-10097	86	63	with	with	ADP
ejop-10097	86	64	sars	sar	NOUN
ejop-10097	86	65	-	-	PUNCT
ejop-10097	86	66	cov-2	cov-2	PART
ejop-10097	86	67	or	or	CCONJ
ejop-10097	86	68	neurological	neurological	ADJ
ejop-10097	86	69	structural	structural	ADJ
ejop-10097	86	70	or	or	CCONJ
ejop-10097	86	71	functional	functional	ADJ
ejop-10097	86	72	changes	change	NOUN
ejop-10097	86	73	that	that	PRON
ejop-10097	86	74	could	could	AUX
ejop-10097	86	75	explain	explain	VERB
ejop-10097	86	76	associations	association	NOUN
ejop-10097	86	77	between	between	ADP
ejop-10097	86	78	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	86	79	symptoms	symptom	NOUN
ejop-10097	86	80	.	.	PUNCT
ejop-10097	87	1	thus	thus	ADV
ejop-10097	87	2	,	,	PUNCT
ejop-10097	87	3	to	to	PART
ejop-10097	87	4	fully	fully	ADV
ejop-10097	87	5	understand	understand	VERB
ejop-10097	87	6	the	the	DET
ejop-10097	87	7	causes	cause	NOUN
ejop-10097	87	8	and	and	CCONJ
ejop-10097	87	9	maintenance	maintenance	NOUN
ejop-10097	87	10	of	of	ADP
ejop-10097	87	11	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	87	12	and	and	CCONJ
ejop-10097	87	13	cognitive	cognitive	ADJ
ejop-10097	87	14	symptoms	symptom	NOUN
ejop-10097	87	15	of	of	ADP
ejop-10097	87	16	the	the	DET
ejop-10097	87	17	post	post	ADJ
ejop-10097	87	18	-	-	ADJ
ejop-10097	87	19	covid	covid	ADJ
ejop-10097	87	20	syndrome	syndrome	NOUN
ejop-10097	87	21	,	,	PUNCT
ejop-10097	87	22	psychological	psychological	ADJ
ejop-10097	87	23	,	,	PUNCT
ejop-10097	87	24	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	87	25	and	and	CCONJ
ejop-10097	87	26	neurological	neurological	ADJ
ejop-10097	87	27	approaches	approach	NOUN
ejop-10097	87	28	should	should	AUX
ejop-10097	87	29	be	be	AUX
ejop-10097	87	30	applied	apply	VERB
ejop-10097	87	31	likewise	likewise	ADV
ejop-10097	87	32	.	.	PUNCT
ejop-10097	88	1	funding	funding	NOUN
ejop-10097	88	2	:	:	PUNCT
ejop-10097	88	3	cw	cw	NOUN
ejop-10097	88	4	received	receive	VERB
ejop-10097	88	5	support	support	NOUN
ejop-10097	88	6	from	from	ADP
ejop-10097	88	7	the	the	DET
ejop-10097	88	8	german	german	ADJ
ejop-10097	88	9	research	research	NOUN
ejop-10097	88	10	foundation	foundation	PROPN
ejop-10097	88	11	(	(	PUNCT
ejop-10097	88	12	wa4101/2–1	wa4101/2–1	PROPN
ejop-10097	88	13	)	)	PUNCT
ejop-10097	88	14	.	.	PUNCT
ejop-10097	89	1	ds	ds	PROPN
ejop-10097	89	2	,	,	PUNCT
ejop-10097	89	3	aks	ak	NOUN
ejop-10097	89	4	and	and	CCONJ
ejop-10097	89	5	fm	fm	PROPN
ejop-10097	89	6	have	have	VERB
ejop-10097	89	7	no	no	DET
ejop-10097	89	8	funding	funding	NOUN
ejop-10097	89	9	to	to	PART
ejop-10097	89	10	report	report	VERB
ejop-10097	89	11	.	.	PUNCT
ejop-10097	90	1	acknowledgments	acknowledgment	NOUN
ejop-10097	90	2	:	:	PUNCT
ejop-10097	90	3	the	the	DET
ejop-10097	90	4	authors	author	NOUN
ejop-10097	90	5	have	have	VERB
ejop-10097	90	6	no	no	DET
ejop-10097	90	7	support	support	NOUN
ejop-10097	90	8	to	to	PART
ejop-10097	90	9	report	report	VERB
ejop-10097	90	10	.	.	PUNCT
ejop-10097	91	1	competing	compete	VERB
ejop-10097	91	2	interests	interest	NOUN
ejop-10097	91	3	:	:	PUNCT
ejop-10097	91	4	cw	cw	NOUN
ejop-10097	91	5	received	receive	VERB
ejop-10097	91	6	personal	personal	ADJ
ejop-10097	91	7	compensation	compensation	NOUN
ejop-10097	91	8	from	from	ADP
ejop-10097	91	9	biontech	biontech	NOUN
ejop-10097	91	10	for	for	ADP
ejop-10097	91	11	participating	participate	VERB
ejop-10097	91	12	in	in	ADP
ejop-10097	91	13	an	an	DET
ejop-10097	91	14	educational	educational	ADJ
ejop-10097	91	15	discussion	discussion	NOUN
ejop-10097	91	16	.	.	PUNCT
ejop-10097	92	1	ds	ds	ADJ
ejop-10097	92	2	,	,	PUNCT
ejop-10097	92	3	aks	ak	NOUN
ejop-10097	92	4	and	and	CCONJ
ejop-10097	92	5	fm	fm	PROPN
ejop-10097	92	6	have	have	AUX
ejop-10097	92	7	declared	declare	VERB
ejop-10097	92	8	that	that	SCONJ
ejop-10097	92	9	no	no	DET
ejop-10097	92	10	competing	compete	VERB
ejop-10097	92	11	interests	interest	NOUN
ejop-10097	92	12	exist	exist	VERB
ejop-10097	92	13	.	.	PUNCT
ejop-10097	93	1	references	reference	NOUN
ejop-10097	93	2	alkodaymi	alkodaymi	VERB
ejop-10097	93	3	,	,	PUNCT
ejop-10097	93	4	m.	m.	NOUN
ejop-10097	93	5	s.	s.	PROPN
ejop-10097	93	6	,	,	PUNCT
ejop-10097	93	7	omrani	omrani	PROPN
ejop-10097	93	8	,	,	PUNCT
ejop-10097	93	9	o.	o.	PROPN
ejop-10097	93	10	a.	a.	PROPN
ejop-10097	93	11	,	,	PUNCT
ejop-10097	93	12	fawzy	fawzy	PROPN
ejop-10097	93	13	,	,	PUNCT
ejop-10097	93	14	n.	n.	PROPN
ejop-10097	93	15	a.	a.	PROPN
ejop-10097	93	16	,	,	PUNCT
ejop-10097	93	17	shaar	shaar	NOUN
ejop-10097	93	18	,	,	PUNCT
ejop-10097	93	19	b.	b.	PROPN
ejop-10097	93	20	a.	a.	PROPN
ejop-10097	93	21	,	,	PUNCT
ejop-10097	93	22	almamlouk	almamlouk	ADV
ejop-10097	93	23	,	,	PUNCT
ejop-10097	93	24	r.	r.	PROPN
ejop-10097	93	25	,	,	PUNCT
ejop-10097	93	26	riaz	riaz	PROPN
ejop-10097	93	27	,	,	PUNCT
ejop-10097	93	28	m.	m.	NOUN
ejop-10097	93	29	,	,	PUNCT
ejop-10097	93	30	obeidat	obeidat	NOUN
ejop-10097	93	31	,	,	PUNCT
ejop-10097	93	32	m.	m.	NOUN
ejop-10097	93	33	,	,	PUNCT
ejop-10097	93	34	obeidat	obeidat	NOUN
ejop-10097	93	35	,	,	PUNCT
ejop-10097	93	36	y.	y.	NOUN
ejop-10097	93	37	,	,	PUNCT
ejop-10097	93	38	gerberi	gerberi	PROPN
ejop-10097	93	39	,	,	PUNCT
ejop-10097	93	40	d.	d.	PROPN
ejop-10097	93	41	,	,	PUNCT
ejop-10097	93	42	taha	taha	PROPN
ejop-10097	93	43	,	,	PUNCT
ejop-10097	93	44	r.	r.	PROPN
ejop-10097	93	45	m.	m.	PROPN
ejop-10097	93	46	,	,	PUNCT
ejop-10097	93	47	kashour	kashour	NOUN
ejop-10097	93	48	,	,	PUNCT
ejop-10097	93	49	z.	z.	PROPN
ejop-10097	93	50	,	,	PUNCT
ejop-10097	93	51	kashour	kashour	NOUN
ejop-10097	93	52	,	,	PUNCT
ejop-10097	93	53	t.	t.	PROPN
ejop-10097	93	54	,	,	PUNCT
ejop-10097	93	55	berbari	berbari	PROPN
ejop-10097	93	56	,	,	PUNCT
ejop-10097	93	57	e.	e.	PROPN
ejop-10097	93	58	f.	f.	PROPN
ejop-10097	93	59	,	,	PUNCT
ejop-10097	93	60	alkattan	alkattan	PROPN
ejop-10097	93	61	,	,	PUNCT
ejop-10097	93	62	k.	k.	PROPN
ejop-10097	93	63	,	,	PUNCT
ejop-10097	93	64	&	&	CCONJ
ejop-10097	93	65	tleyjeh	tleyjeh	PROPN
ejop-10097	93	66	,	,	PUNCT
ejop-10097	93	67	i.	i.	NOUN
ejop-10097	93	68	m.	m.	NOUN
ejop-10097	93	69	(	(	PUNCT
ejop-10097	93	70	2022	2022	NUM
ejop-10097	93	71	)	)	PUNCT
ejop-10097	93	72	.	.	PUNCT
ejop-10097	94	1	prevalence	prevalence	NOUN
ejop-10097	94	2	of	of	ADP
ejop-10097	94	3	post	post	ADJ
ejop-10097	94	4	-	-	ADJ
ejop-10097	94	5	acute	acute	ADJ
ejop-10097	94	6	covid-19	covid-19	PROPN
ejop-10097	94	7	syndrome	syndrome	NOUN
ejop-10097	94	8	symptoms	symptom	NOUN
ejop-10097	94	9	at	at	ADP
ejop-10097	94	10	different	different	ADJ
ejop-10097	94	11	follow	follow	NOUN
ejop-10097	94	12	-	-	PUNCT
ejop-10097	94	13	up	up	ADP
ejop-10097	94	14	periods	period	NOUN
ejop-10097	94	15	:	:	PUNCT
ejop-10097	94	16	a	a	DET
ejop-10097	94	17	systematic	systematic	ADJ
ejop-10097	94	18	review	review	NOUN
ejop-10097	94	19	and	and	CCONJ
ejop-10097	94	20	meta	meta	ADJ
ejop-10097	94	21	-	-	PUNCT
ejop-10097	94	22	analysis	analysis	NOUN
ejop-10097	94	23	.	.	PUNCT
ejop-10097	95	1	clinical	clinical	ADJ
ejop-10097	95	2	microbiology	microbiology	NOUN
ejop-10097	95	3	and	and	CCONJ
ejop-10097	95	4	infection	infection	NOUN
ejop-10097	95	5	,	,	PUNCT
ejop-10097	95	6	28(5	28(5	NUM
ejop-10097	95	7	)	)	PUNCT
ejop-10097	95	8	,	,	PUNCT
ejop-10097	95	9	657	657	NUM
ejop-10097	95	10	–	–	PUNCT
ejop-10097	95	11	666	666	NUM
ejop-10097	95	12	.	.	PUNCT
ejop-10097	96	1	https://doi.org/10.1016/j.cmi.2022.01.014	https://doi.org/10.1016/j.cmi.2022.01.014	PROPN
ejop-10097	96	2	anapa	anapa	PROPN
ejop-10097	96	3	,	,	PUNCT
ejop-10097	96	4	g.	g.	NOUN
ejop-10097	96	5	,	,	PUNCT
ejop-10097	96	6	roheger	roheger	NOUN
ejop-10097	96	7	,	,	PUNCT
ejop-10097	96	8	m.	m.	NOUN
ejop-10097	96	9	,	,	PUNCT
ejop-10097	96	10	seven	seven	NUM
ejop-10097	96	11	,	,	PUNCT
ejop-10097	96	12	ü.	ü.	PROPN
ejop-10097	96	13	s.	s.	PROPN
ejop-10097	96	14	,	,	PUNCT
ejop-10097	96	15	liebermann	liebermann	NOUN
ejop-10097	96	16	-	-	PUNCT
ejop-10097	96	17	jordanidis	jordanidis	PROPN
ejop-10097	96	18	,	,	PUNCT
ejop-10097	96	19	h.	h.	PROPN
ejop-10097	96	20	,	,	PUNCT
ejop-10097	96	21	onur	onur	PROPN
ejop-10097	96	22	,	,	PUNCT
ejop-10097	96	23	o.	o.	NOUN
ejop-10097	96	24	a.	a.	PROPN
ejop-10097	96	25	,	,	PUNCT
ejop-10097	96	26	kessler	kessler	PROPN
ejop-10097	96	27	,	,	PUNCT
ejop-10097	96	28	j.	j.	PROPN
ejop-10097	96	29	,	,	PUNCT
ejop-10097	96	30	&	&	CCONJ
ejop-10097	96	31	kalbe	kalbe	PROPN
ejop-10097	96	32	,	,	PUNCT
ejop-10097	96	33	e.	e.	PROPN
ejop-10097	96	34	(	(	PUNCT
ejop-10097	96	35	2021	2021	NUM
ejop-10097	96	36	)	)	PUNCT
ejop-10097	96	37	.	.	PUNCT
ejop-10097	97	1	effects	effect	NOUN
ejop-10097	97	2	of	of	ADP
ejop-10097	97	3	sociodemographic	sociodemographic	ADJ
ejop-10097	97	4	variables	variable	NOUN
ejop-10097	97	5	and	and	CCONJ
ejop-10097	97	6	depressive	depressive	ADJ
ejop-10097	97	7	symptoms	symptom	NOUN
ejop-10097	97	8	on	on	ADP
ejop-10097	97	9	moca	moca	PROPN
ejop-10097	97	10	test	test	NOUN
ejop-10097	97	11	performance	performance	NOUN
ejop-10097	97	12	in	in	ADP
ejop-10097	97	13	native	native	ADJ
ejop-10097	97	14	germans	german	NOUN
ejop-10097	97	15	and	and	CCONJ
ejop-10097	97	16	turkish	turkish	ADJ
ejop-10097	97	17	migrants	migrant	NOUN
ejop-10097	97	18	in	in	ADP
ejop-10097	97	19	germany	germany	PROPN
ejop-10097	97	20	.	.	PUNCT
ejop-10097	98	1	international	international	ADJ
ejop-10097	98	2	journal	journal	PROPN
ejop-10097	98	3	of	of	ADP
ejop-10097	98	4	environmental	environmental	ADJ
ejop-10097	98	5	research	research	NOUN
ejop-10097	98	6	and	and	CCONJ
ejop-10097	98	7	public	public	ADJ
ejop-10097	98	8	health	health	NOUN
ejop-10097	98	9	,	,	PUNCT
ejop-10097	98	10	18(12	18(12	NUM
ejop-10097	98	11	)	)	PUNCT
ejop-10097	98	12	.	.	PUNCT
ejop-10097	99	1	advance	advance	VERB
ejop-10097	99	2	online	online	ADJ
ejop-10097	99	3	publication	publication	NOUN
ejop-10097	99	4	.	.	PUNCT
ejop-10097	100	1	https://doi.org/10.3390/ijerph18126335	https://doi.org/10.3390/ijerph18126335	PROPN
ejop-10097	100	2	augustin	augustin	PROPN
ejop-10097	100	3	,	,	PUNCT
ejop-10097	100	4	m.	m.	NOUN
ejop-10097	100	5	,	,	PUNCT
ejop-10097	100	6	schommers	schommer	NOUN
ejop-10097	100	7	,	,	PUNCT
ejop-10097	100	8	p.	p.	NOUN
ejop-10097	100	9	,	,	PUNCT
ejop-10097	100	10	stecher	stecher	NOUN
ejop-10097	100	11	,	,	PUNCT
ejop-10097	100	12	m.	m.	NOUN
ejop-10097	100	13	,	,	PUNCT
ejop-10097	100	14	dewald	dewald	NOUN
ejop-10097	100	15	,	,	PUNCT
ejop-10097	100	16	f.	f.	PROPN
ejop-10097	100	17	,	,	PUNCT
ejop-10097	100	18	gieselmann	gieselmann	PROPN
ejop-10097	100	19	,	,	PUNCT
ejop-10097	100	20	l.	l.	PROPN
ejop-10097	100	21	,	,	PUNCT
ejop-10097	100	22	gruell	gruell	PROPN
ejop-10097	100	23	,	,	PUNCT
ejop-10097	100	24	h.	h.	PROPN
ejop-10097	100	25	,	,	PUNCT
ejop-10097	100	26	horn	horn	PROPN
ejop-10097	100	27	,	,	PUNCT
ejop-10097	100	28	c.	c.	NOUN
ejop-10097	100	29	,	,	PUNCT
ejop-10097	100	30	vanshylla	vanshylla	NOUN
ejop-10097	100	31	,	,	PUNCT
ejop-10097	100	32	k.	k.	PROPN
ejop-10097	100	33	,	,	PUNCT
ejop-10097	100	34	di	di	PROPN
ejop-10097	100	35	cristanziano	cristanziano	PROPN
ejop-10097	100	36	,	,	PUNCT
ejop-10097	100	37	v.	v.	ADV
ejop-10097	100	38	,	,	PUNCT
ejop-10097	100	39	osebold	osebold	ADJ
ejop-10097	100	40	,	,	PUNCT
ejop-10097	100	41	l.	l.	PROPN
ejop-10097	100	42	,	,	PUNCT
ejop-10097	100	43	roventa	roventa	NOUN
ejop-10097	100	44	,	,	PUNCT
ejop-10097	100	45	m.	m.	NOUN
ejop-10097	100	46	,	,	PUNCT
ejop-10097	100	47	riaz	riaz	PROPN
ejop-10097	100	48	,	,	PUNCT
ejop-10097	100	49	t.	t.	PROPN
ejop-10097	100	50	,	,	PUNCT
ejop-10097	100	51	tschernoster	tschernoster	PROPN
ejop-10097	100	52	,	,	PUNCT
ejop-10097	100	53	n.	n.	NOUN
ejop-10097	100	54	,	,	PUNCT
ejop-10097	100	55	altmueller	altmueller	NOUN
ejop-10097	100	56	,	,	PUNCT
ejop-10097	100	57	j.	j.	PROPN
ejop-10097	100	58	,	,	PUNCT
ejop-10097	100	59	rose	rise	VERB
ejop-10097	100	60	,	,	PUNCT
ejop-10097	100	61	l.	l.	PROPN
ejop-10097	100	62	,	,	PUNCT
ejop-10097	100	63	salomon	salomon	PROPN
ejop-10097	100	64	,	,	PUNCT
ejop-10097	100	65	s.	s.	PROPN
ejop-10097	100	66	,	,	PUNCT
ejop-10097	100	67	priesner	priesner	NOUN
ejop-10097	100	68	,	,	PUNCT
ejop-10097	100	69	v.	v.	PROPN
ejop-10097	100	70	,	,	PUNCT
ejop-10097	100	71	luers	luers	PROPN
ejop-10097	100	72	,	,	PUNCT
ejop-10097	100	73	j.	j.	PROPN
ejop-10097	100	74	c.	c.	PROPN
ejop-10097	100	75	,	,	PUNCT
ejop-10097	100	76	albus	albus	PROPN
ejop-10097	100	77	,	,	PUNCT
ejop-10097	100	78	c.	c.	PROPN
ejop-10097	100	79	,	,	PUNCT
ejop-10097	100	80	.	.	PUNCT
ejop-10097	100	81	.	.	PUNCT
ejop-10097	101	1	.lehmann	.lehmann	PROPN
ejop-10097	101	2	,	,	PUNCT
ejop-10097	101	3	c.	c.	PROPN
ejop-10097	101	4	(	(	PUNCT
ejop-10097	101	5	2021	2021	NUM
ejop-10097	101	6	)	)	PUNCT
ejop-10097	101	7	.	.	PUNCT
ejop-10097	102	1	post	post	ADJ
ejop-10097	102	2	-	-	ADJ
ejop-10097	102	3	covid	covid	ADJ
ejop-10097	102	4	syndrome	syndrome	NOUN
ejop-10097	102	5	in	in	ADP
ejop-10097	102	6	non	non	ADJ
ejop-10097	102	7	-	-	ADJ
ejop-10097	102	8	hospitalised	hospitalised	ADJ
ejop-10097	102	9	patients	patient	NOUN
ejop-10097	102	10	with	with	ADP
ejop-10097	102	11	covid-19	covid-19	PROPN
ejop-10097	102	12	:	:	PUNCT
ejop-10097	102	13	a	a	DET
ejop-10097	102	14	longitudinal	longitudinal	ADJ
ejop-10097	102	15	prospective	prospective	ADJ
ejop-10097	102	16	cohort	cohort	NOUN
ejop-10097	102	17	study	study	NOUN
ejop-10097	102	18	.	.	PUNCT
ejop-10097	103	1	lancet	lancet	PROPN
ejop-10097	103	2	regional	regional	ADJ
ejop-10097	103	3	health	health	NOUN
ejop-10097	103	4	.	.	PUNCT
ejop-10097	104	1	europe	europe	PROPN
ejop-10097	104	2	,	,	PUNCT
ejop-10097	104	3	6	6	NUM
ejop-10097	104	4	,	,	PUNCT
ejop-10097	104	5	article	article	NOUN
ejop-10097	104	6	e100122	e100122	PROPN
ejop-10097	104	7	.	.	PUNCT
ejop-10097	104	8	https://doi.org/10.1016/j.lanepe.2021.100122	https://doi.org/10.1016/j.lanepe.2021.100122	PROPN
ejop-10097	104	9	beard	beard	PROPN
ejop-10097	104	10	,	,	PUNCT
ejop-10097	104	11	c.	c.	PROPN
ejop-10097	104	12	,	,	PUNCT
ejop-10097	104	13	millner	millner	NOUN
ejop-10097	104	14	,	,	PUNCT
ejop-10097	104	15	a.	a.	PROPN
ejop-10097	104	16	j.	j.	PROPN
ejop-10097	104	17	,	,	PUNCT
ejop-10097	104	18	forgeard	forgeard	PROPN
ejop-10097	104	19	,	,	PUNCT
ejop-10097	104	20	m.	m.	PROPN
ejop-10097	104	21	j.	j.	PROPN
ejop-10097	104	22	c.	c.	PROPN
ejop-10097	104	23	,	,	PUNCT
ejop-10097	104	24	fried	fry	VERB
ejop-10097	104	25	,	,	PUNCT
ejop-10097	104	26	e.	e.	PROPN
ejop-10097	104	27	i.	i.	PROPN
ejop-10097	104	28	,	,	PUNCT
ejop-10097	104	29	hsu	hsu	PROPN
ejop-10097	104	30	,	,	PUNCT
ejop-10097	104	31	k.	k.	PROPN
ejop-10097	104	32	j.	j.	PROPN
ejop-10097	104	33	,	,	PUNCT
ejop-10097	104	34	treadway	treadway	PROPN
ejop-10097	104	35	,	,	PUNCT
ejop-10097	104	36	m.	m.	NOUN
ejop-10097	104	37	t.	t.	PROPN
ejop-10097	104	38	,	,	PUNCT
ejop-10097	104	39	leonard	leonard	PROPN
ejop-10097	104	40	,	,	PUNCT
ejop-10097	104	41	c.	c.	PROPN
ejop-10097	104	42	v.	v.	PROPN
ejop-10097	104	43	,	,	PUNCT
ejop-10097	104	44	kertz	kertz	PROPN
ejop-10097	104	45	,	,	PUNCT
ejop-10097	104	46	s.	s.	PROPN
ejop-10097	104	47	j.	j.	PROPN
ejop-10097	104	48	,	,	PUNCT
ejop-10097	104	49	&	&	CCONJ
ejop-10097	104	50	björgvinsson	björgvinsson	PROPN
ejop-10097	104	51	,	,	PUNCT
ejop-10097	104	52	t.	t.	PROPN
ejop-10097	104	53	(	(	PUNCT
ejop-10097	104	54	2016	2016	NUM
ejop-10097	104	55	)	)	PUNCT
ejop-10097	104	56	.	.	PUNCT
ejop-10097	105	1	network	network	NOUN
ejop-10097	105	2	analysis	analysis	NOUN
ejop-10097	105	3	of	of	ADP
ejop-10097	105	4	depression	depression	NOUN
ejop-10097	105	5	and	and	CCONJ
ejop-10097	105	6	anxiety	anxiety	NOUN
ejop-10097	105	7	symptom	symptom	NOUN
ejop-10097	105	8	relationships	relationship	NOUN
ejop-10097	105	9	in	in	ADP
ejop-10097	105	10	a	a	DET
ejop-10097	105	11	psychiatric	psychiatric	ADJ
ejop-10097	105	12	sample	sample	NOUN
ejop-10097	105	13	.	.	PUNCT
ejop-10097	106	1	psychological	psychological	ADJ
ejop-10097	106	2	medicine	medicine	NOUN
ejop-10097	106	3	,	,	PUNCT
ejop-10097	106	4	46(16	46(16	NOUN
ejop-10097	106	5	)	)	PUNCT
ejop-10097	106	6	,	,	PUNCT
ejop-10097	106	7	3359	3359	NUM
ejop-10097	106	8	–	–	PUNCT
ejop-10097	106	9	3369	3369	NUM
ejop-10097	106	10	.	.	PUNCT
ejop-10097	107	1	https://doi.org/10.1017/s0033291716002300	https://doi.org/10.1017/s0033291716002300	NUM
ejop-10097	107	2	becker	becker	NOUN
ejop-10097	107	3	,	,	PUNCT
ejop-10097	107	4	n.	n.	PROPN
ejop-10097	107	5	b.	b.	PROPN
ejop-10097	107	6	,	,	PUNCT
ejop-10097	107	7	jesus	jesus	PROPN
ejop-10097	107	8	,	,	PUNCT
ejop-10097	107	9	s.	s.	PROPN
ejop-10097	107	10	n.	n.	PROPN
ejop-10097	107	11	,	,	PUNCT
ejop-10097	107	12	joão	joão	PROPN
ejop-10097	107	13	,	,	PUNCT
ejop-10097	107	14	k.	k.	PROPN
ejop-10097	107	15	a.	a.	PROPN
ejop-10097	107	16	d.	d.	PROPN
ejop-10097	107	17	r.	r.	PROPN
ejop-10097	107	18	,	,	PUNCT
ejop-10097	107	19	viseu	viseu	NOUN
ejop-10097	107	20	,	,	PUNCT
ejop-10097	107	21	j.	j.	PROPN
ejop-10097	107	22	n.	n.	PROPN
ejop-10097	107	23	,	,	PUNCT
ejop-10097	107	24	&	&	CCONJ
ejop-10097	107	25	martins	martins	PROPN
ejop-10097	107	26	,	,	PUNCT
ejop-10097	107	27	r.	r.	PROPN
ejop-10097	107	28	i.	i.	PROPN
ejop-10097	107	29	s.	s.	PROPN
ejop-10097	107	30	(	(	PUNCT
ejop-10097	107	31	2017	2017	NUM
ejop-10097	107	32	)	)	PUNCT
ejop-10097	107	33	.	.	PUNCT
ejop-10097	108	1	depression	depression	NOUN
ejop-10097	108	2	and	and	CCONJ
ejop-10097	108	3	sleep	sleep	VERB
ejop-10097	108	4	quality	quality	NOUN
ejop-10097	108	5	in	in	ADP
ejop-10097	108	6	older	old	ADJ
ejop-10097	108	7	adults	adult	NOUN
ejop-10097	108	8	:	:	PUNCT
ejop-10097	108	9	a	a	DET
ejop-10097	108	10	metaanalysis	metaanalysis	NOUN
ejop-10097	108	11	.	.	PUNCT
ejop-10097	109	1	psychology	psychology	NOUN
ejop-10097	109	2	,	,	PUNCT
ejop-10097	109	3	health	health	NOUN
ejop-10097	109	4	and	and	CCONJ
ejop-10097	109	5	medicine	medicine	NOUN
ejop-10097	109	6	,	,	PUNCT
ejop-10097	109	7	22(8	22(8	NUM
ejop-10097	109	8	)	)	PUNCT
ejop-10097	109	9	,	,	PUNCT
ejop-10097	109	10	889–895	889–895	NUM
ejop-10097	109	11	.	.	PUNCT
ejop-10097	110	1	https://doi.org/10.1080/13548506.2016.1274042	https://doi.org/10.1080/13548506.2016.1274042	PROPN
ejop-10097	110	2	bellan	bellan	NOUN
ejop-10097	110	3	,	,	PUNCT
ejop-10097	110	4	m.	m.	NOUN
ejop-10097	110	5	,	,	PUNCT
ejop-10097	110	6	baricich	baricich	PROPN
ejop-10097	110	7	,	,	PUNCT
ejop-10097	110	8	a.	a.	NOUN
ejop-10097	110	9	,	,	PUNCT
ejop-10097	110	10	patrucco	patrucco	PROPN
ejop-10097	110	11	,	,	PUNCT
ejop-10097	110	12	f.	f.	PROPN
ejop-10097	110	13	,	,	PUNCT
ejop-10097	110	14	zeppegno	zeppegno	NOUN
ejop-10097	110	15	,	,	PUNCT
ejop-10097	110	16	p.	p.	PROPN
ejop-10097	110	17	,	,	PUNCT
ejop-10097	110	18	gramaglia	gramaglia	PROPN
ejop-10097	110	19	,	,	PUNCT
ejop-10097	110	20	c.	c.	PROPN
ejop-10097	110	21	,	,	PUNCT
ejop-10097	110	22	balbo	balbo	PROPN
ejop-10097	110	23	,	,	PUNCT
ejop-10097	110	24	p.	p.	PROPN
ejop-10097	110	25	e.	e.	PROPN
ejop-10097	110	26	,	,	PUNCT
ejop-10097	110	27	carriero	carriero	PROPN
ejop-10097	110	28	,	,	PUNCT
ejop-10097	110	29	a.	a.	PROPN
ejop-10097	110	30	,	,	PUNCT
ejop-10097	110	31	amico	amico	PROPN
ejop-10097	110	32	,	,	PUNCT
ejop-10097	110	33	c.	c.	PROPN
ejop-10097	110	34	s.	s.	PROPN
ejop-10097	110	35	,	,	PUNCT
ejop-10097	110	36	avanzi	avanzi	NOUN
ejop-10097	110	37	,	,	PUNCT
ejop-10097	110	38	g.	g.	PROPN
ejop-10097	110	39	c.	c.	PROPN
ejop-10097	110	40	,	,	PUNCT
ejop-10097	110	41	barini	barini	PROPN
ejop-10097	110	42	,	,	PUNCT
ejop-10097	110	43	m.	m.	NOUN
ejop-10097	110	44	,	,	PUNCT
ejop-10097	110	45	battaglia	battaglia	PROPN
ejop-10097	110	46	,	,	PUNCT
ejop-10097	110	47	m.	m.	NOUN
ejop-10097	110	48	,	,	PUNCT
ejop-10097	110	49	bor	bor	PROPN
ejop-10097	110	50	,	,	PUNCT
ejop-10097	110	51	s.	s.	PROPN
ejop-10097	110	52	,	,	PUNCT
ejop-10097	110	53	cantaluppi	cantaluppi	NOUN
ejop-10097	110	54	,	,	PUNCT
ejop-10097	110	55	v.	v.	PROPN
ejop-10097	110	56	,	,	PUNCT
ejop-10097	110	57	cappellano	cappellano	PROPN
ejop-10097	110	58	,	,	PUNCT
ejop-10097	110	59	g.	g.	PROPN
ejop-10097	110	60	,	,	PUNCT
ejop-10097	110	61	ceruti	ceruti	PROPN
ejop-10097	110	62	,	,	PUNCT
ejop-10097	110	63	f.	f.	PROPN
ejop-10097	110	64	,	,	PUNCT
ejop-10097	110	65	chiocchetti	chiocchetti	PROPN
ejop-10097	110	66	,	,	PUNCT
ejop-10097	110	67	a.	a.	NOUN
ejop-10097	110	68	,	,	PUNCT
ejop-10097	110	69	clivati	clivati	NOUN
ejop-10097	110	70	,	,	PUNCT
ejop-10097	110	71	e.	e.	PROPN
ejop-10097	110	72	,	,	PUNCT
ejop-10097	110	73	giordano	giordano	PROPN
ejop-10097	110	74	,	,	PUNCT
ejop-10097	110	75	m.	m.	NOUN
ejop-10097	110	76	,	,	PUNCT
ejop-10097	110	77	cuneo	cuneo	PROPN
ejop-10097	110	78	,	,	PUNCT
ejop-10097	110	79	d.	d.	PROPN
ejop-10097	110	80	,	,	PUNCT
ejop-10097	110	81	.	.	PUNCT
ejop-10097	110	82	.	.	PUNCT
ejop-10097	111	1	.pirisi	.pirisi	ADJ
ejop-10097	111	2	,	,	PUNCT
ejop-10097	111	3	m.	m.	NOUN
ejop-10097	111	4	(	(	PUNCT
ejop-10097	111	5	2021	2021	NUM
ejop-10097	111	6	)	)	PUNCT
ejop-10097	111	7	.	.	PUNCT
ejop-10097	112	1	long	long	ADJ
ejop-10097	112	2	-	-	PUNCT
ejop-10097	112	3	term	term	NOUN
ejop-10097	112	4	sequelae	sequelae	NOUN
ejop-10097	112	5	are	be	AUX
ejop-10097	112	6	highly	highly	ADV
ejop-10097	112	7	prevalent	prevalent	ADJ
ejop-10097	112	8	one	one	NUM
ejop-10097	112	9	year	year	NOUN
ejop-10097	112	10	after	after	ADP
ejop-10097	112	11	hospitalization	hospitalization	NOUN
ejop-10097	112	12	for	for	ADP
ejop-10097	112	13	severe	severe	ADJ
ejop-10097	112	14	covid-19	covid-19	PROPN
ejop-10097	112	15	.	.	PUNCT
ejop-10097	113	1	scientific	scientific	ADJ
ejop-10097	113	2	reports	report	NOUN
ejop-10097	113	3	,	,	PUNCT
ejop-10097	113	4	11(1	11(1	NUM
ejop-10097	113	5	)	)	PUNCT
ejop-10097	113	6	,	,	PUNCT
ejop-10097	113	7	article	article	NOUN
ejop-10097	113	8	e22666	e22666	VERB
ejop-10097	113	9	.	.	PUNCT
ejop-10097	114	1	https://doi.org/10.1038/s41598-021-01215-4	https://doi.org/10.1038/s41598-021-01215-4	NUM
ejop-10097	114	2	bertuccelli	bertuccelli	PROPN
ejop-10097	114	3	,	,	PUNCT
ejop-10097	114	4	m.	m.	NOUN
ejop-10097	114	5	,	,	PUNCT
ejop-10097	114	6	ciringione	ciringione	PROPN
ejop-10097	114	7	,	,	PUNCT
ejop-10097	114	8	l.	l.	PROPN
ejop-10097	114	9	,	,	PUNCT
ejop-10097	114	10	rubega	rubega	NOUN
ejop-10097	114	11	,	,	PUNCT
ejop-10097	114	12	m.	m.	NOUN
ejop-10097	114	13	,	,	PUNCT
ejop-10097	114	14	bisiacchi	bisiacchi	NOUN
ejop-10097	114	15	,	,	PUNCT
ejop-10097	114	16	p.	p.	NOUN
ejop-10097	114	17	,	,	PUNCT
ejop-10097	114	18	masiero	masiero	PROPN
ejop-10097	114	19	,	,	PUNCT
ejop-10097	114	20	s.	s.	PROPN
ejop-10097	114	21	,	,	PUNCT
ejop-10097	114	22	&	&	CCONJ
ejop-10097	114	23	del	del	PROPN
ejop-10097	114	24	felice	felice	PROPN
ejop-10097	114	25	,	,	PUNCT
ejop-10097	114	26	a.	a.	NOUN
ejop-10097	114	27	(	(	PUNCT
ejop-10097	114	28	2022	2022	NUM
ejop-10097	114	29	)	)	PUNCT
ejop-10097	114	30	.	.	PUNCT
ejop-10097	115	1	cognitive	cognitive	ADJ
ejop-10097	115	2	impairment	impairment	NOUN
ejop-10097	115	3	in	in	ADP
ejop-10097	115	4	people	people	NOUN
ejop-10097	115	5	with	with	ADP
ejop-10097	115	6	previous	previous	ADJ
ejop-10097	115	7	covid-19	covid-19	PROPN
ejop-10097	115	8	infection	infection	NOUN
ejop-10097	115	9	:	:	PUNCT
ejop-10097	115	10	a	a	DET
ejop-10097	115	11	scoping	scope	VERB
ejop-10097	115	12	review	review	NOUN
ejop-10097	115	13	.	.	PUNCT
ejop-10097	116	1	cortex	cortex	NOUN
ejop-10097	116	2	,	,	PUNCT
ejop-10097	116	3	154	154	NUM
ejop-10097	116	4	,	,	PUNCT
ejop-10097	116	5	212–230	212–230	NUM
ejop-10097	116	6	.	.	PUNCT
ejop-10097	117	1	https://doi.org/10.1016/j.cortex.2022.06.002	https://doi.org/10.1016/j.cortex.2022.06.002	PROPN
ejop-10097	117	2	borsboom	borsboom	NOUN
ejop-10097	117	3	,	,	PUNCT
ejop-10097	117	4	d.	d.	PROPN
ejop-10097	117	5	(	(	PUNCT
ejop-10097	117	6	2017	2017	NUM
ejop-10097	117	7	)	)	PUNCT
ejop-10097	117	8	.	.	PUNCT
ejop-10097	118	1	a	a	DET
ejop-10097	118	2	network	network	NOUN
ejop-10097	118	3	theory	theory	NOUN
ejop-10097	118	4	of	of	ADP
ejop-10097	118	5	mental	mental	ADJ
ejop-10097	118	6	disorders	disorder	NOUN
ejop-10097	118	7	.	.	PUNCT
ejop-10097	119	1	world	world	NOUN
ejop-10097	119	2	psychiatry	psychiatry	NOUN
ejop-10097	119	3	;	;	PUNCT
ejop-10097	119	4	official	official	ADJ
ejop-10097	119	5	journal	journal	NOUN
ejop-10097	119	6	of	of	ADP
ejop-10097	119	7	the	the	DET
ejop-10097	119	8	world	world	PROPN
ejop-10097	119	9	psychiatric	psychiatric	PROPN
ejop-10097	119	10	association	association	PROPN
ejop-10097	119	11	,	,	PUNCT
ejop-10097	119	12	16(1	16(1	NUM
ejop-10097	119	13	)	)	PUNCT
ejop-10097	119	14	,	,	PUNCT
ejop-10097	119	15	5–13	5–13	PROPN
ejop-10097	119	16	.	.	PUNCT
ejop-10097	120	1	https://doi.org/10.1002/wps.20375	https://doi.org/10.1002/wps.20375	PROPN
ejop-10097	120	2	borsboom	borsboom	NOUN
ejop-10097	120	3	,	,	PUNCT
ejop-10097	120	4	d.	d.	PROPN
ejop-10097	120	5	,	,	PUNCT
ejop-10097	120	6	&	&	CCONJ
ejop-10097	120	7	cramer	cramer	PROPN
ejop-10097	120	8	,	,	PUNCT
ejop-10097	120	9	a.	a.	PROPN
ejop-10097	120	10	o.	o.	PROPN
ejop-10097	120	11	j.	j.	PROPN
ejop-10097	120	12	(	(	PUNCT
ejop-10097	120	13	2013	2013	NUM
ejop-10097	120	14	)	)	PUNCT
ejop-10097	120	15	.	.	PUNCT
ejop-10097	121	1	network	network	NOUN
ejop-10097	121	2	analysis	analysis	NOUN
ejop-10097	121	3	:	:	PUNCT
ejop-10097	121	4	an	an	DET
ejop-10097	121	5	integrative	integrative	ADJ
ejop-10097	121	6	approach	approach	NOUN
ejop-10097	121	7	to	to	ADP
ejop-10097	121	8	the	the	DET
ejop-10097	121	9	structure	structure	NOUN
ejop-10097	121	10	of	of	ADP
ejop-10097	121	11	psychopathology	psychopathology	NOUN
ejop-10097	121	12	.	.	PUNCT
ejop-10097	122	1	annual	annual	ADJ
ejop-10097	122	2	review	review	NOUN
ejop-10097	122	3	of	of	ADP
ejop-10097	122	4	clinical	clinical	ADJ
ejop-10097	122	5	psychology	psychology	NOUN
ejop-10097	122	6	,	,	PUNCT
ejop-10097	122	7	9	9	NUM
ejop-10097	122	8	,	,	PUNCT
ejop-10097	122	9	91–121	91–121	NUM
ejop-10097	122	10	.	.	PUNCT
ejop-10097	123	1	https://doi.org/10.1146/annurev-clinpsy-050212-185608	https://doi.org/10.1146/annurev-clinpsy-050212-185608	NOUN
ejop-10097	123	2	borsboom	borsboom	NOUN
ejop-10097	123	3	,	,	PUNCT
ejop-10097	123	4	d.	d.	PROPN
ejop-10097	123	5	,	,	PUNCT
ejop-10097	123	6	deserno	deserno	NOUN
ejop-10097	123	7	,	,	PUNCT
ejop-10097	123	8	m.	m.	NOUN
ejop-10097	123	9	k.	k.	PROPN
ejop-10097	123	10	,	,	PUNCT
ejop-10097	123	11	rhemtulla	rhemtulla	PROPN
ejop-10097	123	12	,	,	PUNCT
ejop-10097	123	13	m.	m.	NOUN
ejop-10097	123	14	,	,	PUNCT
ejop-10097	123	15	epskamp	epskamp	PROPN
ejop-10097	123	16	,	,	PUNCT
ejop-10097	123	17	s.	s.	PROPN
ejop-10097	123	18	,	,	PUNCT
ejop-10097	123	19	fried	fry	VERB
ejop-10097	123	20	,	,	PUNCT
ejop-10097	123	21	e.	e.	PROPN
ejop-10097	123	22	i.	i.	PROPN
ejop-10097	123	23	,	,	PUNCT
ejop-10097	123	24	mcnally	mcnally	PROPN
ejop-10097	123	25	,	,	PUNCT
ejop-10097	123	26	r.	r.	PROPN
ejop-10097	123	27	j.	j.	PROPN
ejop-10097	123	28	,	,	PUNCT
ejop-10097	123	29	robinaugh	robinaugh	ADJ
ejop-10097	123	30	,	,	PUNCT
ejop-10097	123	31	d.	d.	PROPN
ejop-10097	123	32	j.	j.	PROPN
ejop-10097	123	33	,	,	PUNCT
ejop-10097	123	34	perugini	perugini	PROPN
ejop-10097	123	35	,	,	PUNCT
ejop-10097	123	36	m.	m.	NOUN
ejop-10097	123	37	,	,	PUNCT
ejop-10097	123	38	dalege	dalege	PROPN
ejop-10097	123	39	,	,	PUNCT
ejop-10097	123	40	j.	j.	PROPN
ejop-10097	123	41	,	,	PUNCT
ejop-10097	123	42	costantini	costantini	PROPN
ejop-10097	123	43	,	,	PUNCT
ejop-10097	123	44	g.	g.	PROPN
ejop-10097	123	45	,	,	PUNCT
ejop-10097	123	46	isvoranu	isvoranu	PROPN
ejop-10097	123	47	,	,	PUNCT
ejop-10097	123	48	a.-m	a.-m	PROPN
ejop-10097	123	49	.	.	PROPN
ejop-10097	123	50	,	,	PUNCT
ejop-10097	123	51	wysocki	wysocki	PROPN
ejop-10097	123	52	,	,	PUNCT
ejop-10097	123	53	a.	a.	PROPN
ejop-10097	123	54	c.	c.	PROPN
ejop-10097	123	55	,	,	PUNCT
ejop-10097	123	56	van	van	PROPN
ejop-10097	123	57	borkulo	borkulo	NOUN
ejop-10097	123	58	,	,	PUNCT
ejop-10097	123	59	c.	c.	PROPN
ejop-10097	123	60	d.	d.	PROPN
ejop-10097	123	61	,	,	PUNCT
ejop-10097	123	62	van	van	PROPN
ejop-10097	123	63	bork	bork	PROPN
ejop-10097	123	64	,	,	PUNCT
ejop-10097	123	65	r.	r.	PROPN
ejop-10097	123	66	,	,	PUNCT
ejop-10097	123	67	&	&	CCONJ
ejop-10097	123	68	waldorp	waldorp	PROPN
ejop-10097	123	69	,	,	PUNCT
ejop-10097	123	70	l.	l.	PROPN
ejop-10097	123	71	j.	j.	PROPN
ejop-10097	123	72	(	(	PUNCT
ejop-10097	123	73	2021	2021	NUM
ejop-10097	123	74	)	)	PUNCT
ejop-10097	123	75	.	.	PUNCT
ejop-10097	124	1	network	network	NOUN
ejop-10097	124	2	analysis	analysis	NOUN
ejop-10097	124	3	of	of	ADP
ejop-10097	124	4	multivariate	multivariate	NOUN
ejop-10097	124	5	data	datum	NOUN
ejop-10097	124	6	in	in	ADP
ejop-10097	124	7	psychological	psychological	ADJ
ejop-10097	124	8	science	science	NOUN
ejop-10097	124	9	.	.	PUNCT
ejop-10097	125	1	nature	nature	NOUN
ejop-10097	125	2	reviews	review	VERB
ejop-10097	125	3	methods	method	NOUN
ejop-10097	125	4	primers	primer	NOUN
ejop-10097	125	5	,	,	PUNCT
ejop-10097	125	6	1(1	1(1	NUM
ejop-10097	125	7	)	)	PUNCT
ejop-10097	125	8	.	.	PUNCT
ejop-10097	126	1	advance	advance	VERB
ejop-10097	126	2	online	online	ADJ
ejop-10097	126	3	publication	publication	NOUN
ejop-10097	126	4	.	.	PUNCT
ejop-10097	127	1	https://doi.org/10.1038/s43586-021-00055-w	https://doi.org/10.1038/s43586-021-00055-w	PROPN
ejop-10097	127	2	chen	chen	PROPN
ejop-10097	127	3	,	,	PUNCT
ejop-10097	127	4	c.	c.	PROPN
ejop-10097	127	5	,	,	PUNCT
ejop-10097	127	6	haupert	haupert	NOUN
ejop-10097	127	7	,	,	PUNCT
ejop-10097	127	8	s.	s.	PROPN
ejop-10097	127	9	r.	r.	PROPN
ejop-10097	127	10	,	,	PUNCT
ejop-10097	127	11	zimmermann	zimmermann	PROPN
ejop-10097	127	12	,	,	PUNCT
ejop-10097	127	13	l.	l.	PROPN
ejop-10097	127	14	,	,	PUNCT
ejop-10097	127	15	shi	shi	PROPN
ejop-10097	127	16	,	,	PUNCT
ejop-10097	127	17	x.	x.	PROPN
ejop-10097	127	18	,	,	PUNCT
ejop-10097	127	19	fritsche	fritsche	PROPN
ejop-10097	127	20	,	,	PUNCT
ejop-10097	127	21	l.	l.	PROPN
ejop-10097	127	22	g.	g.	PROPN
ejop-10097	127	23	,	,	PUNCT
ejop-10097	127	24	&	&	CCONJ
ejop-10097	127	25	mukherjee	mukherjee	PROPN
ejop-10097	127	26	,	,	PUNCT
ejop-10097	127	27	b.	b.	PROPN
ejop-10097	127	28	(	(	PUNCT
ejop-10097	127	29	2022	2022	NUM
ejop-10097	127	30	)	)	PUNCT
ejop-10097	127	31	.	.	PUNCT
ejop-10097	128	1	global	global	ADJ
ejop-10097	128	2	prevalence	prevalence	NOUN
ejop-10097	128	3	of	of	ADP
ejop-10097	128	4	post	post	NOUN
ejop-10097	128	5	covid-19	covid-19	PROPN
ejop-10097	128	6	condition	condition	NOUN
ejop-10097	128	7	or	or	CCONJ
ejop-10097	128	8	long	long	ADJ
ejop-10097	128	9	covid	covid	NOUN
ejop-10097	128	10	:	:	PUNCT
ejop-10097	128	11	a	a	DET
ejop-10097	128	12	meta	meta	ADJ
ejop-10097	128	13	-	-	PUNCT
ejop-10097	128	14	analysis	analysis	NOUN
ejop-10097	128	15	and	and	CCONJ
ejop-10097	128	16	systematic	systematic	ADJ
ejop-10097	128	17	review	review	NOUN
ejop-10097	128	18	.	.	PUNCT
ejop-10097	129	1	journal	journal	NOUN
ejop-10097	129	2	of	of	ADP
ejop-10097	129	3	infectious	infectious	ADJ
ejop-10097	129	4	diseases	disease	NOUN
ejop-10097	129	5	.	.	PUNCT
ejop-10097	130	1	advance	advance	VERB
ejop-10097	130	2	online	online	ADJ
ejop-10097	130	3	publication	publication	NOUN
ejop-10097	130	4	.	.	PUNCT
ejop-10097	131	1	https://doi.org/10.1093/infdis/jiac136	https://doi.org/10.1093/infdis/jiac136	PROPN
ejop-10097	132	1	a	a	DET
ejop-10097	132	2	network	network	NOUN
ejop-10097	132	3	perspective	perspective	NOUN
ejop-10097	132	4	on	on	ADP
ejop-10097	132	5	the	the	DET
ejop-10097	132	6	post	post	ADJ
ejop-10097	132	7	-	-	ADJ
ejop-10097	132	8	covid	covid	ADJ
ejop-10097	132	9	syndrome	syndrome	PROPN
ejop-10097	132	10	354	354	NUM
ejop-10097	132	11	europe	europe	PROPN
ejop-10097	132	12	's	's	PART
ejop-10097	132	13	journal	journal	NOUN
ejop-10097	132	14	of	of	ADP
ejop-10097	132	15	psychology	psychology	NOUN
ejop-10097	132	16	2022	2022	NUM
ejop-10097	132	17	,	,	PUNCT
ejop-10097	132	18	vol	vol	NOUN
ejop-10097	132	19	.	.	PUNCT
ejop-10097	132	20	18(4	18(4	NUM
ejop-10097	132	21	)	)	PUNCT
ejop-10097	132	22	,	,	PUNCT
ejop-10097	132	23	350–356	350–356	NUM
ejop-10097	132	24	https://doi.org/10.5964/ejop.10097	https://doi.org/10.5964/ejop.10097	NOUN
ejop-10097	132	25	https://doi.org/10.1016/j.cmi.2022.01.014	https://doi.org/10.1016/j.cmi.2022.01.014	PROPN
ejop-10097	132	26	https://doi.org/10.3390/ijerph18126335	https://doi.org/10.3390/ijerph18126335	NOUN
ejop-10097	132	27	https://doi.org/10.1016/j.lanepe.2021.100122	https://doi.org/10.1016/j.lanepe.2021.100122	PROPN
ejop-10097	132	28	https://doi.org/10.1017/s0033291716002300	https://doi.org/10.1017/s0033291716002300	NUM
ejop-10097	132	29	https://doi.org/10.1080/13548506.2016.1274042	https://doi.org/10.1080/13548506.2016.1274042	PROPN
ejop-10097	132	30	https://doi.org/10.1038/s41598-021-01215-4	https://doi.org/10.1038/s41598-021-01215-4	NUM
ejop-10097	132	31	https://doi.org/10.1016/j.cortex.2022.06.002	https://doi.org/10.1016/j.cortex.2022.06.002	NUM
ejop-10097	132	32	https://doi.org/10.1002/wps.20375	https://doi.org/10.1002/wps.20375	PROPN
ejop-10097	132	33	https://doi.org/10.1146/annurev-clinpsy-050212-185608	https://doi.org/10.1146/annurev-clinpsy-050212-185608	PROPN
ejop-10097	132	34	https://doi.org/10.1038/s43586-021-00055-w	https://doi.org/10.1038/s43586-021-00055-w	VERB
ejop-10097	132	35	https://doi.org/10.1093/infdis/jiac136	https://doi.org/10.1093/infdis/jiac136	NOUN
ejop-10097	133	1	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
ejop-10097	133	2	couzin	couzin	PROPN
ejop-10097	133	3	-	-	PUNCT
ejop-10097	133	4	frankel	frankel	PROPN
ejop-10097	133	5	,	,	PUNCT
ejop-10097	133	6	j.	j.	PROPN
ejop-10097	133	7	,	,	PUNCT
ejop-10097	133	8	&	&	CCONJ
ejop-10097	133	9	vogel	vogel	PROPN
ejop-10097	133	10	,	,	PUNCT
ejop-10097	133	11	g.	g.	PROPN
ejop-10097	133	12	(	(	PUNCT
ejop-10097	133	13	2022	2022	NUM
ejop-10097	133	14	)	)	PUNCT
ejop-10097	133	15	.	.	PUNCT
ejop-10097	134	1	vaccines	vaccine	NOUN
ejop-10097	134	2	may	may	AUX
ejop-10097	134	3	cause	cause	VERB
ejop-10097	134	4	rare	rare	ADJ
ejop-10097	134	5	,	,	PUNCT
ejop-10097	134	6	long	long	ADJ
ejop-10097	134	7	covid	covid	VERB
ejop-10097	134	8	-	-	PUNCT
ejop-10097	134	9	like	like	ADJ
ejop-10097	134	10	symptoms	symptom	NOUN
ejop-10097	134	11	.	.	PUNCT
ejop-10097	135	1	science	science	NOUN
ejop-10097	135	2	,	,	PUNCT
ejop-10097	135	3	375(6579	375(6579	NUM
ejop-10097	135	4	)	)	PUNCT
ejop-10097	135	5	,	,	PUNCT
ejop-10097	135	6	364–366	364–366	NUM
ejop-10097	135	7	.	.	PUNCT
ejop-10097	136	1	https://doi.org/10.1126/science.ada0536	https://doi.org/10.1126/science.ada0536	NUM
ejop-10097	136	2	cox	cox	PROPN
ejop-10097	136	3	,	,	PUNCT
ejop-10097	136	4	r.	r.	PROPN
ejop-10097	136	5	c.	c.	PROPN
ejop-10097	136	6	,	,	PUNCT
ejop-10097	136	7	&	&	CCONJ
ejop-10097	136	8	olatunji	olatunji	PROPN
ejop-10097	136	9	,	,	PUNCT
ejop-10097	136	10	b.	b.	PROPN
ejop-10097	136	11	o.	o.	PROPN
ejop-10097	136	12	(	(	PUNCT
ejop-10097	136	13	2020	2020	NUM
ejop-10097	136	14	)	)	PUNCT
ejop-10097	136	15	.	.	PUNCT
ejop-10097	137	1	sleep	sleep	VERB
ejop-10097	137	2	in	in	ADP
ejop-10097	137	3	the	the	DET
ejop-10097	137	4	anxiety	anxiety	NOUN
ejop-10097	137	5	-	-	PUNCT
ejop-10097	137	6	related	relate	VERB
ejop-10097	137	7	disorders	disorder	NOUN
ejop-10097	137	8	:	:	PUNCT
ejop-10097	137	9	a	a	DET
ejop-10097	137	10	meta	meta	ADJ
ejop-10097	137	11	-	-	PUNCT
ejop-10097	137	12	analysis	analysis	NOUN
ejop-10097	137	13	of	of	ADP
ejop-10097	137	14	subjective	subjective	ADJ
ejop-10097	137	15	and	and	CCONJ
ejop-10097	137	16	objective	objective	ADJ
ejop-10097	137	17	research	research	NOUN
ejop-10097	137	18	.	.	PUNCT
ejop-10097	138	1	sleep	sleep	NOUN
ejop-10097	138	2	medicine	medicine	NOUN
ejop-10097	138	3	reviews	review	NOUN
ejop-10097	138	4	,	,	PUNCT
ejop-10097	138	5	51	51	NUM
ejop-10097	138	6	,	,	PUNCT
ejop-10097	138	7	article	article	NOUN
ejop-10097	138	8	e101282	e101282	PROPN
ejop-10097	138	9	.	.	PUNCT
ejop-10097	139	1	https://doi.org/10.1016/j.smrv.2020.101282	https://doi.org/10.1016/j.smrv.2020.101282	PROPN
ejop-10097	139	2	damiano	damiano	PROPN
ejop-10097	139	3	,	,	PUNCT
ejop-10097	139	4	r.	r.	PROPN
ejop-10097	139	5	f.	f.	PROPN
ejop-10097	139	6	,	,	PUNCT
ejop-10097	139	7	guedes	guedes	PROPN
ejop-10097	139	8	,	,	PUNCT
ejop-10097	139	9	b.	b.	PROPN
ejop-10097	139	10	f.	f.	PROPN
ejop-10097	139	11	,	,	PUNCT
ejop-10097	139	12	de	de	X
ejop-10097	139	13	rocca	rocca	PROPN
ejop-10097	139	14	,	,	PUNCT
ejop-10097	139	15	c.	c.	PROPN
ejop-10097	139	16	c.	c.	PROPN
ejop-10097	139	17	,	,	PUNCT
ejop-10097	139	18	de	de	PROPN
ejop-10097	139	19	pádua	pádua	PROPN
ejop-10097	139	20	serafim	serafim	PROPN
ejop-10097	139	21	,	,	PUNCT
ejop-10097	139	22	a.	a.	PROPN
ejop-10097	139	23	,	,	PUNCT
ejop-10097	139	24	castro	castro	PROPN
ejop-10097	139	25	,	,	PUNCT
ejop-10097	139	26	l.	l.	PROPN
ejop-10097	139	27	h.	h.	PROPN
ejop-10097	139	28	m.	m.	PROPN
ejop-10097	139	29	,	,	PUNCT
ejop-10097	139	30	munhoz	munhoz	ADJ
ejop-10097	139	31	,	,	PUNCT
ejop-10097	139	32	c.	c.	PROPN
ejop-10097	139	33	d.	d.	PROPN
ejop-10097	139	34	,	,	PUNCT
ejop-10097	139	35	nitrini	nitrini	PROPN
ejop-10097	139	36	,	,	PUNCT
ejop-10097	139	37	r.	r.	PROPN
ejop-10097	139	38	,	,	PUNCT
ejop-10097	139	39	filho	filho	NOUN
ejop-10097	139	40	,	,	PUNCT
ejop-10097	139	41	g.	g.	PROPN
ejop-10097	139	42	b.	b.	PROPN
ejop-10097	139	43	,	,	PUNCT
ejop-10097	139	44	miguel	miguel	PROPN
ejop-10097	139	45	,	,	PUNCT
ejop-10097	139	46	e.	e.	PROPN
ejop-10097	139	47	c.	c.	PROPN
ejop-10097	139	48	,	,	PUNCT
ejop-10097	139	49	lucchetti	lucchetti	PROPN
ejop-10097	139	50	,	,	PUNCT
ejop-10097	139	51	g.	g.	PROPN
ejop-10097	139	52	,	,	PUNCT
ejop-10097	139	53	&	&	CCONJ
ejop-10097	139	54	forlenza	forlenza	PROPN
ejop-10097	139	55	,	,	PUNCT
ejop-10097	139	56	o.	o.	PROPN
ejop-10097	139	57	(	(	PUNCT
ejop-10097	139	58	2022	2022	NUM
ejop-10097	139	59	)	)	PUNCT
ejop-10097	139	60	.	.	PUNCT
ejop-10097	140	1	cognitive	cognitive	ADJ
ejop-10097	140	2	decline	decline	NOUN
ejop-10097	140	3	following	follow	VERB
ejop-10097	140	4	acute	acute	ADJ
ejop-10097	140	5	viral	viral	ADJ
ejop-10097	140	6	infections	infection	NOUN
ejop-10097	140	7	:	:	PUNCT
ejop-10097	140	8	literature	literature	NOUN
ejop-10097	140	9	review	review	NOUN
ejop-10097	140	10	and	and	CCONJ
ejop-10097	140	11	projections	projection	NOUN
ejop-10097	140	12	for	for	ADP
ejop-10097	140	13	post	post	NOUN
ejop-10097	140	14	-	-	ADJ
ejop-10097	140	15	covid-19	covid-19	PROPN
ejop-10097	140	16	.	.	PUNCT
ejop-10097	141	1	european	european	ADJ
ejop-10097	141	2	archives	archive	NOUN
ejop-10097	141	3	of	of	ADP
ejop-10097	141	4	psychiatry	psychiatry	NOUN
ejop-10097	141	5	and	and	CCONJ
ejop-10097	141	6	clinical	clinical	ADJ
ejop-10097	141	7	neuroscience	neuroscience	NOUN
ejop-10097	141	8	,	,	PUNCT
ejop-10097	141	9	272(1	272(1	NUM
ejop-10097	141	10	)	)	PUNCT
ejop-10097	141	11	,	,	PUNCT
ejop-10097	141	12	139–154	139–154	NUM
ejop-10097	141	13	.	.	PUNCT
ejop-10097	141	14	https://doi.org/10.1007/s00406-021-01286-4	https://doi.org/10.1007/s00406-021-01286-4	NUM
ejop-10097	141	15	daroische	daroische	PROPN
ejop-10097	141	16	,	,	PUNCT
ejop-10097	141	17	r.	r.	PROPN
ejop-10097	141	18	,	,	PUNCT
ejop-10097	141	19	hemminghyth	hemminghyth	NOUN
ejop-10097	141	20	,	,	PUNCT
ejop-10097	141	21	m.	m.	NOUN
ejop-10097	141	22	s.	s.	PROPN
ejop-10097	141	23	,	,	PUNCT
ejop-10097	141	24	eilertsen	eilertsen	PROPN
ejop-10097	141	25	,	,	PUNCT
ejop-10097	141	26	t.	t.	PROPN
ejop-10097	141	27	h.	h.	PROPN
ejop-10097	141	28	,	,	PUNCT
ejop-10097	141	29	breitve	breitve	PROPN
ejop-10097	141	30	,	,	PUNCT
ejop-10097	141	31	m.	m.	PROPN
ejop-10097	141	32	h.	h.	PROPN
ejop-10097	141	33	,	,	PUNCT
ejop-10097	141	34	&	&	CCONJ
ejop-10097	141	35	chwiszczuk	chwiszczuk	PROPN
ejop-10097	141	36	,	,	PUNCT
ejop-10097	141	37	l.	l.	PROPN
ejop-10097	141	38	j.	j.	PROPN
ejop-10097	141	39	(	(	PUNCT
ejop-10097	141	40	2021	2021	NUM
ejop-10097	141	41	)	)	PUNCT
ejop-10097	141	42	.	.	PUNCT
ejop-10097	142	1	cognitive	cognitive	ADJ
ejop-10097	142	2	impairment	impairment	NOUN
ejop-10097	142	3	after	after	ADP
ejop-10097	142	4	covid-19	covid-19	PROPN
ejop-10097	142	5	:	:	PUNCT
ejop-10097	142	6	a	a	DET
ejop-10097	142	7	review	review	NOUN
ejop-10097	142	8	on	on	ADP
ejop-10097	142	9	objective	objective	ADJ
ejop-10097	142	10	test	test	NOUN
ejop-10097	142	11	data	datum	NOUN
ejop-10097	142	12	.	.	PUNCT
ejop-10097	143	1	frontiers	frontier	NOUN
ejop-10097	143	2	in	in	ADP
ejop-10097	143	3	neurology	neurology	NOUN
ejop-10097	143	4	,	,	PUNCT
ejop-10097	143	5	12	12	NUM
ejop-10097	143	6	,	,	PUNCT
ejop-10097	143	7	article	article	NOUN
ejop-10097	143	8	e699582	e699582	PROPN
ejop-10097	143	9	.	.	PUNCT
ejop-10097	144	1	https://doi.org/10.3389/fneur.2021.699582	https://doi.org/10.3389/fneur.2021.699582	VERB
ejop-10097	144	2	fortier	fortier	NOUN
ejop-10097	144	3	-	-	PUNCT
ejop-10097	144	4	brochu	brochu	PROPN
ejop-10097	144	5	,	,	PUNCT
ejop-10097	144	6	e.	e.	PROPN
ejop-10097	144	7	,	,	PUNCT
ejop-10097	144	8	beaulieu	beaulieu	NOUN
ejop-10097	144	9	-	-	PUNCT
ejop-10097	144	10	bonneau	bonneau	PROPN
ejop-10097	144	11	,	,	PUNCT
ejop-10097	144	12	s.	s.	PROPN
ejop-10097	144	13	,	,	PUNCT
ejop-10097	144	14	ivers	iver	NOUN
ejop-10097	144	15	,	,	PUNCT
ejop-10097	144	16	h.	h.	PROPN
ejop-10097	144	17	,	,	PUNCT
ejop-10097	144	18	&	&	CCONJ
ejop-10097	144	19	morin	morin	PROPN
ejop-10097	144	20	,	,	PUNCT
ejop-10097	144	21	c.	c.	PROPN
ejop-10097	144	22	m.	m.	NOUN
ejop-10097	144	23	(	(	PUNCT
ejop-10097	144	24	2012	2012	NUM
ejop-10097	144	25	)	)	PUNCT
ejop-10097	144	26	.	.	PUNCT
ejop-10097	145	1	insomnia	insomnia	PROPN
ejop-10097	145	2	and	and	CCONJ
ejop-10097	145	3	daytime	daytime	NOUN
ejop-10097	145	4	cognitive	cognitive	ADJ
ejop-10097	145	5	performance	performance	NOUN
ejop-10097	145	6	:	:	PUNCT
ejop-10097	145	7	a	a	DET
ejop-10097	145	8	metaanalysis	metaanalysis	NOUN
ejop-10097	145	9	.	.	PUNCT
ejop-10097	146	1	sleep	sleep	NOUN
ejop-10097	146	2	medicine	medicine	NOUN
ejop-10097	146	3	reviews	review	NOUN
ejop-10097	146	4	,	,	PUNCT
ejop-10097	146	5	16(1	16(1	NUM
ejop-10097	146	6	)	)	PUNCT
ejop-10097	146	7	,	,	PUNCT
ejop-10097	146	8	83–94	83–94	NUM
ejop-10097	146	9	.	.	PUNCT
ejop-10097	147	1	https://doi.org/10.1016/j.smrv.2011.03.008	https://doi.org/10.1016/j.smrv.2011.03.008	NOUN
ejop-10097	147	2	gulpers	gulper	NOUN
ejop-10097	147	3	,	,	PUNCT
ejop-10097	147	4	b.	b.	PROPN
ejop-10097	147	5	,	,	PUNCT
ejop-10097	147	6	ramakers	ramaker	NOUN
ejop-10097	147	7	,	,	PUNCT
ejop-10097	147	8	i.	i.	PROPN
ejop-10097	147	9	,	,	PUNCT
ejop-10097	147	10	hamel	hamel	PROPN
ejop-10097	147	11	,	,	PUNCT
ejop-10097	147	12	r.	r.	PROPN
ejop-10097	147	13	,	,	PUNCT
ejop-10097	147	14	köhler	köhler	PROPN
ejop-10097	147	15	,	,	PUNCT
ejop-10097	147	16	s.	s.	PROPN
ejop-10097	147	17	,	,	PUNCT
ejop-10097	147	18	oude	oude	VERB
ejop-10097	147	19	voshaar	voshaar	NOUN
ejop-10097	147	20	,	,	PUNCT
ejop-10097	147	21	r.	r.	PROPN
ejop-10097	147	22	,	,	PUNCT
ejop-10097	147	23	&	&	CCONJ
ejop-10097	147	24	verhey	verhey	PROPN
ejop-10097	147	25	,	,	PUNCT
ejop-10097	147	26	f.	f.	PROPN
ejop-10097	147	27	(	(	PUNCT
ejop-10097	147	28	2016	2016	NUM
ejop-10097	147	29	)	)	PUNCT
ejop-10097	147	30	.	.	PUNCT
ejop-10097	148	1	anxiety	anxiety	NOUN
ejop-10097	148	2	as	as	ADP
ejop-10097	148	3	a	a	DET
ejop-10097	148	4	predictor	predictor	NOUN
ejop-10097	148	5	for	for	ADP
ejop-10097	148	6	cognitive	cognitive	ADJ
ejop-10097	148	7	decline	decline	NOUN
ejop-10097	148	8	and	and	CCONJ
ejop-10097	148	9	dementia	dementia	NOUN
ejop-10097	148	10	:	:	PUNCT
ejop-10097	148	11	a	a	DET
ejop-10097	148	12	systematic	systematic	ADJ
ejop-10097	148	13	review	review	NOUN
ejop-10097	148	14	and	and	CCONJ
ejop-10097	148	15	meta	meta	ADJ
ejop-10097	148	16	-	-	PUNCT
ejop-10097	148	17	analysis	analysis	NOUN
ejop-10097	148	18	.	.	PUNCT
ejop-10097	149	1	american	american	ADJ
ejop-10097	149	2	journal	journal	PROPN
ejop-10097	149	3	of	of	ADP
ejop-10097	149	4	geriatric	geriatric	PROPN
ejop-10097	149	5	psychiatry	psychiatry	NOUN
ejop-10097	149	6	,	,	PUNCT
ejop-10097	149	7	24(10	24(10	NUM
ejop-10097	149	8	)	)	PUNCT
ejop-10097	149	9	,	,	PUNCT
ejop-10097	149	10	823–842	823–842	NUM
ejop-10097	149	11	.	.	PUNCT
ejop-10097	150	1	https://doi.org/10.1016/j.jagp.2016.05.015	https://doi.org/10.1016/j.jagp.2016.05.015	PROPN
ejop-10097	150	2	hashioka	hashioka	PROPN
ejop-10097	150	3	,	,	PUNCT
ejop-10097	150	4	s.	s.	PROPN
ejop-10097	150	5	,	,	PUNCT
ejop-10097	150	6	inoue	inoue	PROPN
ejop-10097	150	7	,	,	PUNCT
ejop-10097	150	8	k.	k.	PROPN
ejop-10097	150	9	,	,	PUNCT
ejop-10097	150	10	miyaoka	miyaoka	NOUN
ejop-10097	150	11	,	,	PUNCT
ejop-10097	150	12	t.	t.	PROPN
ejop-10097	150	13	,	,	PUNCT
ejop-10097	150	14	hayashida	hayashida	PROPN
ejop-10097	150	15	,	,	PUNCT
ejop-10097	150	16	m.	m.	NOUN
ejop-10097	150	17	,	,	PUNCT
ejop-10097	150	18	wake	wake	VERB
ejop-10097	150	19	,	,	PUNCT
ejop-10097	150	20	r.	r.	PROPN
ejop-10097	150	21	,	,	PUNCT
ejop-10097	150	22	oh	oh	NOUN
ejop-10097	150	23	-	-	PUNCT
ejop-10097	150	24	nishi	nishi	NOUN
ejop-10097	150	25	,	,	PUNCT
ejop-10097	150	26	a.	a.	PROPN
ejop-10097	150	27	,	,	PUNCT
ejop-10097	150	28	&	&	CCONJ
ejop-10097	150	29	inagaki	inagaki	PROPN
ejop-10097	150	30	,	,	PUNCT
ejop-10097	150	31	m.	m.	NOUN
ejop-10097	150	32	(	(	PUNCT
ejop-10097	150	33	2019	2019	NUM
ejop-10097	150	34	)	)	PUNCT
ejop-10097	150	35	.	.	PUNCT
ejop-10097	151	1	the	the	DET
ejop-10097	151	2	possible	possible	ADJ
ejop-10097	151	3	causal	causal	ADJ
ejop-10097	151	4	link	link	NOUN
ejop-10097	151	5	of	of	ADP
ejop-10097	151	6	periodontitis	periodontitis	NOUN
ejop-10097	151	7	to	to	ADP
ejop-10097	151	8	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	151	9	disorders	disorder	NOUN
ejop-10097	151	10	:	:	PUNCT
ejop-10097	151	11	more	more	ADJ
ejop-10097	151	12	than	than	ADP
ejop-10097	151	13	psychosocial	psychosocial	ADJ
ejop-10097	151	14	mechanisms	mechanism	NOUN
ejop-10097	151	15	.	.	PUNCT
ejop-10097	152	1	international	international	ADJ
ejop-10097	152	2	journal	journal	NOUN
ejop-10097	152	3	of	of	ADP
ejop-10097	152	4	molecular	molecular	ADJ
ejop-10097	152	5	sciences	science	NOUN
ejop-10097	152	6	,	,	PUNCT
ejop-10097	152	7	20(15	20(15	NUM
ejop-10097	152	8	)	)	PUNCT
ejop-10097	152	9	,	,	PUNCT
ejop-10097	152	10	article	article	NOUN
ejop-10097	152	11	e3723	e3723	PROPN
ejop-10097	152	12	.	.	PUNCT
ejop-10097	153	1	https://doi.org/10.3390/ijms20153723	https://doi.org/10.3390/ijms20153723	PROPN
ejop-10097	153	2	kaiser	kaiser	PROPN
ejop-10097	153	3	,	,	PUNCT
ejop-10097	153	4	t.	t.	PROPN
ejop-10097	153	5	,	,	PUNCT
ejop-10097	153	6	herzog	herzog	PROPN
ejop-10097	153	7	,	,	PUNCT
ejop-10097	153	8	p.	p.	NOUN
ejop-10097	153	9	,	,	PUNCT
ejop-10097	153	10	voderholzer	voderholzer	NOUN
ejop-10097	153	11	,	,	PUNCT
ejop-10097	153	12	u.	u.	PROPN
ejop-10097	153	13	,	,	PUNCT
ejop-10097	153	14	&	&	CCONJ
ejop-10097	153	15	brakemeier	brakemeier	NOUN
ejop-10097	153	16	,	,	PUNCT
ejop-10097	153	17	e.-l	e.-l	NOUN
ejop-10097	153	18	.	.	PUNCT
ejop-10097	154	1	(	(	PUNCT
ejop-10097	154	2	2021	2021	NUM
ejop-10097	154	3	)	)	PUNCT
ejop-10097	154	4	.	.	PUNCT
ejop-10097	155	1	unraveling	unravel	VERB
ejop-10097	155	2	the	the	DET
ejop-10097	155	3	comorbidity	comorbidity	NOUN
ejop-10097	155	4	of	of	ADP
ejop-10097	155	5	depression	depression	NOUN
ejop-10097	155	6	and	and	CCONJ
ejop-10097	155	7	anxiety	anxiety	NOUN
ejop-10097	155	8	in	in	ADP
ejop-10097	155	9	a	a	DET
ejop-10097	155	10	large	large	ADJ
ejop-10097	155	11	inpatient	inpatient	NOUN
ejop-10097	155	12	sample	sample	NOUN
ejop-10097	155	13	:	:	PUNCT
ejop-10097	155	14	network	network	NOUN
ejop-10097	155	15	analysis	analysis	NOUN
ejop-10097	155	16	to	to	PART
ejop-10097	155	17	examine	examine	VERB
ejop-10097	155	18	bridge	bridge	NOUN
ejop-10097	155	19	symptoms	symptom	NOUN
ejop-10097	155	20	.	.	PUNCT
ejop-10097	156	1	depression	depression	NOUN
ejop-10097	156	2	and	and	CCONJ
ejop-10097	156	3	anxiety	anxiety	NOUN
ejop-10097	156	4	,	,	PUNCT
ejop-10097	156	5	38(3	38(3	NUM
ejop-10097	156	6	)	)	PUNCT
ejop-10097	156	7	,	,	PUNCT
ejop-10097	156	8	307–317	307–317	NUM
ejop-10097	156	9	.	.	PUNCT
ejop-10097	157	1	https://doi.org/10.1002/da.23136	https://doi.org/10.1002/da.23136	PROPN
ejop-10097	157	2	liu	liu	PROPN
ejop-10097	157	3	,	,	PUNCT
ejop-10097	157	4	d.	d.	PROPN
ejop-10097	157	5	,	,	PUNCT
ejop-10097	157	6	epskamp	epskamp	PROPN
ejop-10097	157	7	,	,	PUNCT
ejop-10097	157	8	s.	s.	PROPN
ejop-10097	157	9	,	,	PUNCT
ejop-10097	157	10	isvoranu	isvoranu	PROPN
ejop-10097	157	11	,	,	PUNCT
ejop-10097	157	12	a.-m	a.-m	PROPN
ejop-10097	157	13	.	.	PUNCT
ejop-10097	157	14	,	,	PUNCT
ejop-10097	157	15	chen	chen	PROPN
ejop-10097	157	16	,	,	PUNCT
ejop-10097	157	17	c.	c.	PROPN
ejop-10097	157	18	,	,	PUNCT
ejop-10097	157	19	liu	liu	PROPN
ejop-10097	157	20	,	,	PUNCT
ejop-10097	157	21	w.	w.	PROPN
ejop-10097	157	22	,	,	PUNCT
ejop-10097	157	23	&	&	CCONJ
ejop-10097	157	24	hong	hong	PROPN
ejop-10097	157	25	,	,	PUNCT
ejop-10097	157	26	x.	x.	NOUN
ejop-10097	157	27	(	(	PUNCT
ejop-10097	157	28	2021	2021	NUM
ejop-10097	157	29	)	)	PUNCT
ejop-10097	157	30	.	.	PUNCT
ejop-10097	158	1	network	network	NOUN
ejop-10097	158	2	analysis	analysis	NOUN
ejop-10097	158	3	of	of	ADP
ejop-10097	158	4	physical	physical	ADJ
ejop-10097	158	5	and	and	CCONJ
ejop-10097	158	6	psychiatric	psychiatric	ADJ
ejop-10097	158	7	symptoms	symptom	NOUN
ejop-10097	158	8	of	of	ADP
ejop-10097	158	9	hospital	hospital	NOUN
ejop-10097	158	10	discharged	discharge	VERB
ejop-10097	158	11	patients	patient	NOUN
ejop-10097	158	12	infected	infect	VERB
ejop-10097	158	13	with	with	ADP
ejop-10097	158	14	covid-19	covid-19	PROPN
ejop-10097	158	15	.	.	PROPN
ejop-10097	158	16	journal	journal	PROPN
ejop-10097	158	17	of	of	ADP
ejop-10097	158	18	affective	affective	ADJ
ejop-10097	158	19	disorders	disorder	NOUN
ejop-10097	158	20	,	,	PUNCT
ejop-10097	158	21	294	294	NUM
ejop-10097	158	22	,	,	PUNCT
ejop-10097	158	23	707–713	707–713	NUM
ejop-10097	158	24	.	.	PUNCT
ejop-10097	159	1	https://doi.org/10.1016/j.jad.2021.07.043	https://doi.org/10.1016/j.jad.2021.07.043	X
ejop-10097	159	2	martin	martin	PROPN
ejop-10097	159	3	,	,	PUNCT
ejop-10097	159	4	e.	e.	PROPN
ejop-10097	159	5	,	,	PUNCT
ejop-10097	159	6	&	&	CCONJ
ejop-10097	159	7	velayudhan	velayudhan	PROPN
ejop-10097	159	8	,	,	PUNCT
ejop-10097	159	9	l.	l.	PROPN
ejop-10097	159	10	(	(	PUNCT
ejop-10097	159	11	2020	2020	NUM
ejop-10097	159	12	)	)	PUNCT
ejop-10097	159	13	.	.	PUNCT
ejop-10097	160	1	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	160	2	symptoms	symptom	NOUN
ejop-10097	160	3	in	in	ADP
ejop-10097	160	4	mild	mild	ADJ
ejop-10097	160	5	cognitive	cognitive	ADJ
ejop-10097	160	6	impairment	impairment	NOUN
ejop-10097	160	7	:	:	PUNCT
ejop-10097	160	8	a	a	DET
ejop-10097	160	9	literature	literature	NOUN
ejop-10097	160	10	review	review	NOUN
ejop-10097	160	11	.	.	PUNCT
ejop-10097	161	1	dementia	dementia	NOUN
ejop-10097	161	2	and	and	CCONJ
ejop-10097	161	3	geriatric	geriatric	ADJ
ejop-10097	161	4	cognitive	cognitive	ADJ
ejop-10097	161	5	disorders	disorder	NOUN
ejop-10097	161	6	,	,	PUNCT
ejop-10097	161	7	49(2	49(2	NUM
ejop-10097	161	8	)	)	PUNCT
ejop-10097	161	9	,	,	PUNCT
ejop-10097	161	10	146–155	146–155	NUM
ejop-10097	161	11	.	.	PUNCT
ejop-10097	162	1	https://doi.org/10.1159/000507078	https://doi.org/10.1159/000507078	PROPN
ejop-10097	162	2	mehandru	mehandru	PROPN
ejop-10097	162	3	,	,	PUNCT
ejop-10097	162	4	s.	s.	PROPN
ejop-10097	162	5	,	,	PUNCT
ejop-10097	162	6	&	&	CCONJ
ejop-10097	162	7	merad	merad	PROPN
ejop-10097	162	8	,	,	PUNCT
ejop-10097	162	9	m.	m.	NOUN
ejop-10097	162	10	(	(	PUNCT
ejop-10097	162	11	2022	2022	NUM
ejop-10097	162	12	)	)	PUNCT
ejop-10097	162	13	.	.	PUNCT
ejop-10097	163	1	pathological	pathological	ADJ
ejop-10097	163	2	sequelae	sequelae	NOUN
ejop-10097	163	3	of	of	ADP
ejop-10097	163	4	long	long	ADJ
ejop-10097	163	5	-	-	PUNCT
ejop-10097	163	6	haul	haul	NOUN
ejop-10097	163	7	covid	covid	PROPN
ejop-10097	163	8	.	.	PUNCT
ejop-10097	164	1	nature	nature	PROPN
ejop-10097	164	2	immunology	immunology	NOUN
ejop-10097	164	3	,	,	PUNCT
ejop-10097	164	4	23(2	23(2	NOUN
ejop-10097	164	5	)	)	PUNCT
ejop-10097	164	6	,	,	PUNCT
ejop-10097	164	7	194–202	194–202	NUM
ejop-10097	164	8	.	.	PUNCT
ejop-10097	165	1	https://doi.org/10.1038/s41590-021-01104-y	https://doi.org/10.1038/s41590-021-01104-y	PROPN
ejop-10097	165	2	miyata	miyata	PROPN
ejop-10097	165	3	,	,	PUNCT
ejop-10097	165	4	s.	s.	PROPN
ejop-10097	165	5	,	,	PUNCT
ejop-10097	165	6	noda	noda	PROPN
ejop-10097	165	7	,	,	PUNCT
ejop-10097	165	8	a.	a.	PROPN
ejop-10097	165	9	,	,	PUNCT
ejop-10097	165	10	iwamoto	iwamoto	PROPN
ejop-10097	165	11	,	,	PUNCT
ejop-10097	165	12	k.	k.	PROPN
ejop-10097	165	13	,	,	PUNCT
ejop-10097	165	14	kawano	kawano	PROPN
ejop-10097	165	15	,	,	PUNCT
ejop-10097	165	16	n.	n.	NOUN
ejop-10097	165	17	,	,	PUNCT
ejop-10097	165	18	okuda	okuda	PROPN
ejop-10097	165	19	,	,	PUNCT
ejop-10097	165	20	m.	m.	NOUN
ejop-10097	165	21	,	,	PUNCT
ejop-10097	165	22	&	&	CCONJ
ejop-10097	165	23	ozaki	ozaki	PROPN
ejop-10097	165	24	,	,	PUNCT
ejop-10097	165	25	n.	n.	PROPN
ejop-10097	165	26	(	(	PUNCT
ejop-10097	165	27	2013	2013	NUM
ejop-10097	165	28	)	)	PUNCT
ejop-10097	165	29	.	.	PUNCT
ejop-10097	166	1	poor	poor	ADJ
ejop-10097	166	2	sleep	sleep	NOUN
ejop-10097	166	3	quality	quality	NOUN
ejop-10097	166	4	impairs	impair	VERB
ejop-10097	166	5	cognitive	cognitive	ADJ
ejop-10097	166	6	performance	performance	NOUN
ejop-10097	166	7	in	in	ADP
ejop-10097	166	8	older	old	ADJ
ejop-10097	166	9	adults	adult	NOUN
ejop-10097	166	10	.	.	PUNCT
ejop-10097	167	1	journal	journal	NOUN
ejop-10097	167	2	of	of	ADP
ejop-10097	167	3	sleep	sleep	NOUN
ejop-10097	167	4	research	research	NOUN
ejop-10097	167	5	,	,	PUNCT
ejop-10097	167	6	22(5	22(5	NOUN
ejop-10097	167	7	)	)	PUNCT
ejop-10097	167	8	,	,	PUNCT
ejop-10097	167	9	535–541	535–541	NUM
ejop-10097	167	10	.	.	PUNCT
ejop-10097	168	1	https://doi.org/10.1111/jsr.12054	https://doi.org/10.1111/jsr.12054	PROPN
ejop-10097	168	2	monaco	monaco	PROPN
ejop-10097	168	3	,	,	PUNCT
ejop-10097	168	4	s.	s.	PROPN
ejop-10097	168	5	,	,	PUNCT
ejop-10097	168	6	mariotto	mariotto	NOUN
ejop-10097	168	7	,	,	PUNCT
ejop-10097	168	8	s.	s.	PROPN
ejop-10097	168	9	,	,	PUNCT
ejop-10097	168	10	ferrari	ferrari	PROPN
ejop-10097	168	11	,	,	PUNCT
ejop-10097	168	12	s.	s.	PROPN
ejop-10097	168	13	,	,	PUNCT
ejop-10097	168	14	calabrese	calabrese	PROPN
ejop-10097	168	15	,	,	PUNCT
ejop-10097	168	16	m.	m.	NOUN
ejop-10097	168	17	,	,	PUNCT
ejop-10097	168	18	zanusso	zanusso	NOUN
ejop-10097	168	19	,	,	PUNCT
ejop-10097	168	20	g.	g.	PROPN
ejop-10097	168	21	,	,	PUNCT
ejop-10097	168	22	gajofatto	gajofatto	PROPN
ejop-10097	168	23	,	,	PUNCT
ejop-10097	168	24	a.	a.	NOUN
ejop-10097	168	25	,	,	PUNCT
ejop-10097	168	26	sansonno	sansonno	PROPN
ejop-10097	168	27	,	,	PUNCT
ejop-10097	168	28	d.	d.	PROPN
ejop-10097	168	29	,	,	PUNCT
ejop-10097	168	30	&	&	CCONJ
ejop-10097	168	31	dammacco	dammacco	PROPN
ejop-10097	168	32	,	,	PUNCT
ejop-10097	168	33	f.	f.	PROPN
ejop-10097	168	34	(	(	PUNCT
ejop-10097	168	35	2015	2015	NUM
ejop-10097	168	36	)	)	PUNCT
ejop-10097	168	37	.	.	PUNCT
ejop-10097	169	1	hepatitis	hepatitis	PROPN
ejop-10097	169	2	c	c	PROPN
ejop-10097	169	3	virusassociated	virusassociate	VERB
ejop-10097	169	4	neurocognitive	neurocognitive	ADJ
ejop-10097	169	5	and	and	CCONJ
ejop-10097	169	6	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	169	7	disorders	disorder	NOUN
ejop-10097	169	8	:	:	PUNCT
ejop-10097	169	9	advances	advance	NOUN
ejop-10097	169	10	in	in	ADP
ejop-10097	169	11	2015	2015	NUM
ejop-10097	169	12	.	.	PUNCT
ejop-10097	170	1	world	world	PROPN
ejop-10097	170	2	journal	journal	PROPN
ejop-10097	170	3	of	of	ADP
ejop-10097	170	4	gastroenterology	gastroenterology	NOUN
ejop-10097	170	5	,	,	PUNCT
ejop-10097	170	6	21(42	21(42	NOUN
ejop-10097	170	7	)	)	PUNCT
ejop-10097	170	8	,	,	PUNCT
ejop-10097	170	9	11974	11974	NUM
ejop-10097	170	10	–	–	PUNCT
ejop-10097	170	11	11983	11983	NUM
ejop-10097	170	12	.	.	PUNCT
ejop-10097	171	1	https://doi.org/10.3748/wjg.v21.i42.11974	https://doi.org/10.3748/wjg.v21.i42.11974	PROPN
ejop-10097	171	2	nalbandian	nalbandian	PROPN
ejop-10097	171	3	,	,	PUNCT
ejop-10097	171	4	a.	a.	PROPN
ejop-10097	171	5	,	,	PUNCT
ejop-10097	171	6	sehgal	sehgal	PROPN
ejop-10097	171	7	,	,	PUNCT
ejop-10097	171	8	k.	k.	PROPN
ejop-10097	171	9	,	,	PUNCT
ejop-10097	171	10	gupta	gupta	PROPN
ejop-10097	171	11	,	,	PUNCT
ejop-10097	171	12	a.	a.	PROPN
ejop-10097	171	13	,	,	PUNCT
ejop-10097	171	14	madhavan	madhavan	PROPN
ejop-10097	171	15	,	,	PUNCT
ejop-10097	171	16	m.	m.	NOUN
ejop-10097	171	17	v.	v.	PROPN
ejop-10097	171	18	,	,	PUNCT
ejop-10097	171	19	mcgroder	mcgroder	PROPN
ejop-10097	171	20	,	,	PUNCT
ejop-10097	171	21	c.	c.	PROPN
ejop-10097	171	22	,	,	PUNCT
ejop-10097	171	23	stevens	stevens	PROPN
ejop-10097	171	24	,	,	PUNCT
ejop-10097	171	25	j.	j.	PROPN
ejop-10097	171	26	s.	s.	PROPN
ejop-10097	171	27	,	,	PUNCT
ejop-10097	171	28	cook	cook	VERB
ejop-10097	171	29	,	,	PUNCT
ejop-10097	171	30	j.	j.	PROPN
ejop-10097	171	31	r.	r.	PROPN
ejop-10097	171	32	,	,	PUNCT
ejop-10097	171	33	nordvig	nordvig	PROPN
ejop-10097	171	34	,	,	PUNCT
ejop-10097	171	35	a.	a.	PROPN
ejop-10097	171	36	s.	s.	PROPN
ejop-10097	171	37	,	,	PUNCT
ejop-10097	171	38	shalev	shalev	NOUN
ejop-10097	171	39	,	,	PUNCT
ejop-10097	171	40	d.	d.	PROPN
ejop-10097	171	41	,	,	PUNCT
ejop-10097	171	42	sehrawat	sehrawat	ADV
ejop-10097	171	43	,	,	PUNCT
ejop-10097	171	44	t.	t.	PROPN
ejop-10097	171	45	s.	s.	PROPN
ejop-10097	171	46	,	,	PUNCT
ejop-10097	171	47	ahluwalia	ahluwalia	PROPN
ejop-10097	171	48	,	,	PUNCT
ejop-10097	171	49	n.	n.	NOUN
ejop-10097	171	50	,	,	PUNCT
ejop-10097	171	51	bikdeli	bikdeli	PROPN
ejop-10097	171	52	,	,	PUNCT
ejop-10097	171	53	b.	b.	PROPN
ejop-10097	171	54	,	,	PUNCT
ejop-10097	171	55	dietz	dietz	PROPN
ejop-10097	171	56	,	,	PUNCT
ejop-10097	171	57	d.	d.	PROPN
ejop-10097	171	58	,	,	PUNCT
ejop-10097	171	59	der	der	NOUN
ejop-10097	171	60	-	-	PUNCT
ejop-10097	171	61	nigoghossian	nigoghossian	ADJ
ejop-10097	171	62	,	,	PUNCT
ejop-10097	171	63	c.	c.	NOUN
ejop-10097	171	64	,	,	PUNCT
ejop-10097	171	65	liyanage	liyanage	NOUN
ejop-10097	171	66	-	-	PUNCT
ejop-10097	171	67	don	don	PROPN
ejop-10097	171	68	,	,	PUNCT
ejop-10097	171	69	n.	n.	NOUN
ejop-10097	171	70	,	,	PUNCT
ejop-10097	171	71	rosner	rosner	PROPN
ejop-10097	171	72	,	,	PUNCT
ejop-10097	171	73	g.	g.	PROPN
ejop-10097	171	74	f.	f.	PROPN
ejop-10097	171	75	,	,	PUNCT
ejop-10097	171	76	bernstein	bernstein	PROPN
ejop-10097	171	77	,	,	PUNCT
ejop-10097	171	78	e.	e.	PROPN
ejop-10097	171	79	j.	j.	PROPN
ejop-10097	171	80	,	,	PUNCT
ejop-10097	171	81	mohan	mohan	PROPN
ejop-10097	171	82	,	,	PUNCT
ejop-10097	171	83	s.	s.	PROPN
ejop-10097	171	84	,	,	PUNCT
ejop-10097	171	85	beckley	beckley	PROPN
ejop-10097	171	86	,	,	PUNCT
ejop-10097	171	87	a.	a.	NOUN
ejop-10097	171	88	a.	a.	PROPN
ejop-10097	171	89	,	,	PUNCT
ejop-10097	171	90	.	.	PUNCT
ejop-10097	171	91	.	.	PUNCT
ejop-10097	172	1	.wan	.wan	PROPN
ejop-10097	172	2	,	,	PUNCT
ejop-10097	172	3	e.	e.	PROPN
ejop-10097	172	4	y.	y.	PROPN
ejop-10097	172	5	(	(	PUNCT
ejop-10097	172	6	2021	2021	NUM
ejop-10097	172	7	)	)	PUNCT
ejop-10097	172	8	.	.	PUNCT
ejop-10097	173	1	post	post	ADJ
ejop-10097	173	2	-	-	ADJ
ejop-10097	173	3	acute	acute	ADJ
ejop-10097	173	4	covid-19	covid-19	PROPN
ejop-10097	173	5	syndrome	syndrome	NOUN
ejop-10097	173	6	.	.	PUNCT
ejop-10097	174	1	nature	nature	NOUN
ejop-10097	174	2	medicine	medicine	NOUN
ejop-10097	174	3	,	,	PUNCT
ejop-10097	174	4	27(4	27(4	PROPN
ejop-10097	174	5	)	)	PUNCT
ejop-10097	174	6	,	,	PUNCT
ejop-10097	174	7	601–615	601–615	NUM
ejop-10097	174	8	.	.	PUNCT
ejop-10097	175	1	https://doi.org/10.1038/s41591-021-01283-z	https://doi.org/10.1038/s41591-021-01283-z	PROPN
ejop-10097	175	2	national	national	PROPN
ejop-10097	175	3	institute	institute	PROPN
ejop-10097	175	4	for	for	ADP
ejop-10097	175	5	health	health	NOUN
ejop-10097	175	6	and	and	CCONJ
ejop-10097	175	7	care	care	PROPN
ejop-10097	175	8	excellence	excellence	PROPN
ejop-10097	175	9	.	.	PUNCT
ejop-10097	176	1	(	(	PUNCT
ejop-10097	176	2	2020	2020	NUM
ejop-10097	176	3	)	)	PUNCT
ejop-10097	176	4	.	.	PUNCT
ejop-10097	177	1	covid-19	covid-19	PROPN
ejop-10097	177	2	rapid	rapid	ADJ
ejop-10097	177	3	guideline	guideline	NOUN
ejop-10097	177	4	:	:	PUNCT
ejop-10097	177	5	managing	manage	VERB
ejop-10097	177	6	the	the	DET
ejop-10097	177	7	long	long	ADJ
ejop-10097	177	8	-	-	PUNCT
ejop-10097	177	9	term	term	NOUN
ejop-10097	177	10	effects	effect	NOUN
ejop-10097	177	11	of	of	ADP
ejop-10097	177	12	covid-19	covid-19	PROPN
ejop-10097	177	13	(	(	PUNCT
ejop-10097	177	14	national	national	PROPN
ejop-10097	177	15	institute	institute	PROPN
ejop-10097	177	16	for	for	ADP
ejop-10097	177	17	health	health	NOUN
ejop-10097	177	18	and	and	CCONJ
ejop-10097	177	19	care	care	PROPN
ejop-10097	177	20	excellence	excellence	PROPN
ejop-10097	177	21	:	:	PUNCT
ejop-10097	177	22	clinical	clinical	ADJ
ejop-10097	177	23	guidelines	guideline	NOUN
ejop-10097	177	24	)	)	PUNCT
ejop-10097	177	25	.	.	PUNCT
ejop-10097	178	1	national	national	PROPN
ejop-10097	178	2	institute	institute	PROPN
ejop-10097	178	3	for	for	ADP
ejop-10097	178	4	health	health	NOUN
ejop-10097	178	5	and	and	CCONJ
ejop-10097	178	6	care	care	PROPN
ejop-10097	178	7	excellence	excellence	PROPN
ejop-10097	178	8	(	(	PUNCT
ejop-10097	178	9	nice	nice	ADJ
ejop-10097	178	10	)	)	PUNCT
ejop-10097	178	11	rock	rock	NOUN
ejop-10097	178	12	,	,	PUNCT
ejop-10097	178	13	p.	p.	PROPN
ejop-10097	178	14	l.	l.	PROPN
ejop-10097	178	15	,	,	PUNCT
ejop-10097	178	16	roiser	roiser	NOUN
ejop-10097	178	17	,	,	PUNCT
ejop-10097	178	18	j.	j.	PROPN
ejop-10097	178	19	p.	p.	PROPN
ejop-10097	178	20	,	,	PUNCT
ejop-10097	178	21	riedel	riedel	PROPN
ejop-10097	178	22	,	,	PUNCT
ejop-10097	178	23	w.	w.	PROPN
ejop-10097	178	24	j.	j.	PROPN
ejop-10097	178	25	,	,	PUNCT
ejop-10097	178	26	&	&	CCONJ
ejop-10097	178	27	blackwell	blackwell	PROPN
ejop-10097	178	28	,	,	PUNCT
ejop-10097	178	29	a.	a.	PROPN
ejop-10097	178	30	d.	d.	PROPN
ejop-10097	178	31	(	(	PUNCT
ejop-10097	178	32	2014	2014	NUM
ejop-10097	178	33	)	)	PUNCT
ejop-10097	178	34	.	.	PUNCT
ejop-10097	179	1	cognitive	cognitive	ADJ
ejop-10097	179	2	impairment	impairment	NOUN
ejop-10097	179	3	in	in	ADP
ejop-10097	179	4	depression	depression	NOUN
ejop-10097	179	5	:	:	PUNCT
ejop-10097	179	6	a	a	DET
ejop-10097	179	7	systematic	systematic	ADJ
ejop-10097	179	8	review	review	NOUN
ejop-10097	179	9	and	and	CCONJ
ejop-10097	179	10	metaanalysis	metaanalysis	NOUN
ejop-10097	179	11	.	.	PUNCT
ejop-10097	180	1	psychological	psychological	ADJ
ejop-10097	180	2	medicine	medicine	NOUN
ejop-10097	180	3	,	,	PUNCT
ejop-10097	180	4	44(10	44(10	NOUN
ejop-10097	180	5	)	)	PUNCT
ejop-10097	180	6	,	,	PUNCT
ejop-10097	180	7	2029–2040	2029–2040	NUM
ejop-10097	180	8	.	.	PUNCT
ejop-10097	181	1	https://doi.org/10.1017/s0033291713002535	https://doi.org/10.1017/s0033291713002535	NUM
ejop-10097	181	2	rogers	roger	NOUN
ejop-10097	181	3	,	,	PUNCT
ejop-10097	181	4	j.	j.	PROPN
ejop-10097	181	5	p.	p.	PROPN
ejop-10097	181	6	,	,	PUNCT
ejop-10097	181	7	chesney	chesney	PROPN
ejop-10097	181	8	,	,	PUNCT
ejop-10097	181	9	e.	e.	PROPN
ejop-10097	181	10	,	,	PUNCT
ejop-10097	181	11	oliver	oliver	PROPN
ejop-10097	181	12	,	,	PUNCT
ejop-10097	181	13	d.	d.	PROPN
ejop-10097	181	14	,	,	PUNCT
ejop-10097	181	15	pollak	pollak	PROPN
ejop-10097	181	16	,	,	PUNCT
ejop-10097	181	17	t.	t.	PROPN
ejop-10097	181	18	a.	a.	PROPN
ejop-10097	181	19	,	,	PUNCT
ejop-10097	181	20	mcguire	mcguire	PROPN
ejop-10097	181	21	,	,	PUNCT
ejop-10097	181	22	p.	p.	PROPN
ejop-10097	181	23	,	,	PUNCT
ejop-10097	181	24	fusar	fusar	VERB
ejop-10097	181	25	-	-	PUNCT
ejop-10097	181	26	poli	poli	PROPN
ejop-10097	181	27	,	,	PUNCT
ejop-10097	181	28	p.	p.	PROPN
ejop-10097	181	29	,	,	PUNCT
ejop-10097	181	30	zandi	zandi	PROPN
ejop-10097	181	31	,	,	PUNCT
ejop-10097	181	32	m.	m.	NOUN
ejop-10097	181	33	s.	s.	PROPN
ejop-10097	181	34	,	,	PUNCT
ejop-10097	181	35	lewis	lewis	PROPN
ejop-10097	181	36	,	,	PUNCT
ejop-10097	181	37	g.	g.	PROPN
ejop-10097	181	38	,	,	PUNCT
ejop-10097	181	39	&	&	CCONJ
ejop-10097	181	40	david	david	PROPN
ejop-10097	181	41	,	,	PUNCT
ejop-10097	181	42	a.	a.	PROPN
ejop-10097	181	43	s.	s.	PROPN
ejop-10097	181	44	(	(	PUNCT
ejop-10097	181	45	2020	2020	NUM
ejop-10097	181	46	)	)	PUNCT
ejop-10097	181	47	.	.	PUNCT
ejop-10097	182	1	psychiatric	psychiatric	ADJ
ejop-10097	182	2	and	and	CCONJ
ejop-10097	182	3	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	182	4	presentations	presentation	NOUN
ejop-10097	182	5	associated	associate	VERB
ejop-10097	182	6	with	with	ADP
ejop-10097	182	7	severe	severe	ADJ
ejop-10097	182	8	coronavirus	coronavirus	NOUN
ejop-10097	182	9	infections	infection	NOUN
ejop-10097	182	10	:	:	PUNCT
ejop-10097	182	11	a	a	DET
ejop-10097	182	12	systematic	systematic	ADJ
ejop-10097	182	13	review	review	NOUN
ejop-10097	182	14	and	and	CCONJ
ejop-10097	182	15	meta	meta	NOUN
ejop-10097	182	16	-	-	PUNCT
ejop-10097	182	17	analysis	analysis	NOUN
ejop-10097	182	18	with	with	ADP
ejop-10097	182	19	comparison	comparison	NOUN
ejop-10097	182	20	to	to	ADP
ejop-10097	182	21	the	the	DET
ejop-10097	182	22	covid-19	covid-19	PROPN
ejop-10097	182	23	pandemic	pandemic	NOUN
ejop-10097	182	24	.	.	PUNCT
ejop-10097	183	1	lancet	lancet	PROPN
ejop-10097	183	2	.	.	PUNCT
ejop-10097	184	1	psychiatry	psychiatry	NOUN
ejop-10097	184	2	,	,	PUNCT
ejop-10097	184	3	7(7	7(7	NUM
ejop-10097	184	4	)	)	PUNCT
ejop-10097	184	5	,	,	PUNCT
ejop-10097	184	6	611–627	611–627	NUM
ejop-10097	184	7	.	.	PUNCT
ejop-10097	184	8	https://doi.org/10.1016/s2215-0366(20)30203-0	https://doi.org/10.1016/s2215-0366(20)30203-0	PROPN
ejop-10097	184	9	schild	schild	PROPN
ejop-10097	184	10	,	,	PUNCT
ejop-10097	184	11	a.-k	a.-k	PROPN
ejop-10097	184	12	.	.	PUNCT
ejop-10097	184	13	,	,	PUNCT
ejop-10097	184	14	goereci	goereci	PROPN
ejop-10097	184	15	,	,	PUNCT
ejop-10097	184	16	y.	y.	PROPN
ejop-10097	184	17	,	,	PUNCT
ejop-10097	184	18	scharfenberg	scharfenberg	PROPN
ejop-10097	184	19	,	,	PUNCT
ejop-10097	184	20	d.	d.	PROPN
ejop-10097	184	21	,	,	PUNCT
ejop-10097	184	22	klein	klein	PROPN
ejop-10097	184	23	,	,	PUNCT
ejop-10097	184	24	k.	k.	PROPN
ejop-10097	184	25	,	,	PUNCT
ejop-10097	184	26	lülling	lülle	VERB
ejop-10097	184	27	,	,	PUNCT
ejop-10097	184	28	j.	j.	PROPN
ejop-10097	184	29	,	,	PUNCT
ejop-10097	184	30	meiberth	meiberth	PROPN
ejop-10097	184	31	,	,	PUNCT
ejop-10097	184	32	d.	d.	PROPN
ejop-10097	184	33	,	,	PUNCT
ejop-10097	184	34	schweitzer	schweitzer	PROPN
ejop-10097	184	35	,	,	PUNCT
ejop-10097	184	36	f.	f.	PROPN
ejop-10097	184	37	,	,	PUNCT
ejop-10097	184	38	stürmer	stürmer	PROPN
ejop-10097	184	39	,	,	PUNCT
ejop-10097	184	40	s.	s.	PROPN
ejop-10097	184	41	,	,	PUNCT
ejop-10097	184	42	zeyen	zeyen	NOUN
ejop-10097	184	43	,	,	PUNCT
ejop-10097	184	44	p.	p.	PROPN
ejop-10097	184	45	,	,	PUNCT
ejop-10097	184	46	sahin	sahin	PROPN
ejop-10097	184	47	,	,	PUNCT
ejop-10097	184	48	d.	d.	PROPN
ejop-10097	184	49	,	,	PUNCT
ejop-10097	184	50	fink	fink	PROPN
ejop-10097	184	51	,	,	PUNCT
ejop-10097	184	52	g.	g.	PROPN
ejop-10097	184	53	f.	f.	PROPN
ejop-10097	184	54	,	,	PUNCT
ejop-10097	184	55	jessen	jessen	PROPN
ejop-10097	184	56	,	,	PUNCT
ejop-10097	184	57	f.	f.	PROPN
ejop-10097	184	58	,	,	PUNCT
ejop-10097	184	59	franke	franke	PROPN
ejop-10097	184	60	,	,	PUNCT
ejop-10097	184	61	c.	c.	PROPN
ejop-10097	184	62	,	,	PUNCT
ejop-10097	184	63	onur	onur	PROPN
ejop-10097	184	64	,	,	PUNCT
ejop-10097	184	65	o.	o.	NOUN
ejop-10097	184	66	a.	a.	PROPN
ejop-10097	184	67	,	,	PUNCT
ejop-10097	184	68	kessler	kessler	PROPN
ejop-10097	184	69	,	,	PUNCT
ejop-10097	184	70	j.	j.	PROPN
ejop-10097	184	71	,	,	PUNCT
ejop-10097	184	72	warnke	warnke	PROPN
ejop-10097	184	73	,	,	PUNCT
ejop-10097	184	74	c.	c.	PROPN
ejop-10097	184	75	,	,	PUNCT
ejop-10097	184	76	&	&	CCONJ
ejop-10097	184	77	maier	maier	PROPN
ejop-10097	184	78	,	,	PUNCT
ejop-10097	184	79	f.	f.	PROPN
ejop-10097	184	80	(	(	PUNCT
ejop-10097	184	81	2022	2022	NUM
ejop-10097	184	82	)	)	PUNCT
ejop-10097	184	83	.	.	PUNCT
ejop-10097	185	1	multidomain	multidomain	PROPN
ejop-10097	185	2	cognitive	cognitive	ADJ
ejop-10097	185	3	impairment	impairment	NOUN
ejop-10097	185	4	in	in	ADP
ejop-10097	185	5	nonhospitalized	nonhospitalize	VERB
ejop-10097	185	6	patients	patient	NOUN
ejop-10097	185	7	with	with	ADP
ejop-10097	185	8	the	the	DET
ejop-10097	185	9	post	post	ADJ
ejop-10097	185	10	-	-	ADJ
ejop-10097	185	11	covid-19	covid-19	ADJ
ejop-10097	185	12	syndrome	syndrome	NOUN
ejop-10097	185	13	:	:	PUNCT
ejop-10097	185	14	results	result	NOUN
ejop-10097	185	15	from	from	ADP
ejop-10097	185	16	a	a	DET
ejop-10097	185	17	prospective	prospective	ADJ
ejop-10097	185	18	monocentric	monocentric	ADJ
ejop-10097	185	19	cohort	cohort	NOUN
ejop-10097	185	20	.	.	PUNCT
ejop-10097	186	1	journal	journal	PROPN
ejop-10097	186	2	of	of	ADP
ejop-10097	186	3	neurology	neurology	NOUN
ejop-10097	186	4	.	.	PUNCT
ejop-10097	187	1	advance	advance	VERB
ejop-10097	187	2	online	online	ADJ
ejop-10097	187	3	publication	publication	NOUN
ejop-10097	187	4	.	.	PUNCT
ejop-10097	188	1	https://doi.org/10.1007/s00415-022-11444-w	https://doi.org/10.1007/s00415-022-11444-w	PROPN
ejop-10097	188	2	scharfenberg	scharfenberg	PROPN
ejop-10097	188	3	,	,	PUNCT
ejop-10097	188	4	schild	schild	PROPN
ejop-10097	188	5	,	,	PUNCT
ejop-10097	188	6	warnke	warnke	NOUN
ejop-10097	188	7	,	,	PUNCT
ejop-10097	188	8	&	&	CCONJ
ejop-10097	188	9	maier	maier	PROPN
ejop-10097	188	10	355	355	NUM
ejop-10097	188	11	europe	europe	PROPN
ejop-10097	188	12	's	's	PART
ejop-10097	188	13	journal	journal	NOUN
ejop-10097	188	14	of	of	ADP
ejop-10097	188	15	psychology	psychology	NOUN
ejop-10097	188	16	2022	2022	NUM
ejop-10097	188	17	,	,	PUNCT
ejop-10097	188	18	vol	vol	NOUN
ejop-10097	188	19	.	.	PUNCT
ejop-10097	188	20	18(4	18(4	NUM
ejop-10097	188	21	)	)	PUNCT
ejop-10097	188	22	,	,	PUNCT
ejop-10097	188	23	350–356	350–356	NUM
ejop-10097	188	24	https://doi.org/10.5964/ejop.10097	https://doi.org/10.5964/ejop.10097	NOUN
ejop-10097	188	25	https://doi.org/10.1126/science.ada0536	https://doi.org/10.1126/science.ada0536	NUM
ejop-10097	188	26	https://doi.org/10.1016/j.smrv.2020.101282	https://doi.org/10.1016/j.smrv.2020.101282	ADJ
ejop-10097	188	27	https://doi.org/10.1007/s00406-021-01286-4	https://doi.org/10.1007/s00406-021-01286-4	NUM
ejop-10097	188	28	https://doi.org/10.3389/fneur.2021.699582	https://doi.org/10.3389/fneur.2021.699582	PROPN
ejop-10097	188	29	https://doi.org/10.1016/j.smrv.2011.03.008	https://doi.org/10.1016/j.smrv.2011.03.008	NOUN
ejop-10097	188	30	https://doi.org/10.1016/j.jagp.2016.05.015	https://doi.org/10.1016/j.jagp.2016.05.015	NUM
ejop-10097	188	31	https://doi.org/10.3390/ijms20153723	https://doi.org/10.3390/ijms20153723	NOUN
ejop-10097	188	32	https://doi.org/10.1002/da.23136	https://doi.org/10.1002/da.23136	PUNCT
ejop-10097	188	33	https://doi.org/10.1016/j.jad.2021.07.043	https://doi.org/10.1016/j.jad.2021.07.043	NOUN
ejop-10097	188	34	https://doi.org/10.1159/000507078	https://doi.org/10.1159/000507078	NOUN
ejop-10097	188	35	https://doi.org/10.1038/s41590-021-01104-y	https://doi.org/10.1038/s41590-021-01104-y	PROPN
ejop-10097	188	36	https://doi.org/10.1111/jsr.12054	https://doi.org/10.1111/jsr.12054	PROPN
ejop-10097	188	37	https://doi.org/10.3748/wjg.v21.i42.11974	https://doi.org/10.3748/wjg.v21.i42.11974	PROPN
ejop-10097	188	38	https://doi.org/10.1038/s41591-021-01283-z	https://doi.org/10.1038/s41591-021-01283-z	PROPN
ejop-10097	188	39	https://doi.org/10.1017/s0033291713002535	https://doi.org/10.1017/s0033291713002535	NUM
ejop-10097	188	40	https://doi.org/10.1016/s2215-0366(20)30203-0	https://doi.org/10.1016/s2215-0366(20)30203-0	ADV
ejop-10097	188	41	https://doi.org/10.1007/s00415-022-11444-w	https://doi.org/10.1007/s00415-022-11444-w	PROPN
ejop-10097	188	42	https://www.psychopen.eu/	https://www.psychopen.eu/	PROPN
ejop-10097	188	43	schweitzer	schweitzer	NOUN
ejop-10097	188	44	,	,	PUNCT
ejop-10097	188	45	f.	f.	PROPN
ejop-10097	188	46	,	,	PUNCT
ejop-10097	188	47	goereci	goereci	PROPN
ejop-10097	188	48	,	,	PUNCT
ejop-10097	188	49	y.	y.	NOUN
ejop-10097	188	50	,	,	PUNCT
ejop-10097	188	51	franke	franke	PROPN
ejop-10097	188	52	,	,	PUNCT
ejop-10097	188	53	c.	c.	NOUN
ejop-10097	188	54	,	,	PUNCT
ejop-10097	188	55	silling	silling	NOUN
ejop-10097	188	56	,	,	PUNCT
ejop-10097	188	57	s.	s.	PROPN
ejop-10097	188	58	,	,	PUNCT
ejop-10097	188	59	bösl	bösl	PROPN
ejop-10097	188	60	,	,	PUNCT
ejop-10097	188	61	f.	f.	PROPN
ejop-10097	188	62	,	,	PUNCT
ejop-10097	188	63	maier	maier	PROPN
ejop-10097	188	64	,	,	PUNCT
ejop-10097	188	65	f.	f.	PROPN
ejop-10097	188	66	,	,	PUNCT
ejop-10097	188	67	heger	heger	PROPN
ejop-10097	188	68	,	,	PUNCT
ejop-10097	188	69	e.	e.	PROPN
ejop-10097	188	70	,	,	PUNCT
ejop-10097	188	71	deiman	deiman	PROPN
ejop-10097	188	72	,	,	PUNCT
ejop-10097	188	73	b.	b.	PROPN
ejop-10097	188	74	,	,	PUNCT
ejop-10097	188	75	prüss	prüss	NOUN
ejop-10097	188	76	,	,	PUNCT
ejop-10097	188	77	h.	h.	PROPN
ejop-10097	188	78	,	,	PUNCT
ejop-10097	188	79	onur	onur	PROPN
ejop-10097	188	80	,	,	PUNCT
ejop-10097	188	81	o.	o.	PROPN
ejop-10097	188	82	a.	a.	PROPN
ejop-10097	188	83	,	,	PUNCT
ejop-10097	188	84	klein	klein	PROPN
ejop-10097	188	85	,	,	PUNCT
ejop-10097	188	86	f.	f.	PROPN
ejop-10097	188	87	,	,	PUNCT
ejop-10097	188	88	fink	fink	PROPN
ejop-10097	188	89	,	,	PUNCT
ejop-10097	188	90	g.	g.	PROPN
ejop-10097	188	91	r.	r.	PROPN
ejop-10097	188	92	,	,	PUNCT
ejop-10097	188	93	di	di	PROPN
ejop-10097	188	94	cristanziano	cristanziano	PROPN
ejop-10097	188	95	,	,	PUNCT
ejop-10097	188	96	v.	v.	PROPN
ejop-10097	188	97	,	,	PUNCT
ejop-10097	188	98	&	&	CCONJ
ejop-10097	188	99	warnke	warnke	PROPN
ejop-10097	188	100	,	,	PUNCT
ejop-10097	188	101	c.	c.	NOUN
ejop-10097	188	102	(	(	PUNCT
ejop-10097	188	103	2022	2022	NUM
ejop-10097	188	104	)	)	PUNCT
ejop-10097	188	105	.	.	PUNCT
ejop-10097	189	1	cerebrospinal	cerebrospinal	ADJ
ejop-10097	189	2	fluid	fluid	ADJ
ejop-10097	189	3	analysis	analysis	NOUN
ejop-10097	189	4	post	post	ADJ
ejop-10097	189	5	-	-	ADJ
ejop-10097	189	6	covid-19	covid-19	PROPN
ejop-10097	189	7	is	be	AUX
ejop-10097	189	8	not	not	PART
ejop-10097	189	9	suggestive	suggestive	ADJ
ejop-10097	189	10	of	of	ADP
ejop-10097	189	11	persistent	persistent	ADJ
ejop-10097	189	12	central	central	ADJ
ejop-10097	189	13	nervous	nervous	ADJ
ejop-10097	189	14	system	system	NOUN
ejop-10097	189	15	infection	infection	NOUN
ejop-10097	189	16	.	.	PUNCT
ejop-10097	190	1	annals	annal	NOUN
ejop-10097	190	2	of	of	ADP
ejop-10097	190	3	neurology	neurology	NOUN
ejop-10097	190	4	,	,	PUNCT
ejop-10097	190	5	91(1	91(1	NUM
ejop-10097	190	6	)	)	PUNCT
ejop-10097	190	7	,	,	PUNCT
ejop-10097	190	8	150–157	150–157	NUM
ejop-10097	190	9	.	.	PUNCT
ejop-10097	191	1	https://doi.org/10.1002/ana.26262	https://doi.org/10.1002/ana.26262	PROPN
ejop-10097	191	2	taquet	taquet	NOUN
ejop-10097	191	3	,	,	PUNCT
ejop-10097	191	4	m.	m.	NOUN
ejop-10097	191	5	,	,	PUNCT
ejop-10097	191	6	dercon	dercon	NOUN
ejop-10097	191	7	,	,	PUNCT
ejop-10097	191	8	q.	q.	PROPN
ejop-10097	191	9	,	,	PUNCT
ejop-10097	191	10	luciano	luciano	PROPN
ejop-10097	191	11	,	,	PUNCT
ejop-10097	191	12	s.	s.	PROPN
ejop-10097	191	13	,	,	PUNCT
ejop-10097	191	14	geddes	geddes	PROPN
ejop-10097	191	15	,	,	PUNCT
ejop-10097	191	16	j.	j.	PROPN
ejop-10097	191	17	r.	r.	PROPN
ejop-10097	191	18	,	,	PUNCT
ejop-10097	191	19	husain	husain	PROPN
ejop-10097	191	20	,	,	PUNCT
ejop-10097	191	21	m.	m.	NOUN
ejop-10097	191	22	,	,	PUNCT
ejop-10097	191	23	&	&	CCONJ
ejop-10097	191	24	harrison	harrison	PROPN
ejop-10097	191	25	,	,	PUNCT
ejop-10097	191	26	p.	p.	PROPN
ejop-10097	191	27	j.	j.	PROPN
ejop-10097	191	28	(	(	PUNCT
ejop-10097	191	29	2021	2021	NUM
ejop-10097	191	30	)	)	PUNCT
ejop-10097	191	31	.	.	PUNCT
ejop-10097	192	1	incidence	incidence	NOUN
ejop-10097	192	2	,	,	PUNCT
ejop-10097	192	3	co	co	NOUN
ejop-10097	192	4	-	-	NOUN
ejop-10097	192	5	occurrence	occurrence	NOUN
ejop-10097	192	6	,	,	PUNCT
ejop-10097	192	7	and	and	CCONJ
ejop-10097	192	8	evolution	evolution	NOUN
ejop-10097	192	9	of	of	ADP
ejop-10097	192	10	longcovid	longcovid	PROPN
ejop-10097	192	11	features	feature	NOUN
ejop-10097	192	12	:	:	PUNCT
ejop-10097	192	13	a	a	DET
ejop-10097	192	14	6	6	NUM
ejop-10097	192	15	-	-	PUNCT
ejop-10097	192	16	month	month	NOUN
ejop-10097	192	17	retrospective	retrospective	ADJ
ejop-10097	192	18	cohort	cohort	NOUN
ejop-10097	192	19	study	study	NOUN
ejop-10097	192	20	of	of	ADP
ejop-10097	192	21	273,618	273,618	NUM
ejop-10097	192	22	survivors	survivor	NOUN
ejop-10097	192	23	of	of	ADP
ejop-10097	192	24	covid-19	covid-19	PROPN
ejop-10097	192	25	.	.	PUNCT
ejop-10097	193	1	plos	plos	PROPN
ejop-10097	193	2	medicine	medicine	PROPN
ejop-10097	193	3	,	,	PUNCT
ejop-10097	193	4	18(9	18(9	NOUN
ejop-10097	193	5	)	)	PUNCT
ejop-10097	193	6	,	,	PUNCT
ejop-10097	193	7	article	article	NOUN
ejop-10097	193	8	e1003773	e1003773	PROPN
ejop-10097	193	9	.	.	PUNCT
ejop-10097	194	1	https://doi.org/10.1371/journal.pmed.1003773	https://doi.org/10.1371/journal.pmed.1003773	PROPN
ejop-10097	194	2	troyer	troyer	PROPN
ejop-10097	194	3	,	,	PUNCT
ejop-10097	194	4	e.	e.	PROPN
ejop-10097	194	5	a.	a.	PROPN
ejop-10097	194	6	,	,	PUNCT
ejop-10097	194	7	kohn	kohn	PROPN
ejop-10097	194	8	,	,	PUNCT
ejop-10097	194	9	j.	j.	PROPN
ejop-10097	194	10	n.	n.	PROPN
ejop-10097	194	11	,	,	PUNCT
ejop-10097	194	12	&	&	CCONJ
ejop-10097	194	13	hong	hong	PROPN
ejop-10097	194	14	,	,	PUNCT
ejop-10097	194	15	s.	s.	PROPN
ejop-10097	194	16	(	(	PUNCT
ejop-10097	194	17	2020	2020	NUM
ejop-10097	194	18	)	)	PUNCT
ejop-10097	194	19	.	.	PUNCT
ejop-10097	195	1	are	be	AUX
ejop-10097	195	2	we	we	PRON
ejop-10097	195	3	facing	face	VERB
ejop-10097	195	4	a	a	DET
ejop-10097	195	5	crashing	crash	VERB
ejop-10097	195	6	wave	wave	NOUN
ejop-10097	195	7	of	of	ADP
ejop-10097	195	8	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	195	9	sequelae	sequelae	NOUN
ejop-10097	195	10	of	of	ADP
ejop-10097	195	11	covid-19	covid-19	PROPN
ejop-10097	195	12	?	?	PUNCT
ejop-10097	195	13	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	195	14	symptoms	symptom	NOUN
ejop-10097	195	15	and	and	CCONJ
ejop-10097	195	16	potential	potential	ADJ
ejop-10097	195	17	immunologic	immunologic	ADJ
ejop-10097	195	18	mechanisms	mechanism	NOUN
ejop-10097	195	19	.	.	PUNCT
ejop-10097	196	1	brain	brain	NOUN
ejop-10097	196	2	,	,	PUNCT
ejop-10097	196	3	behavior	behavior	NOUN
ejop-10097	196	4	,	,	PUNCT
ejop-10097	196	5	and	and	CCONJ
ejop-10097	196	6	immunity	immunity	NOUN
ejop-10097	196	7	,	,	PUNCT
ejop-10097	196	8	87	87	NUM
ejop-10097	196	9	,	,	PUNCT
ejop-10097	196	10	34–39	34–39	NUM
ejop-10097	196	11	.	.	PUNCT
ejop-10097	197	1	https://doi.org/10.1016/j.bbi.2020.04.027	https://doi.org/10.1016/j.bbi.2020.04.027	NOUN
ejop-10097	197	2	about	about	ADP
ejop-10097	197	3	the	the	DET
ejop-10097	197	4	authors	author	NOUN
ejop-10097	197	5	daniel	daniel	PROPN
ejop-10097	197	6	scharfenberg	scharfenberg	PROPN
ejop-10097	197	7	is	be	AUX
ejop-10097	197	8	a	a	DET
ejop-10097	197	9	psychologist	psychologist	NOUN
ejop-10097	197	10	and	and	CCONJ
ejop-10097	197	11	phd	phd	NOUN
ejop-10097	197	12	student	student	NOUN
ejop-10097	197	13	at	at	ADP
ejop-10097	197	14	the	the	DET
ejop-10097	197	15	department	department	PROPN
ejop-10097	197	16	of	of	ADP
ejop-10097	197	17	medical	medical	ADJ
ejop-10097	197	18	psychology	psychology	NOUN
ejop-10097	197	19	|	|	ADP
ejop-10097	197	20	neuropsychology	neuropsychology	PROPN
ejop-10097	197	21	&	&	CCONJ
ejop-10097	197	22	gender	gender	PROPN
ejop-10097	197	23	studies	study	NOUN
ejop-10097	197	24	,	,	PUNCT
ejop-10097	197	25	center	center	NOUN
ejop-10097	197	26	for	for	ADP
ejop-10097	197	27	neuropsychological	neuropsychological	ADJ
ejop-10097	197	28	diagnostic	diagnostic	ADJ
ejop-10097	197	29	and	and	CCONJ
ejop-10097	197	30	intervention	intervention	NOUN
ejop-10097	197	31	(	(	PUNCT
ejop-10097	197	32	cendi	cendi	PROPN
ejop-10097	197	33	)	)	PUNCT
ejop-10097	197	34	,	,	PUNCT
ejop-10097	197	35	at	at	ADP
ejop-10097	197	36	the	the	DET
ejop-10097	197	37	university	university	NOUN
ejop-10097	197	38	hospital	hospital	NOUN
ejop-10097	197	39	and	and	CCONJ
ejop-10097	197	40	medical	medical	ADJ
ejop-10097	197	41	faculty	faculty	NOUN
ejop-10097	197	42	of	of	ADP
ejop-10097	197	43	the	the	DET
ejop-10097	197	44	university	university	NOUN
ejop-10097	197	45	of	of	ADP
ejop-10097	197	46	cologne	cologne	NOUN
ejop-10097	197	47	.	.	PUNCT
ejop-10097	198	1	he	he	PRON
ejop-10097	198	2	is	be	AUX
ejop-10097	198	3	interested	interested	ADJ
ejop-10097	198	4	in	in	ADP
ejop-10097	198	5	neuropsychological	neuropsychological	ADJ
ejop-10097	198	6	assessments	assessment	NOUN
ejop-10097	198	7	,	,	PUNCT
ejop-10097	198	8	non	non	ADJ
ejop-10097	198	9	-	-	ADJ
ejop-10097	198	10	pharmacological	pharmacological	ADJ
ejop-10097	198	11	interventions	intervention	NOUN
ejop-10097	198	12	of	of	ADP
ejop-10097	198	13	neurocognitive	neurocognitive	ADJ
ejop-10097	198	14	disorders	disorder	NOUN
ejop-10097	198	15	and	and	CCONJ
ejop-10097	198	16	cognitive	cognitive	ADJ
ejop-10097	198	17	symptoms	symptom	NOUN
ejop-10097	198	18	in	in	ADP
ejop-10097	198	19	patients	patient	NOUN
ejop-10097	198	20	with	with	ADP
ejop-10097	198	21	the	the	DET
ejop-10097	198	22	post	post	ADJ
ejop-10097	198	23	-	-	ADJ
ejop-10097	198	24	covid	covid	ADJ
ejop-10097	198	25	syndrome	syndrome	NOUN
ejop-10097	198	26	.	.	PUNCT
ejop-10097	199	1	dr	dr	PROPN
ejop-10097	199	2	.	.	PROPN
ejop-10097	199	3	ann	ann	PROPN
ejop-10097	199	4	-	-	PUNCT
ejop-10097	199	5	katrin	katrin	PROPN
ejop-10097	199	6	schild	schild	PROPN
ejop-10097	199	7	is	be	AUX
ejop-10097	199	8	a	a	DET
ejop-10097	199	9	psychologist	psychologist	NOUN
ejop-10097	199	10	and	and	CCONJ
ejop-10097	199	11	head	head	NOUN
ejop-10097	199	12	of	of	ADP
ejop-10097	199	13	neuropsychology	neuropsychology	NOUN
ejop-10097	199	14	at	at	ADP
ejop-10097	199	15	the	the	DET
ejop-10097	199	16	center	center	NOUN
ejop-10097	199	17	for	for	ADP
ejop-10097	199	18	memory	memory	NOUN
ejop-10097	199	19	disorders	disorder	NOUN
ejop-10097	199	20	at	at	ADP
ejop-10097	199	21	the	the	DET
ejop-10097	199	22	department	department	NOUN
ejop-10097	199	23	of	of	ADP
ejop-10097	199	24	psychiatry	psychiatry	NOUN
ejop-10097	199	25	of	of	ADP
ejop-10097	199	26	the	the	DET
ejop-10097	199	27	university	university	NOUN
ejop-10097	199	28	hospital	hospital	NOUN
ejop-10097	199	29	of	of	ADP
ejop-10097	199	30	cologne	cologne	NOUN
ejop-10097	199	31	.	.	PUNCT
ejop-10097	200	1	her	her	PRON
ejop-10097	200	2	research	research	NOUN
ejop-10097	200	3	addresses	address	NOUN
ejop-10097	200	4	cognition	cognition	NOUN
ejop-10097	200	5	in	in	ADP
ejop-10097	200	6	aging	age	VERB
ejop-10097	200	7	,	,	PUNCT
ejop-10097	200	8	mild	mild	ADJ
ejop-10097	200	9	cognitive	cognitive	ADJ
ejop-10097	200	10	impairment	impairment	NOUN
ejop-10097	200	11	and	and	CCONJ
ejop-10097	200	12	dementia	dementia	NOUN
ejop-10097	200	13	.	.	PUNCT
ejop-10097	201	1	dr	dr	PROPN
ejop-10097	201	2	.	.	PROPN
ejop-10097	201	3	clemens	clemens	PROPN
ejop-10097	201	4	warnke	warnke	PROPN
ejop-10097	201	5	is	be	AUX
ejop-10097	201	6	a	a	DET
ejop-10097	201	7	consultant	consultant	NOUN
ejop-10097	201	8	in	in	ADP
ejop-10097	201	9	neurology	neurology	NOUN
ejop-10097	201	10	and	and	CCONJ
ejop-10097	201	11	head	head	NOUN
ejop-10097	201	12	of	of	ADP
ejop-10097	201	13	the	the	DET
ejop-10097	201	14	office	office	NOUN
ejop-10097	201	15	for	for	ADP
ejop-10097	201	16	clinical	clinical	ADJ
ejop-10097	201	17	studies	study	NOUN
ejop-10097	201	18	at	at	ADP
ejop-10097	201	19	the	the	DET
ejop-10097	201	20	department	department	PROPN
ejop-10097	201	21	of	of	ADP
ejop-10097	201	22	neurology	neurology	NOUN
ejop-10097	201	23	of	of	ADP
ejop-10097	201	24	the	the	DET
ejop-10097	201	25	university	university	NOUN
ejop-10097	201	26	hospital	hospital	NOUN
ejop-10097	201	27	of	of	ADP
ejop-10097	201	28	cologne	cologne	NOUN
ejop-10097	201	29	.	.	PUNCT
ejop-10097	202	1	his	his	PRON
ejop-10097	202	2	research	research	NOUN
ejop-10097	202	3	focuses	focus	VERB
ejop-10097	202	4	on	on	ADP
ejop-10097	202	5	clinical	clinical	ADJ
ejop-10097	202	6	neuroimmunology	neuroimmunology	NOUN
ejop-10097	202	7	,	,	PUNCT
ejop-10097	202	8	including	include	VERB
ejop-10097	202	9	multiple	multiple	ADJ
ejop-10097	202	10	sclerosis	sclerosis	NOUN
ejop-10097	202	11	and	and	CCONJ
ejop-10097	202	12	related	related	ADJ
ejop-10097	202	13	diseases	disease	NOUN
ejop-10097	202	14	,	,	PUNCT
ejop-10097	202	15	as	as	ADV
ejop-10097	202	16	well	well	ADV
ejop-10097	202	17	as	as	ADP
ejop-10097	202	18	neurological	neurological	ADJ
ejop-10097	202	19	aspects	aspect	NOUN
ejop-10097	202	20	of	of	ADP
ejop-10097	202	21	covid-19	covid-19	PROPN
ejop-10097	202	22	.	.	PUNCT
ejop-10097	203	1	dr	dr	PROPN
ejop-10097	203	2	.	.	PROPN
ejop-10097	203	3	franziska	franziska	PROPN
ejop-10097	203	4	maier	maier	PROPN
ejop-10097	203	5	is	be	AUX
ejop-10097	203	6	a	a	DET
ejop-10097	203	7	psychologist	psychologist	NOUN
ejop-10097	203	8	,	,	PUNCT
ejop-10097	203	9	psychiatrist	psychiatrist	NOUN
ejop-10097	203	10	and	and	CCONJ
ejop-10097	203	11	post	post	ADJ
ejop-10097	203	12	-	-	ADJ
ejop-10097	203	13	doctoral	doctoral	ADJ
ejop-10097	203	14	researcher	researcher	NOUN
ejop-10097	203	15	at	at	ADP
ejop-10097	203	16	the	the	DET
ejop-10097	203	17	department	department	PROPN
ejop-10097	203	18	of	of	ADP
ejop-10097	203	19	psychiatry	psychiatry	NOUN
ejop-10097	203	20	of	of	ADP
ejop-10097	203	21	the	the	DET
ejop-10097	203	22	university	university	NOUN
ejop-10097	203	23	hospital	hospital	NOUN
ejop-10097	203	24	of	of	ADP
ejop-10097	203	25	cologne	cologne	NOUN
ejop-10097	203	26	.	.	PUNCT
ejop-10097	204	1	her	her	PRON
ejop-10097	204	2	research	research	NOUN
ejop-10097	204	3	focuses	focus	VERB
ejop-10097	204	4	on	on	ADP
ejop-10097	204	5	neuropsychiatric	neuropsychiatric	ADJ
ejop-10097	204	6	symptoms	symptom	NOUN
ejop-10097	204	7	and	and	CCONJ
ejop-10097	204	8	neuroimaging	neuroimaging	NOUN
ejop-10097	204	9	of	of	ADP
ejop-10097	204	10	neurodegenerative	neurodegenerative	ADJ
ejop-10097	204	11	diseases	disease	NOUN
ejop-10097	204	12	.	.	PUNCT
ejop-10097	205	1	a	a	DET
ejop-10097	205	2	network	network	NOUN
ejop-10097	205	3	perspective	perspective	NOUN
ejop-10097	205	4	on	on	ADP
ejop-10097	205	5	the	the	DET
ejop-10097	205	6	post	post	ADJ
ejop-10097	205	7	-	-	ADJ
ejop-10097	205	8	covid	covid	ADJ
ejop-10097	205	9	syndrome	syndrome	NOUN
ejop-10097	205	10	356	356	NUM
ejop-10097	205	11	psychopen	psychopen	ADJ
ejop-10097	205	12	gold	gold	NOUN
ejop-10097	205	13	is	be	AUX
ejop-10097	205	14	a	a	DET
ejop-10097	205	15	publishing	publishing	NOUN
ejop-10097	205	16	service	service	NOUN
ejop-10097	205	17	by	by	ADP
ejop-10097	205	18	leibniz	leibniz	PROPN
ejop-10097	205	19	institute	institute	PROPN
ejop-10097	205	20	for	for	ADP
ejop-10097	205	21	psychology	psychology	NOUN
ejop-10097	205	22	(	(	PUNCT
ejop-10097	205	23	zpid	zpid	NOUN
ejop-10097	205	24	)	)	PUNCT
ejop-10097	205	25	,	,	PUNCT
ejop-10097	205	26	germany	germany	PROPN
ejop-10097	205	27	.	.	PUNCT
ejop-10097	206	1	www.leibniz-psychology.org	www.leibniz-psychology.org	PROPN
ejop-10097	206	2	https://doi.org/10.1002/ana.26262	https://doi.org/10.1002/ana.26262	PROPN
ejop-10097	206	3	https://doi.org/10.1371/journal.pmed.1003773	https://doi.org/10.1371/journal.pmed.1003773	PROPN
ejop-10097	206	4	https://doi.org/10.1016/j.bbi.2020.04.027	https://doi.org/10.1016/j.bbi.2020.04.027	PROPN
ejop-10097	206	5	https://www.leibniz-psychology.org/	https://www.leibniz-psychology.org/	PRON
ejop-10097	206	6	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
ejop-10097	206	7	a	a	DET
ejop-10097	206	8	network	network	NOUN
ejop-10097	206	9	perspective	perspective	NOUN
ejop-10097	206	10	on	on	ADP
ejop-10097	206	11	the	the	DET
ejop-10097	206	12	post	post	ADJ
ejop-10097	206	13	-	-	ADJ
ejop-10097	206	14	covid	covid	ADJ
ejop-10097	206	15	syndrome	syndrome	NOUN
ejop-10097	206	16	(	(	PUNCT
ejop-10097	206	17	introduction	introduction	NOUN
ejop-10097	206	18	)	)	PUNCT
ejop-10097	206	19	hypothesis	hypothesis	NOUN
ejop-10097	206	20	discussion	discussion	NOUN
ejop-10097	206	21	conclusion	conclusion	NOUN
ejop-10097	206	22	(	(	PUNCT
ejop-10097	206	23	additional	additional	ADJ
ejop-10097	206	24	information	information	NOUN
ejop-10097	206	25	)	)	PUNCT
ejop-10097	206	26	funding	funding	NOUN
ejop-10097	206	27	acknowledgments	acknowledgment	NOUN
ejop-10097	206	28	competing	compete	VERB
ejop-10097	206	29	interests	interest	NOUN
ejop-10097	206	30	references	reference	NOUN
ejop-10097	206	31	about	about	ADP
ejop-10097	206	32	the	the	DET
ejop-10097	206	33	authors	author	NOUN